<SEC-DOCUMENT>0001193125-25-181862.txt : 20250815
<SEC-HEADER>0001193125-25-181862.hdr.sgml : 20250815
<ACCEPTANCE-DATETIME>20250815161049
ACCESSION NUMBER:		0001193125-25-181862
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		19
CONFORMED PERIOD OF REPORT:	20250811
ITEM INFORMATION:		Other Events
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20250815
DATE AS OF CHANGE:		20250815

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			CVS HEALTH Corp
		CENTRAL INDEX KEY:			0000064803
		STANDARD INDUSTRIAL CLASSIFICATION:	RETAIL-DRUG STORES AND PROPRIETARY STORES [5912]
		ORGANIZATION NAME:           	07 Trade & Services
		EIN:				050494040
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-01011
		FILM NUMBER:		251224712

	BUSINESS ADDRESS:	
		STREET 1:		ONE CVS DR.
		CITY:			WOONSOCKET
		STATE:			RI
		ZIP:			02895
		BUSINESS PHONE:		4017651500

	MAIL ADDRESS:	
		STREET 1:		ONE CVS DR.
		CITY:			WOONSOCKET
		STATE:			RI
		ZIP:			02895

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	CVS CAREMARK CORP
		DATE OF NAME CHANGE:	20070509

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	CVS/CAREMARK CORP
		DATE OF NAME CHANGE:	20070322

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	CVS CORP
		DATE OF NAME CHANGE:	19970128
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>d32562d8k.htm
<DESCRIPTION>8-K
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<html xmlns:dei="http://xbrl.sec.gov/dei/2025" xmlns:us-types="http://fasb.org/us-types/2025" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:cvs="http://www.cvshealth.com/20250811" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns="http://www.w3.org/1999/xhtml">
<head>
<title>8-K</title>
<meta http-equiv="Content-Type" content="text/html"/>
</head>
   <body><div style="display:none"> <ix:header> <ix:hidden> <ix:nonNumeric id="Hidden_dei_EntityRegistrantName" name="dei:EntityRegistrantName" contextRef="duration_2025-08-11_to_2025-08-11">CVS HEALTH Corp</ix:nonNumeric> <ix:nonNumeric name="dei:AmendmentFlag" contextRef="duration_2025-08-11_to_2025-08-11" id="ixv-347">false</ix:nonNumeric> <ix:nonNumeric id="Hidden_dei_EntityCentralIndexKey" name="dei:EntityCentralIndexKey" contextRef="duration_2025-08-11_to_2025-08-11">0000064803</ix:nonNumeric> </ix:hidden> <ix:references> <link:schemaRef xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xlink:type="simple" xlink:href="cvs-20250811.xsd" xlink:arcrole="http://www.xbrl.org/2003/linkbase"/> </ix:references> <ix:resources> <xbrli:context id="duration_2025-08-11_to_2025-08-11"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier> </xbrli:entity> <xbrli:period> <xbrli:startDate>2025-08-11</xbrli:startDate> <xbrli:endDate>2025-08-11</xbrli:endDate> </xbrli:period> </xbrli:context> </ix:resources> </ix:header> </div> <div style="text-align:center"> <div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto"> <div style="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&#160;</div> <div style="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&#160;</div> <p style="margin-top:8pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman;font-weight:bold;text-align:center">UNITED STATES</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman;font-weight:bold;text-align:center">SECURITIES AND EXCHANGE COMMISSION</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">Washington, D.C. 20549</p> <p style="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <div style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</div></div> <p style="margin-top:8pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman;font-weight:bold;text-align:center">FORM <span style="white-space:nowrap"><ix:nonNumeric name="dei:DocumentType" contextRef="duration_2025-08-11_to_2025-08-11" id="ixv-358">8-K</ix:nonNumeric></span></p> <p style="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <div style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</div></div> <p style="margin-top:8pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">CURRENT REPORT</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">Pursuant to Section&#160;13 OR 15(d)</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">of The Securities Exchange Act of 1934</p> <p style="margin-top:10pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">Date of Report (Date of earliest event reported): <ix:nonNumeric name="dei:DocumentPeriodEndDate" contextRef="duration_2025-08-11_to_2025-08-11" format="ixt:datemonthdayyearen" id="ixv-359">August&#160;11, 2025</ix:nonNumeric></p> <p style="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <div style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</div></div> <p style="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <p style="margin-top:0pt;margin-bottom:0pt;text-align:center">
<img src="g32562g0814233928094.jpg" alt="LOGO"/></p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:24pt; font-family:Times New Roman;font-weight:bold;text-align:center"> <span style=" -sec-ix-hidden:Hidden_dei_EntityRegistrantName">CVS HEALTH CORPORATION</span> </p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">(Exact name of registrant as specified in its charter)</p> <p style="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <div style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</div></div> <p style="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="border-collapse:collapse; font-family:Times New Roman; font-size:8pt;width:100%;border-spacing:0;margin:0 auto">
<tr>
<td style="width:34%"/>
<td style="vertical-align:bottom"/>
<td style="width:32%"/>
<td style="vertical-align:bottom;width:1%"/>
<td style="width:32%"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;text-align:center"><span style="font-weight:bold"><ix:nonNumeric name="dei:EntityIncorporationStateCountryCode" contextRef="duration_2025-08-11_to_2025-08-11" format="ixt-sec:stateprovnameen" id="ixv-360">Delaware</ix:nonNumeric></span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top;text-align:center"><span style="font-weight:bold"><span style="white-space:nowrap"><ix:nonNumeric name="dei:EntityFileNumber" contextRef="duration_2025-08-11_to_2025-08-11" id="ixv-361">001-01011</ix:nonNumeric></span></span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top;text-align:center"><span style="font-weight:bold"><span style="white-space:nowrap"><ix:nonNumeric name="dei:EntityTaxIdentificationNumber" contextRef="duration_2025-08-11_to_2025-08-11" id="ixv-362">05-0494040</ix:nonNumeric></span></span></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:top;text-align:center"><span style="font-weight:bold">(State or other jurisdiction<br/>of incorporation)</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top;text-align:center"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">(Commission</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">File Number)</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top;text-align:center"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">(IRS Employer</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Identification No.)</p></td></tr></table> <p style="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;width:100%;border-spacing:0;margin:0 auto">
<tr>
<td style="width:50%"/>
<td style="vertical-align:bottom;width:1%"/>
<td style="width:48%"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:bottom;text-align:center"><span style="font-weight:bold"><ix:nonNumeric name="dei:EntityAddressAddressLine1" contextRef="duration_2025-08-11_to_2025-08-11" id="ixv-363">One CVS Drive</ix:nonNumeric>, <ix:nonNumeric name="dei:EntityAddressCityOrTown" contextRef="duration_2025-08-11_to_2025-08-11" id="ixv-364">Woonsocket</ix:nonNumeric>, <ix:nonNumeric name="dei:EntityAddressStateOrProvince" contextRef="duration_2025-08-11_to_2025-08-11" format="ixt-sec:stateprovnameen" id="ixv-365">Rhode Island</ix:nonNumeric></span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap;text-align:center"><span style="font-weight:bold"><ix:nonNumeric name="dei:EntityAddressPostalZipCode" contextRef="duration_2025-08-11_to_2025-08-11" id="ixv-366">02895</ix:nonNumeric></span></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:top;text-align:center"><span style="font-weight:bold">(Address of principal executive offices)</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top;text-align:center"><span style="font-weight:bold">(Zip Code)</span></td></tr></table> <p style="margin-top:10pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">Registrant&#8217;s telephone number, including area code: <ix:nonNumeric name="dei:CityAreaCode" contextRef="duration_2025-08-11_to_2025-08-11" id="ixv-367">(401)</ix:nonNumeric> <span style="white-space:nowrap"><ix:nonNumeric name="dei:LocalPhoneNumber" contextRef="duration_2025-08-11_to_2025-08-11" id="ixv-368">765-1500</ix:nonNumeric></span></p> <p style="margin-top:10pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">Former name or former address, if changed since last report: N/A</p> <p style="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <div style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</div></div> <p style="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Check the appropriate box below if the Form <span style="white-space:nowrap">8-K</span> filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:</p> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top;text-align:left"><ix:nonNumeric name="dei:WrittenCommunications" contextRef="duration_2025-08-11_to_2025-08-11" format="ixt-sec:boolballotbox" id="ixv-369">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top;text-align:left"><ix:nonNumeric name="dei:SolicitingMaterial" contextRef="duration_2025-08-11_to_2025-08-11" format="ixt-sec:boolballotbox" id="ixv-370">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Soliciting material pursuant to Rule <span style="white-space:nowrap">14a-12</span> under the Exchange Act (17 CFR <span style="white-space:nowrap">240.14a-12)</span></p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top;text-align:left"><ix:nonNumeric name="dei:PreCommencementTenderOffer" contextRef="duration_2025-08-11_to_2025-08-11" format="ixt-sec:boolballotbox" id="ixv-371">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><span style="white-space:nowrap">Pre-commencement</span> communications pursuant to Rule <span style="white-space:nowrap">14d-2(b)</span> under the Exchange Act (17 CFR <span style="white-space:nowrap">240.14d-2(b))</span></p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top;text-align:left"><ix:nonNumeric name="dei:PreCommencementIssuerTenderOffer" contextRef="duration_2025-08-11_to_2025-08-11" format="ixt-sec:boolballotbox" id="ixv-372">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><span style="white-space:nowrap">Pre-commencement</span> communications pursuant to Rule <span style="white-space:nowrap">13e-4(c)</span> under the Exchange Act (17 CFR <span style="white-space:nowrap">240.13e-4(c))</span></p></td></tr></table> <p style="margin-top:10pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Securities registered pursuant to Section&#160;12(b) of the Act:</p> <p style="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="border-collapse:collapse; font-family:Times New Roman; font-size:8pt;width:100%;border-spacing:0;margin:0 auto">
<tr>
<td style="width:34%"/>
<td style="vertical-align:bottom"/>
<td style="width:32%"/>
<td style="vertical-align:bottom;width:1%"/>
<td style="width:32%"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="border-bottom:1.00pt solid #000000;vertical-align:bottom;white-space:nowrap;text-align:center"> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Title of each class</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center"> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Trading<br/>Symbol(s)</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center"> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Name of each exchange<br/>on which registered</p></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;text-align:center"><ix:nonNumeric name="dei:Security12bTitle" contextRef="duration_2025-08-11_to_2025-08-11" id="ixv-373">Common Stock, par value $0.01 per share</ix:nonNumeric></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top;text-align:center"><ix:nonNumeric name="dei:TradingSymbol" contextRef="duration_2025-08-11_to_2025-08-11" id="ixv-374">CVS</ix:nonNumeric></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top;text-align:center"><ix:nonNumeric name="dei:SecurityExchangeName" contextRef="duration_2025-08-11_to_2025-08-11" format="ixt-sec:exchnameen" id="ixv-375">New York Stock Exchange</ix:nonNumeric></td></tr></table> <p style="margin-top:10pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;230.405 of this chapter) or Rule <span style="white-space:nowrap">12b-2</span> of the Securities Exchange Act of 1934 <span style="white-space:nowrap">(&#167;240.12b-2</span> of this chapter).</p> <p style="margin-top:10pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Emerging growth company&#8194;<ix:nonNumeric name="dei:EntityEmergingGrowthCompany" contextRef="duration_2025-08-11_to_2025-08-11" format="ixt-sec:boolballotbox" id="ixv-376">&#9744;</ix:nonNumeric></p> <p style="margin-top:10pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section&#160;13(a) of the Exchange Act.&#8194;&#9744;</p> <p style="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&#160;</div> <div style="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&#160;</div></div></div>

<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%;clear:both"/>

<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><span style="font-weight:bold">Section&#160;8 </span>&#8211;<span style="font-weight:bold"> Other Events </span></p> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:11%;vertical-align:top;text-align:left"><span style="font-weight:bold">Item&#8201;8.01</span></td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:left">Other Events. </p></td></tr></table> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">On August&#160;11, 2025, CVS Health Corporation, a Delaware corporation (the &#8220;Company&#8221;), entered into an Underwriting Agreement (the &#8220;Underwriting Agreement&#8221;) with Barclays Capital Inc., J.P. Morgan Securities LLC and Wells Fargo Securities, LLC as representatives of the several underwriters named in Schedule I thereto (collectively, the &#8220;Underwriters&#8221;), pursuant to which the Company agreed to issue and sell to the Underwriters $750,000,000 aggregate principal amount of its 5.000% Senior Notes due 2032 (the &#8220;2032 Notes&#8221;), $1,500,000,000 aggregate principal amount of its 5.450% Senior Notes due 2035 (the &#8220;2035 Notes&#8221;), $1,250,000,000 aggregate principal amount of its 6.200% Senior Notes due 2055 (the &#8220;2055 Notes&#8221;) and $500,000,000 aggregate principal amount of its 6.250% Senior Notes due 2065 (the &#8220;2065 Notes&#8221; and, together with the 2032 Notes, the 2035 Notes and the 2055 Notes, the &#8220;Notes&#8221;). The Notes were offered pursuant to the Company&#8217;s Registration Statement on Form <span style="white-space:nowrap">S-3ASR,</span> File <span style="white-space:nowrap">No.&#160;333-272200,</span> dated May&#160;25, 2023 (the &#8220;Registration Statement&#8221;) and were issued on August&#160;15, 2025. The net proceeds to the Company from the sale of the Notes, after deducting the Underwriters&#8217; discounts and the estimated offering expenses payable by the Company, are approximately $3,958,207,500. A copy of the Underwriting Agreement is filed as Exhibit 1.1 to this Current Report on Form <span style="white-space:nowrap">8-K</span> and is incorporated herein by reference and incorporated by reference into the Registration Statement. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Notes are governed by and issued pursuant to a Senior Indenture dated August&#160;15, 2006 between the Company and The Bank of New York Mellon Trust Company, N.A., as trustee (the &#8220;Senior Indenture&#8221;). The Company may issue additional senior debt securities from time to time pursuant to the Senior Indenture. The form of Senior Indenture was filed as Exhibit 4.1 to the Company&#8217;s Current Report on Form <span style="white-space:nowrap">8-K</span> filed on August&#160;15, 2006 and shall be incorporated by reference into this Current Report on Form <span style="white-space:nowrap">8-K.</span> The forms of the Notes are filed as Exhibits 4.1, 4.2, 4.3 and 4.4 to this Current Report on Form <span style="white-space:nowrap">8-K</span> and are incorporated by reference into the Registration Statement. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><span style="font-weight:bold">Section</span><span style="font-weight:bold"></span><span style="font-weight:bold">&#160;9</span>&#160;&#8211;<span style="font-weight:bold">&#160;Financial Statements and Exhibits</span> </p> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:11%;vertical-align:top;text-align:left"><span style="font-weight:bold">Item&#8201;9.01</span></td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:left">Financial Statements and Exhibits. </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top;text-align:left">(d)<span style="text-decoration:underline"></span></td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><span style="text-decoration:underline">Exhibits</span>. </p></td></tr></table> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The exhibits to this Current Report on Form <span style="white-space:nowrap">8-K</span> are as follows: </p> <p style="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">INDEX TO EXHIBITS </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:100%;border-spacing:0;margin:0 auto">


<tr>

<td/>

<td style="vertical-align:bottom;width:4%"/>
<td style="width:93%"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom;white-space:nowrap;text-align:center"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:inline-block; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Exhibit</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman;font-weight:bold">Description</p></td></tr>


<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">1.1</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="d32562dex11.htm">Underwriting Agreement dated August&#160;11, 2025, among CVS Health Corporation and Barclays Capital Inc., J.P. Morgan Securities LLC and Wells Fargo Securities, LLC as representatives of the several Underwriters named in Schedule I thereto. </a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">4.1</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="d32562dex41.htm">Form of the 2032 Note. </a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">4.2</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="d32562dex42.htm">Form of the 2035 Note. </a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">4.3</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="d32562dex43.htm">Form of the 2055 Note. </a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">4.4</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="d32562dex44.htm">Form of the 2065 Note. </a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">5.1</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="d32562dex51.htm">Opinion of Wachtell, Lipton, Rosen&#160;&amp; Katz. </a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">23.1</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="d32562dex51.htm">Consent of Wachtell, Lipton, Rosen&#160;&amp; Katz (included in Exhibit&#160;5.1). </a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">104</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top">Cover Page Interactive Data File (the cover page XBRL tags are embedded within the Inline XBRL document).</td></tr>
</table> <p style="font-size:18pt; margin-top:0pt; margin-bottom:0pt">&#160;</p>
</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%;clear:both"/>

<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">SIGNATURES </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:100%;border-spacing:0">


<tr>

<td style="width:45%"/>

<td style="vertical-align:bottom;width:1%"/>
<td style="width:4%"/>

<td style="vertical-align:bottom"/>
<td style="width:3%"/>

<td style="vertical-align:bottom;width:1%"/>
<td style="width:45%"/></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:0pt">&#160;</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:0pt">&#160;</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><span style="font-weight:bold">CVS HEALTH CORPORATION</span></td></tr>
<tr style="font-size:1pt">
<td style="height:12pt"/>
<td style="height:12pt" colspan="2"/>
<td style="height:12pt" colspan="2"/>
<td style="height:12pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:bottom">Date: August 15, 2025</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top">By:</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic">/s/ Brian Newman</span></p></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:0pt">&#160;</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:0pt">&#160;</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">Brian Newman</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:0pt">&#160;</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:0pt">&#160;</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">Executive Vice President and Chief Financial Officer</td></tr>
</table>
</div></div>

</body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-1.1
<SEQUENCE>2
<FILENAME>d32562dex11.htm
<DESCRIPTION>EX-1.1
<TEXT>
<HTML><HEAD>
<TITLE>EX-1.1</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE" STYLE="line-height:Normal">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 1.1 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>CVS HEALTH CORPORATION </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>$750,000,000 5.000% Senior Notes due 2032 </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>$1,500,000,000 5.450% Senior Notes due 2035 </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>$1,250,000,000 6.200% Senior Notes due 2055 </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>$500,000,000 6.250% Senior Notes due 2065 </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>Underwriting Agreement </U></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">August&nbsp;11, 2025 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Barclays Capital Inc. </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">J.P. Morgan Securities LLC </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Wells Fargo Securities, LLC </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">As Representatives of the several Underwriters </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">named in <U>Schedule I</U> hereto </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">c/o Barclays
Capital Inc. </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">745 Seventh Avenue </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">New York, New York 10019
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">c/o J.P. Morgan Securities LLC </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">383 Madison Avenue </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">New York, New York 10179 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">c/o Wells Fargo Securities, LLC </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">550 South Tryon Street, 5th Floor </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Charlotte, NC 28202 </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Ladies and Gentlemen: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">CVS Health Corporation, a
Delaware corporation (the &#8220;<B>Company</B>&#8221;), proposes to issue and sell $750,000,000 aggregate principal amount of its 5.000% Senior Notes due 2032 (the &#8220;<B>20</B><B>32</B><B> Notes</B>&#8221;), $1,500,000,000 aggregate principal
amount of its 5.450% Senior Notes due 2035 (the &#8220;<B>20</B><B>35</B><B> Notes</B>&#8221;), $1,250,000,000 aggregate principal amount of its 6.200% Senior Notes due 2055 (the &#8220;<B>20</B><B>55</B><B> Notes</B>&#8221;) and $500,000,000
aggregate principal amount of its 6.250% Senior Notes due 2065 (the &#8220;<B>20</B><B>65</B><B> Notes</B>&#8221; and together with the 2032 Notes, the 2035 Notes and the 2055 Notes, the<B> </B>&#8220;<B>Notes</B>&#8221;) to the several underwriters
named on <U>Schedule I</U> hereto (the &#8220;<B>Underwriters</B>&#8221;), for which Barclays Capital Inc., J.P. Morgan Securities LLC and Wells Fargo Securities, LLC are acting as representatives (the &#8220;<B>Representatives</B>&#8221;). The
Notes will (a)&nbsp;have terms and provisions which are summarized in the Disclosure Package as of the Applicable Time and the Prospectus dated as of the date hereof (each as defined in Section&nbsp;1(a) hereof) and (b)&nbsp;be issued pursuant to an
Indenture dated as of August&nbsp;15, 2006 (the &#8220;<B>Indenture</B>&#8221;) between the Company (formerly known as &#8220;CVS Corporation&#8221;) and The Bank of New York Mellon Trust Company, N.A. (formerly known as The Bank of New York Trust
Company, N.A.), as trustee (the &#8220;<B>Trustee</B>&#8221;). This agreement (this &#8220;<B>Agreement</B>&#8221;) is to confirm the agreement concerning the purchase of the Notes from the Company by the Underwriters. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">1. <I>Representations, Warranties and Agreements of the Company</I>. The Company represents and warrants to, and agrees with, each Underwriter
that: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) An &#8220;automatic shelf registration statement&#8221; (as defined in Rule 405 under the Securities Act of
1933, as amended (the &#8220;<B>Securities Act</B>&#8221;)) on Form <FONT STYLE="white-space:nowrap">S-3</FONT> in respect of the Notes (File <FONT STYLE="white-space:nowrap">No.&nbsp;333-272200)</FONT> (i) has been prepared by the Company in
conformity with the requirements of the Securities Act and the rules and regulations (the &#8220;<B>Rules and Regulations</B>&#8221;) of the Securities and Exchange Commission (the &#8220;<B>Commission</B>&#8221;)
</P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">
thereunder, (ii)&nbsp;has been filed with the Commission under the Securities Act not earlier than the date that is three years prior to the Closing Date and (iii)&nbsp;upon its filing with the
Commission, automatically became and is effective under the Securities Act. Copies of such registration statement and any amendment thereto (excluding exhibits to such registration statement but including all documents incorporated by reference in
each prospectus contained therein) have been delivered by the Company to the Representatives; and no other document with respect to such registration statement or any such document incorporated by reference therein has heretofore been filed or
transmitted for filing with the Commission. For purposes of this Agreement, the following terms have the specified meanings: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<B>Applicable Time</B>&#8221; means 4:15 p.m. (New York City time) on the date of this Agreement; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<B>Base Prospectus</B>&#8221; means the base prospectus filed as part of the Registration Statement, in the form in
which it has most recently been amended on or prior to the date hereof, relating to the Notes; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>&#8220;</B><B>Disclosure
Package</B>&#8221; means, as of the Applicable Time, the most recent Preliminary Prospectus, together with each Issuer Free Writing Prospectus filed or used by the Company on or before the Applicable Time and identified on <U>Schedule II</U> hereto,
other than a road show that is an Issuer Free Writing Prospectus under Rule 433 of the Rules and Regulations; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<B>Effective Date</B>&#8221; means any date as of which any part of the Registration Statement or any post-effective
amendment thereto relating to the Notes became, or is deemed to have become, effective under the Securities Act in accordance with the Rules and Regulations (including pursuant to Rule 430B of the Rules and Regulations); </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<B>Final Term Sheet</B>&#8221; means the term sheet prepared pursuant to Section&nbsp;4(a) of this Agreement and
substantially in the form attached in <U>Schedule III</U> hereto; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<B>Issuer Free Writing Prospectus</B>&#8221;
means each &#8220;free writing prospectus&#8221; (as defined in Rule 405 of the Rules and Regulations) prepared by or on behalf of the Company or used or referred to by the Company in connection with the offering of the Notes, including the Final
Term Sheet and any other Issuer Free Writing Prospectus identified on <U>Schedule II</U> hereto; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<B>Preliminary
Prospectus</B>&#8221; means any preliminary prospectus relating to the Notes, including the Base Prospectus and any preliminary prospectus supplement thereto, included in the Registration Statement or as filed with the Commission pursuant to Rule
424(b) of the Rules and Regulations and provided to the Representatives for use by the Underwriters; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<B>Prospectus</B>&#8221; means the final prospectus relating to the Notes, including the Base Prospectus and the final
prospectus supplement thereto relating to the Notes, as filed with the Commission pursuant to Rule 424(b) of the Rules and Regulations and provided to the Representatives for use by the Underwriters; and </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<B>Registration Statement</B>&#8221; means, collectively, the various parts of the above-referenced registration
statement, each as amended as of the Effective Date for such part, including any Preliminary Prospectus and the Prospectus, all exhibits to such registration statement and all documents incorporated by reference therein. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Any reference to &#8220;<B>the most recent Preliminary Prospectus</B>&#8221; will be deemed to refer to the latest Preliminary Prospectus
included in the Registration Statement or filed pursuant to Rule 424(b) of the Rules and Regulations prior to or on the date hereof (including, for purposes of this Agreement, any documents incorporated by reference therein prior to or on the date
of this Agreement). Any reference to any Preliminary Prospectus or the Prospectus will be deemed to refer to and include any documents incorporated by reference therein pursuant to Form <FONT STYLE="white-space:nowrap">S-3</FONT> under the
Securities Act as of the date of such Preliminary Prospectus or the Prospectus, as the case may be. Any reference to any amendment or supplement to any Preliminary Prospectus or the Prospectus will be deemed to refer to and include any document
filed under the Securities Exchange Act of 1934, as amended (the &#8220;<B>Exchange Act</B>&#8221;), after the date of such Preliminary Prospectus or the Prospectus, as the case may be, and incorporated by reference in such Preliminary Prospectus or
the Prospectus, as the case may be; and any reference to any amendment to the Registration Statement will be deemed to include any annual report of the Company on Form 10-K filed with the Commission pursuant to Section&nbsp;13(a) or 15(d) of the
Exchange Act after the Effective Date that is incorporated by reference in the Registration Statement. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">2 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) The Commission has not issued any order preventing or suspending the
effectiveness of the Registration Statement or preventing or suspending the use of any Preliminary Prospectus, any Issuer Free Writing Prospectus or the Prospectus; and no proceeding for any such purpose or pursuant to Section&nbsp;8A of the
Securities Act against the Company or related to the offering has been instituted or, to the Company&#8217;s knowledge, threatened by the Commission. The Commission has not issued any order directed to any document incorporated by reference in the
most recent Preliminary Prospectus or the Prospectus, and no proceeding has been instituted or, to the Company&#8217;s knowledge, threatened by the Commission with respect to any document incorporated by reference in the most recent Preliminary
Prospectus or the Prospectus. The Commission has not notified the Company of any objection to the use of the form of the Registration Statement. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) The Company has been, and continues to be, a &#8220;well-known seasoned issuer&#8221; (as defined in Rule 405 of the Rules
and Regulations) and has not been, and continues not to be, an &#8220;ineligible issuer&#8221; (as defined in Rule 405 of the Rules and Regulations), in each case at all times relevant under the Securities Act in connection with the offering of the
Notes. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) The Registration Statement conformed on the Effective Date and conforms, and any amendment to the Registration
Statement filed after the date hereof will conform, in all material respects, to the requirements of the Securities Act and the Rules and Regulations. The most recent Preliminary Prospectus conforms on the date hereof, and the Prospectus, and any
amendment or supplement thereto, will conform as of its date and as of the Closing Date, in all material respects, to the requirements of the Securities Act and the Rules and Regulations. The documents of the Company incorporated by reference in the
most recent Preliminary Prospectus or the Prospectus conformed, and any further documents so incorporated will conform, when filed with the Commission, in all material respects to the requirements of the Exchange Act or the Securities Act, as
applicable, and the Rules and Regulations; and no such documents have been filed with the Commission since the close of business of the Commission on the Business Day immediately prior to the date hereof (other than those documents disclosed to the
Representatives prior to the time of filing). </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e) The Registration Statement does not, as of the date hereof, contain any
untrue statement of a material fact or omit to state any material fact required to be stated therein or necessary to make the statements therein not misleading; <I>provided, however,</I> that no representation or warranty is made as to information
contained in or omitted from the Registration Statement in reliance upon and in conformity with written information furnished to the Company through the Representatives by or on behalf of any Underwriter specifically for inclusion therein (which
information is specified in Section&nbsp;12 hereof) or relating to that part of the Registration Statement that constitutes the Statement of Eligibility and Qualifications on Form <FONT STYLE="white-space:nowrap">T-1</FONT> of the Trustee under the
Trust Indenture Act of 1939. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(f) The Disclosure Package did not, as of the Applicable Time, contain any untrue statement
of a material fact or omit to state any material fact required to be stated therein or necessary to make the statements therein, in the light of the circumstances under which they were made, not misleading; <I>provided, however,</I> that no
representation or warranty is made as to information contained in or omitted from the Disclosure Package in reliance upon and in conformity with written information furnished to the Company through the Representatives by or on behalf of any
Underwriter specifically for inclusion therein (which information is specified in Section&nbsp;12 hereof). </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(g) The
Prospectus, and any amendment or supplement thereto, will not, as of its date and on the Closing Date, contain any untrue statement of a material fact or omit to state any material fact required to be stated therein or necessary to make the
statements therein, in the light of the circumstances under which they were made, not misleading; <I>provided, however,</I> that no representation or warranty is made as to information contained in or omitted from the Prospectus in reliance upon and
in conformity with written information furnished to the Company through the Representatives by or on behalf of any Underwriter specifically for inclusion therein (which information is specified in Section&nbsp;12 hereof). </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(h) The documents of the Company incorporated by reference in the most recent Preliminary Prospectus or the Prospectus did not,
and any further documents incorporated by reference therein will not, when filed with the Commission, contain any untrue statement of a material fact or omit to state any material fact required to be stated therein or necessary to make the
statements therein, in the light of the circumstances under which they were made, not misleading. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">3 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(i) The Company has been duly incorporated and is an existing corporation in
good standing under the laws of the State of Delaware, with corporate power and authority to own its properties and conduct its business as described in the most recent Preliminary Prospectus and the Prospectus; and the Company is duly qualified to
do business as a foreign corporation in good standing in all other jurisdictions in which its ownership or lease of property or the conduct of its business requires such qualification, except where the failure to be so qualified or be in good
standing would not, individually or in the aggregate, have a material adverse effect on the financial condition, business, properties, results of operations or affairs of the Company and its subsidiaries taken as a whole (a &#8220;<B>Material
Adverse Effect</B>&#8221;). </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(j) Each subsidiary of the Company that is material to the Company and its subsidiaries taken
as a whole (collectively, the &#8220;<B>Significant Subsidiaries</B>&#8221;) is listed on <U>Exhibit A</U> hereto, together with its jurisdiction of organization and the beneficial ownership of the Company therein. Each Significant Subsidiary has
been duly organized and is an existing corporation or limited liability company in good standing under the laws of the jurisdiction of its organization, with corporate or limited liability company power and authority, as the case may be, to own its
properties and conduct its business as described in the most recent Preliminary Prospectus and the Prospectus; and each Significant Subsidiary of the Company is duly qualified to do business as a foreign entity in good standing in all other
jurisdictions in which its ownership or lease of property or the conduct of its business requires such qualification, except where the failure to be so qualified or be in good standing would not have a Material Adverse Effect; all of the issued and
outstanding capital stock or membership interests of each Significant Subsidiary of the Company have been duly authorized and validly issued and are fully paid and nonassessable; and the capital stock or membership interests of each Significant
Subsidiary owned by the Company, directly or through subsidiaries, are owned, except to the extent set forth in <U>Exhibit A</U> hereto, free and clear of any mortgage, pledge, lien, security interest, claim, encumbrance or defect of any kind. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(k) This Agreement has been duly authorized, executed and delivered by the Company. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(l) The Indenture has been duly authorized and executed by the Company and, assuming due authorization, execution and delivery
by the Trustee, constitutes a valid and legally binding obligation of the Company, enforceable against the Company in accordance with its terms, except to the extent that enforceability may be limited by bankruptcy, insolvency, reorganization,
moratorium or other similar laws relating to creditors&#8217; rights and remedies generally and by general principles of equity and concepts of reasonableness (regardless of whether enforcement is sought in a proceeding at law or in equity); and the
Indenture conforms in all material respects to the description thereof contained in the most recent Preliminary Prospectus and the Prospectus. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(m) The Notes have been duly authorized by the Company, and when executed, authenticated and delivered and paid for as provided
in this Agreement and the Indenture, the Notes will have been duly executed, authenticated, issued and delivered and will constitute valid and legally binding obligations of the Company entitled to the benefits of the Indenture and enforceable
against the Company in accordance with their terms, except to the extent that enforceability may be limited by bankruptcy, insolvency, reorganization, moratorium or other similar laws relating to creditors&#8217; rights and remedies generally and by
general principles of equity and concepts of reasonableness (regardless of whether enforcement is sought in a proceeding at law or in equity); and the Notes conform in all material respects to the description thereof contained in the Disclosure
Package and the Prospectus. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(n) The execution, delivery and performance of the Indenture and this Agreement and the
issuance and sale of the Notes will not require the consent, approval, authorization or order of, or filing with, any governmental agency or body or any court (except such as have been obtained or made and such as may be required under state
securities laws). </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(o) The execution, delivery and performance of the Indenture and this Agreement and the issuance and
sale of the Notes and compliance with the terms and provisions thereof will not conflict with or result in a breach or violation of any of the terms and provisions of, and do not and will not constitute a default (or an event that, but for the
giving of notice or the lapse of time or both, would constitute an event of default) under, or result in the creation or imposition of any lien, charge or encumbrance upon any material assets or properties of the Company or any of its subsidiaries
under (i)&nbsp;the charter, <FONT STYLE="white-space:nowrap">by-laws</FONT> or other organizational documents of the Company or any Significant Subsidiary, (ii)&nbsp;any statute, rule, regulation, order or decree of any governmental or regulatory
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">4 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">
agency or body or any court, domestic or foreign, having jurisdiction over the Company or any subsidiary or any of their properties, assets or operations or (iii)&nbsp;any indenture, mortgage,
loan or credit agreement, note, lease, permit, license or other agreement or instrument to which the Company or any subsidiary is a party or by which the Company or any subsidiary is bound or to which any of the properties, assets or operations of
the Company or any subsidiary is subject, except, in the case of clauses (ii)&nbsp;and (iii), for such breaches or violations which would not, individually or in the aggregate, have a Material Adverse Effect. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(p) The Company and its subsidiaries have good and marketable title to all real properties owned by them, in each case free and
clear of any mortgage, pledge, lien, security interest, claim or other encumbrance or defect; the Company and its subsidiaries hold any leased real property under valid, subsisting and enforceable leases or subleases with no exceptions that would
materially interfere with the use made or to be made thereof by them; neither the Company nor any of its subsidiaries is in material default under any such lease or sublease; and no material claim of any sort has been asserted by anyone adverse to
the rights of the Company or any subsidiary under any such lease or sublease or affecting or questioning the right of such entity to the continued possession of the leased or subleased properties under any such lease or sublease, except in each case
as would not, individually or in the aggregate, have a Material Adverse Effect. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(q) Except as described in the most recent
Preliminary Prospectus and the Prospectus, the Company and its subsidiaries possess adequate certificates, authorizations, licenses or permits issued by appropriate governmental agencies or bodies necessary to conduct the business now operated by
them, except as would not, individually or in the aggregate, have a Material Adverse Effect, and have not received any notice of proceedings relating to the revocation or modification of any such certificate, authorization, license or permit that,
individually or in the aggregate, could have a Material Adverse Effect. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(r) The Company and each of its subsidiaries have
filed all tax returns required to be filed, which returns are complete and correct in all material respects, and neither the Company nor any of its subsidiaries is in default in the payment of any taxes which were payable pursuant to said returns or
any assessments with respect thereto, in each case except as would not, individually or in the aggregate, have a Material Adverse Effect. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(s) Neither the filing of the Registration Statement, the most recent Preliminary Prospectus or the Prospectus nor the offer or
sale of the Notes as contemplated by this Agreement gives rise to any rights, other than those which have been duly waived or satisfied, for or relating to the registration of any securities of the Company. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(t) Except as described in the most recent Preliminary Prospectus and the Prospectus, (i)&nbsp;neither the Company nor any of
its Significant Subsidiaries is in violation of its charter or <FONT STYLE="white-space:nowrap">by-laws</FONT> or other organizational documents, (ii)&nbsp;neither the Company nor any of its subsidiaries is in violation of any applicable law,
ordinance, administrative or governmental rule or regulation, or any order, decree or judgment of any court or governmental agency or body having jurisdiction over the Company or any of its subsidiaries and (iii)&nbsp;no event of default or event
that, but for the giving of notice or the lapse of time or both, would constitute an event of default, exists, or as a result of the consummation of the sale of the Notes will exist, under any indenture, mortgage, loan agreement, note, lease,
permit, license or other agreement or instrument to which the Company or any of its subsidiaries is a party or to which any of the properties, assets or operations of the Company or any such subsidiary is subject, except, in the case of clauses
(ii)&nbsp;and (iii), for such violations and defaults that would not, individually or in the aggregate, have a Material Adverse Effect. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(u) Except as described in the most recent Preliminary Prospectus and the Prospectus, there are no pending actions, suits or
proceedings against or, to the knowledge of the Company, affecting the Company, any of its subsidiaries or any of their respective properties, assets or operations that would have, individually or in the aggregate, a Material Adverse Effect, or
could materially and adversely affect the ability of the Company to perform its obligations under this Agreement, the Indenture or any other document governing the sale of the Notes; and no such actions, suits or proceedings are, to the knowledge of
the Company, threatened. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(v) The financial statements of the Company and its consolidated subsidiaries, together with the
related schedules, if any, and notes included or incorporated by reference in the most recent Preliminary Prospectus and the Prospectus, present fairly, in all material respects, the respective financial position of the Company and its consolidated
subsidiaries as of the dates shown and their results of operations and cash flows for the periods shown, and have been prepared in conformity with generally accepted accounting principles in the </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">5 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">
United States applied on a consistent basis, except as disclosed therein. The other financial and statistical information set forth in the most recent Preliminary Prospectus and the Prospectus
present fairly, in all material respects, the information shown therein and have been, except as disclosed therein, compiled on a basis consistent with that of the financial statements included or incorporated by reference in the most recent
Preliminary Prospectus and the Prospectus. The interactive data in eXtensible Business Reporting Language incorporated by reference in the most recent Preliminary Prospectus and the Prospectus has been prepared in accordance with the
Commission&#8217;s rules and guidelines applicable thereto (as of the dates such interactive data were filed) in all material respects. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(w) Since the date of the latest audited financial statements of the Company included or incorporated by reference in the most
recent Preliminary Prospectus and the Prospectus, there has been no material adverse change, nor any development or event expected to result in a prospective material adverse change, in the financial condition, business, properties or results of
operations of the Company and its subsidiaries taken as a whole, other than those set forth in or contemplated by the most recent Preliminary Prospectus and the Prospectus. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(x) There is no contract or document required to be described in the Registration Statement, the most recent Preliminary
Prospectus or the Prospectus or to be filed as an exhibit to the Registration Statement or to a document incorporated by reference into the Registration Statement, the most recent Preliminary Prospectus or the Prospectus which is not described or
filed as required. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(y) The Company is not and, after giving effect to the offering and sale of the Notes and the
application of the proceeds thereof as described in the most recent Preliminary Prospectus and the Prospectus, will not be required to register as, an &#8220;investment company&#8221; as defined in the Investment Company Act of 1940, as amended.
</P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(z) The Company and its Significant Subsidiaries maintain a system of internal accounting controls over financial
reporting. The Company&#8217;s internal control over financial reporting include those policies and procedures that pertain to the Company&#8217;s ability to record, process, summarize and report a system of internal accounting controls and
procedures to provide reasonable assurance, at an appropriate cost/benefit relationship, that the unauthorized acquisition, use or disposition of assets are prevented or timely detected and that transactions are authorized, recorded and reported
properly to permit the preparation of financial statements in accordance with generally accepted accounting principles in the United States and receipts and expenditures are duly authorized. The Company&#8217;s internal control over financial
reporting were effective and provided such reasonable assurance for the preparation of financial statements as of December&nbsp;31, 2024, and there has been no change in the Company&#8217;s internal control over financial reporting subsequent to
December&nbsp;31, 2024 that has materially affected, or is reasonably likely to materially affect, the Company&#8217;s internal control over financial reporting. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(aa) The Company has made the evaluations of the Company&#8217;s disclosure controls and procedures required under Rule <FONT
STYLE="white-space:nowrap">13a-15(b)</FONT> under the Exchange Act and management&#8217;s conclusions regarding the effectiveness of such disclosure controls and procedures were included in the Company&#8217;s annual report on Form <FONT
STYLE="white-space:nowrap">10-K</FONT> for the fiscal year ended December&nbsp;31, 2024. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(bb) Neither the Company nor any
of its subsidiaries nor, to the Company&#8217;s knowledge, any director, officer, agent, employee or affiliate of the Company or any of its subsidiaries is aware of or has taken any action (with respect to any agent or affiliate, while acting on
behalf of the Company or any of its subsidiaries), directly or indirectly, that would result in a violation by such persons of the FCPA, including, without limitation, making use of the mails or any means or instrumentality of interstate commerce
corruptly in furtherance of an offer, payment, promise to pay or authorization of the payment of any money, or other property, gift, promise to give, or authorization of the giving of anything of value to any &#8220;foreign official&#8221; (as such
term is defined in the FCPA) or any foreign political party or official thereof or any candidate for foreign political office, in contravention of the FCPA, and the Company, its subsidiaries and, to the Company&#8217;s knowledge, its affiliates,
have conducted their businesses in compliance in all material respects with the FCPA and have instituted and maintain policies and procedures designed to ensure, and which are reasonably expected to continue to ensure, continued compliance
therewith. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">6 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#8220;<B>FCPA</B>&#8221; means Foreign Corrupt Practices Act of 1977, as amended, and the
rules&nbsp;and regulations thereunder. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(cc) The operations of the Company and its subsidiaries are and have been conducted
at all times in compliance in all material respects with applicable financial recordkeeping and reporting requirements of the Currency and Foreign Transactions Reporting Act of 1970, as amended, the money laundering statutes of all applicable
jurisdictions, the rules&nbsp;and regulations thereunder and any related or similar rules, regulations or guidelines issued, administered or enforced by any governmental agency (collectively, the &#8220;<B>Money Laundering Laws</B>&#8221;) and no
action, suit or proceeding by or before any court or governmental agency, authority or body or any arbitrator involving the Company or any of its subsidiaries with respect to the Money Laundering Laws is pending or, to the Company&#8217;s knowledge,
threatened. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(dd) Neither the Company nor any of its subsidiaries nor, to the Company&#8217;s knowledge, any director,
officer, agent, employee or affiliate of the Company or any of its subsidiaries is currently subject to any U.S. sanctions administered by the Office of Foreign Assets Control of the U.S. Treasury Department (&#8220;<B>OFAC</B>&#8221;); and the
Company will not directly or indirectly use the net proceeds from the sale of the Notes, or lend, contribute or otherwise make available such proceeds, to any subsidiary, joint venture partner or other person or entity, for the purpose of financing
the activities of any person, that at the time of such financing, is subject to any U.S. sanctions administered by OFAC. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(ee) Except as would not, individually or in the aggregate, have a Material Adverse Effect: (i)&nbsp;the Company and its
subsidiaries&#8217; information technology assets and equipment, computers, systems, networks, hardware, software, websites and applications (collectively, &#8220;<B>IT Systems</B>&#8221;) are, to the Company&#8217;s knowledge, free and clear of all
bugs, errors, defects, Trojan horses, time bombs, malware and other corruptants; (ii)&nbsp;the Company and its subsidiaries have implemented and maintain commercially reasonable controls, policies, procedures, and safeguards (including
administrative, technical, an physical safeguards) to maintain and protect their material confidential information and the integrity, continuous operation, redundancy and security of all IT Systems and data (including all personal, personally
identifiable, sensitive, confidential or regulated data (&#8220;<B>Personal Data</B>&#8221;)) used in connection with their businesses; and (iii)&nbsp;there have been no breaches, violations, outages or unauthorized uses of, acquisitions of,
disclosures of or accesses to same, except for those that have been remedied without material cost or liability or the duty to notify any other person, nor are there any incidents currently under internal review or pending investigations relating to
the same. The Company and its subsidiaries are presently in material compliance with all applicable laws, statutes and judgments, orders, rules and regulations of any court or arbitrator or governmental or regulatory authority relating to the
privacy and security of IT Systems and Personal Data. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">For purposes of this Section&nbsp;1, as well as for Section&nbsp;6 hereof,
references to &#8220;<B>the most recent Preliminary Prospectus and the Prospectus</B>&#8221; or &#8220;<B>the Disclosure Package and the Prospectus</B>&#8221; are to each of the most recent Preliminary Prospectus or the Disclosure Package, as the
case may be, and the Prospectus as separate or stand-alone documentation (and not the most recent Preliminary Prospectus or the Disclosure Package, as the case may be, and the Prospectus taken together), so that representations, warranties,
agreements, conditions and legal opinions will be made, given or measured independently in respect of each of the most recent Preliminary Prospectus or the Disclosure Package, as the case may be, and the Prospectus. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">2. <I>Purchase of the Notes by the Underwriters</I>. Subject to the terms and conditions and upon the basis of the representations and
warranties herein set forth, the Company agrees to issue and sell to the Underwriters, and each of the Underwriters agrees, severally and not jointly, to purchase from the Company, at a price equal to (i)&nbsp;in the case of the 2032 Notes, 99.294%
of the principal amount of the 2032 Notes, (ii)&nbsp;in the case of the 2035 Notes, 99.520% of the principal amount of the 2035 Notes, (iii)&nbsp;in the case of the 2055 Notes, 99.021% of the principal amount of the 2055 Notes and (iv)&nbsp;in the
case of the 2065 Notes, 98.722% of the principal amount of the 2065 Notes plus, in each case, accrued interest, if any, from August&nbsp;15, 2025 to, but excluding, the Closing Date with respect to each of the applicable series of Notes, the
respective principal amount of the Notes set forth opposite such Underwriter&#8217;s name in <U>Schedule I</U> hereto. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">3. <I>Delivery of
and Payment for the Notes</I>. Delivery of the Notes will be made at the offices of Simpson Thacher&nbsp;&amp; Bartlett LLP, 425 Lexington Avenue, New York, NY 10017, or at such place or places as mutually may be agreed upon by the Company and the
Underwriters, at 9:00 A.M., New York City time, on August&nbsp;15, 2025 or on such later date not more than seven Business Days after such date as may be determined by the Representatives and the Company (the &#8220;<B>Closing Date</B>&#8221;). </P>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">7 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Delivery of the Notes will be made to the Representatives by or on behalf of the Company
against payment of the purchase price therefor by wire transfer of immediately available funds. Delivery of the Notes will be made through the facilities of The Depository Trust Company unless the Representatives will otherwise instruct. Delivery of
the Notes at the time and place specified in this Agreement is a further condition to the obligations of each Underwriter. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">4.
<I>Covenants of the Company</I>. The Company covenants and agrees with each Underwriter that: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) The Company
(i)&nbsp;will prepare the Prospectus in a form approved by the Representatives and file the Prospectus pursuant to Rule 424(b) of the Rules and Regulations within the time period prescribed by such Rule; (ii)&nbsp;will not file any amendment or
supplement to the Registration Statement or the Prospectus or file any document under the Exchange Act (except for filings of annual reports on Form 10-K and quarterly reports on Form 10-Q under the Exchange Act) before the termination of the
offering of the Notes by the Underwriters if such document would be deemed to be incorporated by reference into the Prospectus, which filing is not consented to by the Representatives after reasonable notice thereof (such consent not to be
unreasonably withheld or delayed); (iii) will advise the Representatives, promptly after it receives notice thereof, of the time when any amendment or supplement to the Registration Statement, the most recent Preliminary Prospectus or the Prospectus
has been filed and will furnish the Representatives with copies thereof; (iv)&nbsp;will prepare the Final Term Sheet, substantially in the form of <U>Schedule III</U> hereto and approved by the Representatives and file the Final Term Sheet pursuant
to Rule 433(d) of the Rules and Regulations within the time period prescribed by such Rule; (v)&nbsp;will advise the Representatives promptly after it receives notice thereof, of the issuance by the Commission or any state or other regulatory body
of any stop order or any order suspending the effectiveness of the Registration Statement, suspending or preventing the use of any Preliminary Prospectus, the Prospectus or any Issuer Free Writing Prospectus or suspending the qualification of the
Notes for offering or sale in any jurisdiction, of the initiation or threatening of any proceedings for any such purpose or pursuant to Section&nbsp;8A of the Securities Act, of receipt by the Company from the Commission of any notice of objection
to the use of the Registration Statement or any post-effective amendment thereto or of any request by the Commission for the amending or supplementing of the Registration Statement, the Prospectus or any Issuer Free Writing Prospectus or for
additional information; and (vi)&nbsp;will use its reasonable best efforts to prevent the issuance of any stop order or other such order or any such notice of objection and, if a stop order or other such order is issued or any such notice of
objection is received, to obtain as soon as possible the lifting or withdrawal thereof. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) The Company will furnish to
each of the Underwriters and to counsel for the Underwriters such number of conformed copies of the Registration Statement, as originally filed and each amendment thereto (excluding exhibits other than this Agreement), any Preliminary Prospectus,
the Final Term Sheet and any other Issuer Free Writing Prospectus, the Prospectus and all amendments and supplements to any of such documents (including any document filed under the Exchange Act and deemed to be incorporated by reference in the
Registration Statement, any Preliminary Prospectus or the Prospectus), in each case as soon as available and in such quantities as the Representatives may from time to time reasonably request. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) During the period in which the Prospectus relating to the Notes (or in lieu thereof, the notice referred to in Rule 173(a)
of the Rules and Regulations) is required to be delivered under the Securities Act, the Company will comply with all requirements imposed upon it by the Securities Act and by the Rules and Regulations, as from time to time in force, so far as is
necessary to permit the continuance of sales of or dealings in the Notes as contemplated by the provisions of this Agreement and by the Prospectus. If during such period any event occurs as a result of which the Prospectus as then amended or
supplemented would include an untrue statement of a material fact or omit to state any material fact necessary to make the statements therein, in the light of the circumstances under which they were made, not misleading, or if during such period it
is necessary to amend the Registration Statement or amend or supplement the Prospectus or file any document to comply with the Securities Act, the Company will promptly notify the Representatives and will, subject to Section&nbsp;4(a) hereof, amend
the Registration Statement, or amend or supplement the Prospectus, as the case may be, or file any document (in each case, at the expense of the Company) so as to correct such statement or omission or to effect such compliance, and will furnish
without charge to each Underwriter as many written and electronic copies of any such amendment or supplement as the Representatives may from time to time reasonably request. Neither the Representatives&#8217; consent to nor their delivery to
offerees or investors of, any such amendment or supplement shall constitute a waiver of any of the conditions set forth in Section&nbsp;6 of this Agreement. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">8 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) As soon as practicable, the Company will make generally available to its
security holders and the Underwriters an earnings statement satisfying the requirements of Section&nbsp;11(a) of the Securities Act and Rule 158 of the Rules and Regulations. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e) The Company agrees, whether or not this Agreement becomes effective or is terminated or the sale of the Notes to the
Underwriters is consummated, to pay all fees, expenses, costs and charges in connection with: (i)&nbsp;the preparation, printing, filing, registration, delivery and shipping of the Registration Statement (including any exhibits thereto), any
Preliminary Prospectus, any Issuer Free Writing Prospectus, the Prospectus and any amendments or supplements thereto; (ii)&nbsp;the printing, producing, copying and delivering of this Agreement, the Indenture, closing documents (including any
compilations thereof) and any other agreements, memoranda, correspondence and other documents printed and delivered in connection with the offering, purchase, sale and delivery of the Notes; (iii)&nbsp;the services of the Company&#8217;s independent
registered public accounting firm; (iv)&nbsp;the services of the Company&#8217;s counsel; (v)&nbsp;the qualification of the Notes under the securities laws of the several jurisdictions as provided in Section&nbsp;4(i) hereof; (vi)&nbsp;any rating of
the Notes by rating agencies; (vii)&nbsp;the services of the Trustee and any agent of the Trustee (including the fees and disbursements of counsel for the Trustee); (viii) any &#8220;road show&#8221; or other investor presentations relating to the
offering of the Notes (including, without limitation, for meetings and travel); and (ix)&nbsp;the performance of its otherwise incident obligations hereunder for which provision is not otherwise made in this Section&nbsp;4(e). It is understood,
however, that, except as provided in this Section&nbsp;4(e) or Sections 7 and 9 hereof, the Underwriters will pay all of their own costs and expenses, including the fees and expenses of counsel to the Underwriters and any advertising expenses
incurred in connection with the offering of the Notes. If the sale of the Notes provided for herein is not consummated by reason of acts of the Company or changes in circumstances of the Company pursuant to Section&nbsp;9 of this Agreement which
prevent this Agreement from becoming effective, or by reason of any failure, refusal or inability on the part of the Company to perform any agreement on its part to be performed or because any other condition of the Underwriters&#8217; obligations
hereunder is not fulfilled or if the Underwriters decline to purchase the Notes for any reason permitted under this Agreement (other than by reason of a default by any of the Underwriters pursuant to Section&nbsp;8 or if the Underwriters terminate
this Agreement under Section&nbsp;9 of this Agreement upon the occurrence of any event specified in clause (iii), (iv), (vi), (vii) or (viii)&nbsp;of Section&nbsp;6(d)), the Company will reimburse the Underwriters for all reasonable <FONT
STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">out-of-pocket</FONT></FONT> disbursements (including fees and expenses of counsel to the Underwriters) incurred by the Underwriters in connection with any investigation or preparation made
by them in respect of the marketing of the Notes or in contemplation of the performance by them of their obligations hereunder. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(f) Until termination of the offering of the Notes, the Company will timely file all reports, documents and amendments to
previously filed documents required to be filed by it pursuant to Section&nbsp;12, 13(a), 13(c), 14 or 15(d) of the Exchange Act. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(g) The Company will apply the net proceeds from the sale of the Notes as set forth in the most recent Preliminary Prospectus
and the Prospectus under the caption &#8220;Use of Proceeds.&#8221; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(h) The Company will pay the required Commission
filing fees relating to the Notes within the time period required by Rule 456(b)(1) of the Rules and Regulations without regard to the proviso therein and otherwise in accordance with Rules 456(b) and 457(r) of the Rules and Regulations. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(i) The Company will use reasonable best efforts to arrange for the qualification of the Notes and the determination of their
eligibility for investment under the blue sky laws of such jurisdictions as the Representatives designate and will continue such qualifications in effect so long as required for the distribution of the Notes by the Underwriters; <I>provided</I> that
the Company will not be required to qualify as a foreign corporation or to file a general consent to service of process or subject itself to taxation in any such jurisdiction. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">5. <I>Free Writing Prospectuses</I>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) The Company represents and warrants to, and agrees with, each Underwriter that (i)&nbsp;the Company has not made, and will
not make, any offer relating to the Notes that would constitute an Issuer Free Writing Prospectus without the prior consent of the Representatives (which consent being deemed to have been given with respect to (A)&nbsp;the Final Term Sheet prepared
and filed pursuant to Section&nbsp;4(a) hereof and (B)&nbsp;any other Issuer Free Writing Prospectus identified on <U>Schedule II</U> hereto); (ii) each Issuer Free Writing Prospectus conformed or will conform in all material respects to the
requirements of the Securities Act and the Rules and Regulations on the date of first use, and the Company has complied with any filing requirements applicable to such Issuer Free </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">9 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">
Writing Prospectus pursuant to Rule 433 of the Rules and Regulations; (iii)&nbsp;each Issuer Free Writing Prospectus will not, as of its issue date and through the time the Notes are delivered
pursuant to Section&nbsp;3 hereof, include any information that conflicts with the information contained in the Registration Statement, the most recent Preliminary Prospectus and the Prospectus; and (iv)&nbsp;each Issuer Free Writing Prospectus,
when considered together with the information contained in the most recent Preliminary Prospectus, did not, as of the Applicable Time, does not, as of the date hereof, and will not, as of the Closing Date, contain any untrue statement of a material
fact or omit to state any material fact required to be stated therein or necessary to make the statements therein, in the light of the circumstances under which they were made, not misleading. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) Each Underwriter represents and warrants to, and agrees with, the Company and each other Underwriter that it has not made,
and will not make any offer relating to the Notes that would constitute a &#8220;free writing prospectus&#8221; (as defined in Rule&nbsp;405 of the Rules and Regulations) required to be filed with the Commission, without the prior consent of the
Company and the Representatives. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) The Company agrees that if at any time following issuance of an Issuer Free Writing
Prospectus any event occurred or occurs as a result of which such Issuer Free Writing Prospectus would conflict with the information in the Registration Statement, the most recent Preliminary Prospectus or the Prospectus or would include any untrue
statement of a material fact or omit to state any material fact necessary in order to make the statements therein, in the light of the circumstances then prevailing, not misleading, the Company will give prompt notice thereof to the Representatives
and, if requested by the Representatives, will prepare and furnish without charge to each Underwriter an Issuer Free Writing Prospectus or other document which will correct such conflict, statement or omission. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">6. <I>Conditions of Underwriters</I><I>&#8217;</I><I> Obligations</I>. The obligations of the Underwriters hereunder are subject to the
accuracy, as of the date hereof and the Closing Date (as if made at the Closing Date), of the representations and warranties of the Company contained herein, to the performance by the Company of its obligations hereunder and to the following
additional conditions: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) The Prospectus shall have been filed with the Commission in a timely fashion in accordance with
Section&nbsp;4(a) hereof; all filings (including, without limitation, the Final Term Sheet) required by Rule 424(b) or Rule 433 of the Rules and Regulations shall have been made within the time periods prescribed by such Rules, and no such filings
will have been made without the consent of the Representatives (such consent not to be unreasonably withheld or delayed); no stop order suspending the effectiveness of the Registration Statement or any amendment or supplement thereto, preventing or
suspending the use of any Preliminary Prospectus, any Issuer Free Writing Prospectus or the Prospectus, or suspending the qualification of the Notes for offering or sale in any jurisdiction shall have been issued; no proceedings for the issuance of
any such order shall have been initiated or threatened pursuant to Section&nbsp;8A of the Securities Act; no notice of objection of the Commission to use of the Registration Statement or any post-effective amendment thereto shall have been received
by the Company; and any request of the Commission for additional information (to be included in the Registration Statement or the Prospectus or otherwise) shall have been disclosed to the Representatives and complied with to the
Representatives&#8217; reasonable satisfaction. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) The Representatives shall have received a letter, dated the date of
this Agreement, from Ernst&nbsp;&amp; Young LLP (&#8220;<B>E&amp;Y</B>&#8221;) addressed to the Underwriters, confirming that they are the independent public accountants with respect to the Company, within the meaning of the Securities Act and the
applicable published rules and regulations thereunder and to the effect that: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(i) in their opinion the financial
statements and schedules of the Company, if any, examined by them and included or incorporated by reference in the most recent Preliminary Prospectus or the Prospectus, comply as to form in all material respects with the applicable accounting
requirements of the Securities Act and the Exchange Act and the related rules and regulations adopted by the Commission; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(ii) on the basis of a reading of the latest available interim financial statements of the Company, inquiries of officials of
the Company, who have responsibility for financial and accounting matters and other specified procedures, nothing came to their attention that caused them to believe that: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="13%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(A)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">at the date of the latest available balance sheet read by such accountants, and at a subsequent specified date
not more than three Business Days prior to the date of this Agreement, there was any change in the common stock, increase in long-term debt or decrease in consolidated net current assets or shareholders&#8217; equity of the Company, as compared with
amounts shown on the latest balance sheet included or incorporated by reference in the most recent Preliminary Prospectus or the Prospectus; or </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">10 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="13%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(B)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">for the period from the closing date of the latest income statement included or incorporated by reference in
the most recent Preliminary Prospectus or the Prospectus to the closing date of the latest available income statement read by such accountants and to a subsequent specified date not more than three Business Days prior to the date of this Agreement,
there were any decreases, as compared with the corresponding period in the preceding year, in consolidated net revenues or in the total or <FONT STYLE="white-space:nowrap">per-share</FONT> amounts of consolidated income from continuing operations or
of consolidated net income of the Company, or any increases or decreases, as the case may be, in other items specified by the Representatives; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="13%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(C)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">except in all cases set forth in clauses (A)&nbsp;and (B) above for changes, increases or decreases which the
most recent Preliminary Prospectus or the Prospectus discloses have occurred or may occur or which are described in such letter; and </P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(iii) they have compared specified dollar amounts (or percentages derived from such dollar amounts), numerical data and other
financial information contained in the most recent Preliminary Prospectus or the Prospectus (in each case to the extent that such dollar amounts, percentages, numerical data and other financial information are derived from the general accounting
records of the Company and its subsidiaries, subject to the internal controls of the Company&#8217;s accounting system, or are derived directly from such records by analysis or computation) with the results obtained from inquiries, a reading of such
general accounting records and other procedures specified in such letter and have found such dollar amounts, percentages, numerical data and other financial information to be in agreement with such results except as otherwise specified in such
letter. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) The Representatives shall have received a letter, addressed to the Underwriters, dated the Closing Date, from
E&amp;Y, which meets the requirements of subsection (b)&nbsp;of this Section, except that the specified date referred to in such subsection will be a date not more than three days prior to the Closing Date for the purposes of this subsection. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) Subsequent to the execution and delivery of this Agreement, there shall not have occurred (i)&nbsp;any change, or any
development involving a prospective change, in the condition (financial or other), business, properties or results of operations of the Company and its subsidiaries, taken as a whole, which, in the judgment of the Representatives, is material and
adverse and makes it impractical or inadvisable to proceed with completion of the offering or the sale of and payment for the Notes; (ii)&nbsp;any downgrading in the rating of any debt securities of the Company by any &#8220;nationally recognized
statistical rating organization&#8221; (as defined for purposes of Section&nbsp;3(a)(62) of the Exchange Act), or any public announcement that any such organization has under surveillance or review its rating of any debt securities of the Company
(other than an announcement with positive implications of a possible upgrading, and no implication of a possible downgrading, of such rating); (iii)&nbsp;any change in U.S. or international financial, political or economic conditions or currency
exchange rates or exchange controls as would, in the judgment of the Representatives, be likely to prejudice materially the success of the proposed issue, sale or distribution of the Notes, whether in the primary market or in respect of dealings in
the secondary market; (iv)&nbsp;any material suspension or material limitation of trading in securities generally on the New York Stock Exchange or any setting of minimum prices for trading on such exchange; (v)&nbsp;any suspension of trading of any
securities of the Company on any exchange or in the <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">over-the-counter</FONT></FONT> market; (vi)&nbsp;any banking moratorium declared by U.S. Federal or New York authorities;
(vii)&nbsp;any major disruption of settlements of securities or clearance services in the United States; or (viii)&nbsp;any attack on the United States, outbreak or escalation of major hostilities or act of terrorism involving the United States, any
declaration of war by Congress or any other substantial national or international calamity or emergency if, in the judgment of the Representatives, the effect of any such attack, outbreak, escalation, act, declaration, calamity or emergency makes it
impractical or inadvisable to proceed with completion of the offering or sale of and payment for the Notes. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">11 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e) The Representatives shall have received from Wachtell, Lipton,
Rosen&nbsp;&amp; Katz, counsel for the Company, an opinion and <FONT STYLE="white-space:nowrap">10b-5</FONT> letter, addressed to the Underwriters, dated the Closing Date substantially to the effect set forth in <U>Exhibits B</U> and <U>C</U>
hereto, respectively. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(f) The Representatives shall have received from Thomas S. Moffatt, Vice President, Assistant
Secretary and Senior Legal Counsel - Corporate Services of the Company, an opinion, addressed to the Underwriters, dated the Closing Date substantially in the form of <U>Exhibit D</U> hereto. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(g) The Representatives shall have received from Simpson Thacher&nbsp;&amp; Bartlett LLP, counsel to the Underwriters, such
opinion or opinions, addressed to the Underwriters, dated the Closing Date and in form and substance satisfactory to the Representatives, with respect to the Notes, Indenture, Registration Statement, Prospectus and Disclosure Package and other
related matters as the Representatives may reasonably require, and the Company shall have furnished to such counsel such documents as they may reasonably request for the purpose of enabling them to pass upon such matters. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(h) The Representatives shall have received a certificate, dated the Closing Date, of the President or any Vice President and
the principal financial or accounting officer of the Company in which such officers, to the best of their knowledge after reasonable investigation, shall state that (i)&nbsp;the representations and warranties of the Company in this Agreement are
true and correct, (ii)&nbsp;the Company has complied with all the agreements and satisfied all the conditions on its part to be performed or satisfied hereunder at or prior to the Closing Date, (iii)&nbsp;no stop order suspending the effectiveness
of the Registration Statement has been issued, no proceedings for any such purpose have been initiated or threatened and (iv)&nbsp;subsequent to the dates of the most recent financial statements in the most recent Preliminary Prospectus and the
Prospectus, there has been no material adverse change, nor any development or event involving a prospective material adverse change, in the financial condition, business, properties or results of operations of the Company and its subsidiaries, taken
as a whole, other than those set forth in or contemplated by the most recent Preliminary Prospectus and the Prospectus or as described in such certificate. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Company will furnish the Underwriters with such conformed copies of such opinions, certificates, letters and documents as the Underwriters
reasonably request. The Representatives may in their sole discretion waive on behalf of the Underwriters compliance with any conditions to the obligations of the Underwriters hereunder. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">7. <I>Indemnification and Contribution</I>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) The Company will indemnify and hold harmless each Underwriter, its partners, members, directors and officers and affiliates
and each person, if any, who controls such Underwriter within the meaning of Section&nbsp;15 of the Securities Act, from and against any loss, claim, damage or liability (or any action in respect thereof), joint or several, to which such Underwriter
or such person may become subject, under the Securities Act or otherwise, insofar as such loss, claim, damage or liability (or action in respect thereof) arises out of or is based upon (i)&nbsp;any untrue statement or alleged untrue statement of a
material fact contained in the Registration Statement, any Preliminary Prospectus, the Prospectus, or the Disclosure Package, each as amended or supplemented, any Issuer Free Writing Prospectus or any &#8220;issuer information&#8221; filed or
required to be filed pursuant to Rule&nbsp;433(d) of the Rules and Regulations or (ii)&nbsp;the omission or alleged omission to state therein a material fact required to be stated therein or necessary to make the statements therein (in the case of
any Preliminary Prospectus, Issuer Free Writing Prospectus, the Prospectus and the Disclosure Package, in the light of the circumstances under which they were made) not misleading, and will reimburse each Underwriter for any legal or other expenses
as reasonably incurred by such Underwriter in connection with investigating, preparing to defend or defending against or appearing as a third-party witness in connection with any such loss, claim, damage, liability or action, notwithstanding the
possibility that payments for such expenses might later be held to be improper, in which case such payments will be promptly refunded; <I>provided</I>, <I>however</I>, that the Company will not be liable under this Section&nbsp;7(a) in any such case
to the extent that any such loss, claim, damage, liability or action arises out of or is based upon an untrue statement or alleged untrue statement or omission or alleged omission made in reliance upon and in conformity with written information
furnished to the Company by any Underwriter through the Representatives specifically for use therein (which information is specified in Section&nbsp;12 hereof). The foregoing indemnity agreement shall not inure to the benefit of any Underwriter if
(i)&nbsp;such loss, claim, damage or liability (or action in respect thereof) arises out of or is based upon an untrue statement or alleged untrue statement or omission or alleged omission made in any Preliminary Prospectus, (ii)&nbsp;the Company
informed the Representatives of such untrue statement or alleged untrue statement or omission or alleged omission prior to the Applicable Time, (iii)&nbsp;such untrue statement or alleged untrue statement or omission or alleged omission was
corrected in an amended or </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">12 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">
supplemented Preliminary Prospectus (or, where permitted by law, an Issuer Free Writing Prospectus) and such corrected Preliminary Prospectus (or Issuer Free Writing Prospectus) was provided to
the Underwriters such that the Underwriters had a reasonably sufficient amount of time prior to the Applicable Time to deliver such corrected Preliminary Prospectus (or Issuer Free Writing Prospectus) to the persons to whom the Underwriters are
selling the Notes, (iv)&nbsp;the timely delivery of such corrected Preliminary Prospectus (or Issuer Free Writing Prospectus) to such person prior to the Applicable Time would have constituted a complete defense to the losses, claims, damages and
liabilities asserted by such person and (v)&nbsp;such corrected Preliminary Prospectus (or Issuer Free Writing Prospectus) was not sent or given by or on behalf of such Underwriter to such person prior to the Applicable Time. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) Each Underwriter severally, but not jointly, will indemnify and hold harmless the Company, its directors, officers and
affiliates and each person, if any, who controls the Company within the meaning of Section&nbsp;15 of the Securities Act against any loss, claim, damage or liability (or any action in respect thereof) to which the Company or such person may become
subject, under the Securities Act or otherwise, insofar as such loss, claim, damage or liability (or action in respect thereof) arises out of or is based upon (i)&nbsp;any untrue statement or alleged untrue statement of a material fact contained in
the Registration Statement, any Preliminary Prospectus, the Prospectus, the Disclosure Package, each as amended or supplemented, or any Issuer Free Writing Prospectus or (ii)&nbsp;the omission or alleged omission to state therein a material fact
required to be stated therein or necessary to make the statements therein (in the case of any Preliminary Prospectus, Issuer Free Writing Prospectus, the Prospectus and the Disclosure Package, in the light of the circumstances under which they were
made) not misleading, and will reimburse the Company for any legal or other expenses reasonably incurred by the Company in connection with investigating, preparing to defend or defending against or appearing as a third-party witness in connection
with any such loss, claim, damage, liability or action notwithstanding the possibility that payments for such expenses might later be held to be improper, in which case such payments will be promptly refunded; <I>provided</I>, <I>however</I>, that
such indemnification or reimbursement will be available in each such case to the extent, but only to the extent, that such untrue statement or alleged untrue statement or omission or alleged omission was made in reliance upon and in conformity with
written information furnished to the Company by such Underwriter through the Representatives, specifically for use therein (which information is specified in Section&nbsp;12 hereof). </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) Promptly after receipt by an indemnified party under this Section of notice of the commencement of any action, such
indemnified party will, if a claim in respect thereof is to be made against an indemnifying party under subsection (a)&nbsp;or (b) above, notify the indemnifying party of the commencement thereof; but the failure to notify the indemnifying party
shall not relieve it from any liability that it may have under subsection (a)&nbsp;or (b) above, except to the extent that it has been materially prejudiced (through the forfeiture of substantive rights or defenses) by such failure; and provided
further that the failure to notify the indemnifying party shall not relieve it from any liability that it may have to an indemnified party otherwise than under subsection (a)&nbsp;or (b) above. In case any such action is brought against any
indemnified party and it notifies an indemnifying party of the commencement thereof, the indemnifying party will be entitled to participate therein and, to the extent that it may wish, jointly with any other indemnifying party similarly notified, to
assume the defense thereof, with counsel satisfactory to such indemnified party (who shall not, except with the consent of the indemnified party, be counsel to the indemnifying party), and after notice from the indemnifying party to such indemnified
party of its election to assume the defense thereof, the indemnifying party will not be liable to such indemnified party under this Section for any legal or other expenses subsequently incurred by such indemnified party in connection with the
defense thereof other than reasonable costs of investigation. No indemnifying party shall, without the prior written consent of the indemnified party, effect any settlement of any pending or threatened action in respect of which any indemnified
party is or could have been a party and indemnity could have been sought hereunder by such indemnified party unless such settlement (i)&nbsp;includes an unconditional release of such indemnified party from all liability on any claims that are the
subject matter of such action and (ii)&nbsp;does not include a statement as to or an admission of fault, culpability or a failure to act, by or on behalf of any indemnified party. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) If the indemnification provided for in this Section is unavailable or insufficient to hold harmless an indemnified party
under subsection (a)&nbsp;or (b) above, then the indemnifying party shall contribute to the amount paid or payable by such indemnified party as a result of the losses, claims, damages or liabilities referred to in subsection (a)&nbsp;or (b) above
(i)&nbsp;in such proportion as is appropriate to reflect the relative benefits received by the Company on the one hand and the Underwriters on the other from the offering of the Notes or (ii)&nbsp;if the allocation provided by clause (i)&nbsp;above
is not permitted by applicable law, in such proportion as is appropriate to reflect not only the relative benefits referred to in clause (i)&nbsp;above but also the relative fault of the Company on the one hand and the Underwriters on the other in
connection with the statements or omissions which resulted in such losses, claims, damages or liabilities as well as any other relevant equitable considerations. The relative benefits received </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">13 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">
by the Company on the one hand and the Underwriters on the other shall be deemed to be in the same proportion as the total net proceeds from the offering (before deducting expenses) received by
the Company bear to the total discounts and commissions received by the Underwriters from the Company under this Agreement. The relative fault shall be determined by reference to, among other things, whether the untrue or alleged untrue statement of
a material fact or the omission or alleged omission to state a material fact relates to information supplied by the Company or the Underwriters and the parties&#8217; relative intent, knowledge, access to information and opportunity to correct or
prevent such untrue statement or omission. The amount paid by an indemnified party as a result of the losses, claims, damages or liabilities referred to in the first sentence of this subsection (d)&nbsp;shall be deemed to include any legal or other
expenses reasonably incurred by such indemnified party in connection with investigating or defending any action or claim which is the subject of this subsection (d). Notwithstanding the provisions of this subsection (d), no Underwriter shall be
required to contribute any amount in excess of the amount by which the total price at which the Notes purchased by it were resold exceeds the amount of any damages which such Underwriter has otherwise been required to pay by reason of such untrue or
alleged untrue statement or omission or alleged omission. The Underwriters&#8217; obligations in this subsection (d)&nbsp;to contribute are several in proportion to their respective purchase obligations and not joint. No person guilty of fraudulent
misrepresentation (within the meaning of Section&nbsp;11(f) of the Securities Act) shall be entitled to contribution from any person who was not guilty of such fraudulent misrepresentation. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e) The obligations of the Company under this Section shall be in addition to any liability which the Company may otherwise
have and shall extend, upon the same terms and conditions, to each person, if any, who controls any Underwriter within the meaning of the Securities Act or the Exchange Act; and the obligations of the Underwriters under this Section shall be in
addition to any liability which the Underwriters may otherwise have and shall extend, upon the same terms and conditions, to each director of the Company and to each person, if any, who controls the Company within the meaning of the Securities Act
or the Exchange Act. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">8. <I>Substitution of Underwriters</I>. If any Underwriter or Underwriters default in their obligations to purchase
Notes hereunder and the aggregate principal amount of the Notes that such defaulting Underwriter or Underwriters agreed but failed to purchase does not exceed 10% of the total principal amount of the Notes, the Representatives may make arrangements
satisfactory to the Company for the purchase of such Notes by other persons, including any of the Underwriters, but if no such arrangements are made by the Closing Date, the <FONT STYLE="white-space:nowrap">non-defaulting</FONT> Underwriters shall
be obligated severally, in proportion to their respective commitments hereunder, to purchase the Notes that such defaulting Underwriter or Underwriters agreed but failed to purchase. If any Underwriter or Underwriters so default and the aggregate
principal amount of the Notes with respect to which such default or defaults occur exceeds 10% of the total principal amount of the Notes and arrangements satisfactory to the Representatives and the Company for the purchase of such Notes by other
persons are not made within 36 hours after such default, this Agreement will terminate without liability on the part of any <FONT STYLE="white-space:nowrap">non-defaulting</FONT> Underwriter or the Company, except as provided in Section&nbsp;7. As
used in this Agreement, the term &#8220;Underwriter&#8221; includes any person substituted for an Underwriter under this Section. Nothing herein will relieve a defaulting Underwriter from liability for its default. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">9. <I>Termination</I>. Until the Closing Date, this Agreement may be terminated by the Representatives on behalf of the Underwriters by giving
notice as hereinafter provided to the Company if (i)&nbsp;the Company will have failed, refused or been unable, at or prior to the Closing Date, to perform any agreement on its part to be performed hereunder, (ii)&nbsp;any of the events described in
Sections 6(d) of this Agreement, shall have occurred, or (iii)&nbsp;any other condition to the Underwriters&#8217; obligations hereunder is not fulfilled. Any termination of this Agreement pursuant to this Section&nbsp;9 will be without liability on
the part of the Company or any Underwriter, except as otherwise provided in Sections&nbsp;4(e) and 7 hereof. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Any notice referred to above
may be given at the address specified in Section&nbsp;11 of this Agreement in writing by mail, facsimile or email. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">10. <I>Survival of
Certain Provisions</I>. The agreements contained in Section&nbsp;7 of this Agreement and the representations, warranties and agreements of the Company contained in Sections&nbsp;1 and 4 of this Agreement will survive the delivery of the Notes to the
Underwriters hereunder and will remain in full force and effect, regardless of any termination or cancellation of this Agreement or any investigation made by or on behalf of any indemnified party. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">14 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">11. <I>Notices</I>. Except as otherwise provided in the Agreement, (a)&nbsp;whenever notice
is required by the provisions of this Agreement to be given to the Company, such notice will be in writing by mail or facsimile transmission addressed to the Company at One CVS Drive, Woonsocket, Rhode Island 02895, facsimile number (401) <FONT
STYLE="white-space:nowrap">765-7887,</FONT> Attention: General Counsel, and (b)&nbsp;whenever notice is required by the provisions of this Agreement to be given to the several Underwriters, such notice will be in writing by mail, email or facsimile
transmission addressed to the Representatives in care of Barclays Capital Inc., 745 Seventh Ave, New York, New York 10019, facsimile number: (646) <FONT STYLE="white-space:nowrap">834-8133,</FONT> Attention: Syndicate Registration, J.P. Morgan
Securities LLC, 383 Madison Avenue, New York, New York 10179, facsimile number: (212) <FONT STYLE="white-space:nowrap">834-6081,</FONT> Attention: Investment Grade Syndicate Desk, and Wells Fargo Securities, LLC, 550 South Tryon Street, 5th Floor,
Charlotte, North Carolina 28202, Attention: Transaction Management, email: tmgcapitalmarkets@wellsfargo.com. The Company shall be entitled to act and rely upon any request, consent, notice or agreement given or made on behalf of the Underwriters by
the Representatives. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">12. <I>Information Furnished by Underwriters</I>. The Underwriters severally confirm that the names of each of the
Underwriters under the caption &#8220;Underwriting&#8221; in the most recent Preliminary Prospectus and the Prospectus, the concession and reallowance figures appearing in the table below the third paragraph under the caption
&#8220;Underwriting&#8221; in the most recent Preliminary Prospectus and the Prospectus, and the statements in the first two paragraphs (including the bullet points between those paragraphs) of the subsection entitled &#8220;Price Stabilization,
Short Positions and Penalty Bids&#8221; under the caption &#8220;Underwriting&#8221; in the most recent Preliminary Prospectus and the Prospectus, constitute the only written information furnished to the Company by the Representatives on behalf of
the Underwriters, referred to in Sections&nbsp;1(e), 1(f), 1(g), 7(a) and 7(b) of this Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">13. <I>Nature of Relationship</I>. The
Company acknowledges and agrees that in connection with the offering and the sale of the Notes or any other services the Underwriters may be deemed to be providing hereunder, notwithstanding any preexisting relationship, advisory or otherwise,
between the parties or any oral representations or assurances previously or subsequently made by the Underwriters: (i)&nbsp;no fiduciary or agency relationship between the Company and any other person, on the one hand, and the Underwriters, on the
other hand, exists; (ii)&nbsp;the Underwriters are not acting as advisors, experts or otherwise, to the Company, including, without limitation, with respect to the determination of the public offering price of the Notes, and such relationship
between the Company, on the one hand, and the Underwriters, on the other hand, is entirely and solely a commercial relationship, based on arms-length negotiations; (iii)&nbsp;any duties and obligations that the Underwriters may have to the Company
shall be limited to those duties and obligations specifically stated herein; and (iv)&nbsp;the Underwriters and their respective affiliates may have interests that differ from those of the Company. The Company hereby waives any claims that the
Company may have against the Underwriters with respect to any breach of fiduciary duty in connection with this offering. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">14.
<I>Recognition of the U.S. Special Resolution Regime</I> </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) In the event that any Underwriter is a Covered Entity and
becomes subject to a proceeding under a U.S. Special Resolution Regime, the transfer from such Underwriter of this Agreement, and any interest and obligation in or under this Agreement, will be effective to the same extent as the transfer would be
effective under the U.S. Special Resolution Regime if this Agreement, and any such interest and obligation, were governed by the laws of the United States or a state of the United States.<I> </I> </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) In the event that any Underwriter is a Covered Entity and it or a BHC Act Affiliate of such Underwriter becomes subject to
a proceeding under a U.S. Special Resolution Regime, Default Rights under this Agreement that may be exercised against such Underwriter are permitted to be exercised to no greater extent than such Default Rights could be exercised under the U.S.
Special Resolution Regime if this Agreement were governed by the laws of the United States or a state of the United States. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">As used in this Section&nbsp;14: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<B>BHC Act Affiliate</B>&#8221; has the meaning assigned to the term &#8220;<B>affiliate</B>&#8221; in, and shall be
interpreted in accordance with, 12 U.S.C. &#167; 1841(k). </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<B>Covered Entity</B>&#8221; means any of the following:
</P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(i) a &#8220;covered entity&#8221; as that term is defined in, and interpreted in accordance with, 12 C.F.R. &#167;
252.82(b); </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">15 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(ii) a &#8220;covered bank&#8221; as that term is defined in, and
interpreted in accordance with, 12 C.F.R. &#167; 47.3(b); or </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(iii) a &#8220;covered FSI&#8221; as that term is defined in,
and interpreted in accordance with, 12 C.F.R. &#167; 382.2(b).</P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<B>Default Right</B>&#8221; has the meaning assigned
to that term in, and shall be interpreted in accordance with, 12 C.F.R. &#167;&#167; 252.81, 47.2 or 382.1, as applicable. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<B>U.S. Special Resolution Regime</B>&#8221; means each of (i)&nbsp;the Federal Deposit Insurance Act and the
regulations promulgated thereunder and (ii)&nbsp;Title II of the Dodd-Frank Wall Street Reform and Consumer Protection Act and the regulations promulgated thereunder. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">15. <I>Parties</I>. This Agreement will inure to the benefit of and be binding upon the several Underwriters, the Company and their respective
successors. This Agreement and the terms and provisions hereof are for the sole benefit of only those persons, except as specifically provided in Section&nbsp;7 of this Agreement. Nothing in this Agreement will be construed to give any person, other
than the persons referred to in this paragraph, any legal or equitable right, remedy or claim under or in respect of this Agreement or any provision contained herein. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">16. <I>Definition of </I><I>&#8220;</I><I>Business Day</I><I>&#8221;</I><I>.</I> For purposes of this Agreement, the term &#8220;<B>Business
Day</B>&#8221; means any day on which the New York Stock Exchange is open for trading, other than any day on which commercial banks are authorized or required to be closed in New York City. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">17. <I>Governing Law</I>. This Agreement will be governed by, and construed in accordance with, the laws of the State of New York. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">18. <I>Headings</I>. The headings herein are inserted for convenience of reference only and are not intended to be part of, or to affect the
meaning or interpretation of, this Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">19. <I>Counterparts</I>. This Agreement may be signed in one or more counterparts, each of
which will constitute an original and all of which together will constitute one and the same agreement. Counterparts may be delivered via facsimile, electronic mail (including any electronic signature covered by the U.S. federal ESIGN Act of 2000,
Uniform Electronic Transactions Act, the Electronic Signatures and Records Act or other applicable law, e.g., www.docusign.com) or other transmission method and any counterpart so delivered shall be deemed to have been duly and validly delivered and
be valid and effective for all purposes. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[<I>Remainder of page intentionally left blank; Signatures follow</I>] </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">16 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Please confirm, by signing and returning to us one or more counterparts of this Agreement,
that the foregoing correctly sets forth the Agreement between the Company and the several Underwriters. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="7%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="92%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">Very truly yours,</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">CVS HEALTH CORPORATION</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Tracy L. Smith</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Name: Tracy L. Smith</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Title: &#8194;Senior Vice President and Treasurer</TD></TR>
</TABLE></DIV>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[<I>Signature Page to
Underwriting Agreement</I>] </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Confirmed and accepted as of </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">the date first above mentioned </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="7%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="92%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">BARCLAYS CAPITAL INC.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ James Gutow</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Name: James Gutow</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Title: &#8194;Managing Director</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">J.P. MORGAN SECURITIES LLC</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Som Bhattacharyya</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Name: Som Bhattacharyya</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Title: &#8194;Executive Director</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">WELLS FARGO SECURITIES, LLC</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Carolyn Hurley</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Name: Carolyn Hurley</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Title: &#8194;Managing Director</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">As Representatives and on behalf of the several Underwriters </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">named in <U>Schedule I</U> hereto </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[<I>Signature Page to
Underwriting Agreement</I>] </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>SCHEDULE I </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="48%"></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; "><B>Underwriters</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Principal&nbsp;amount</B><br><B>of&nbsp;the&nbsp;2032&nbsp;Notes&nbsp;to<BR>be purchased</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Principal amount<BR>of&nbsp;the&nbsp;2035&nbsp;Notes&nbsp;to</B><br><B>be purchased</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Principal amount<BR>of&nbsp;the&nbsp;2055&nbsp;Notes&nbsp;to<BR>be purchased</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Principal&nbsp;amount<BR>of&nbsp;the&nbsp;2065&nbsp;Notes&nbsp;to</B><br><B>be purchased</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Barclays Capital Inc.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">95,625,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">191,250,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">159,375,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">63,750,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">J.P. Morgan Securities LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">95,625,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">191,250,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">159,375,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">63,750,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Wells Fargo Securities, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">95,625,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">191,250,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">159,375,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">63,750,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">BofA Securities, Inc.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">75,000,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">150,000,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">125,000,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">50,000,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Citigroup Global Markets Inc.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">75,000,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">150,000,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">125,000,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">50,000,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Goldman Sachs&nbsp;&amp; Co. LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">75,000,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">150,000,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">125,000,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">50,000,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Mizuho Securities USA LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">22,500,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">45,000,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">37,500,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">15,000,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">RBC Capital Markets, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">22,500,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">45,000,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">37,500,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">15,000,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Truist Securities, Inc.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">22,500,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">45,000,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">37,500,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">15,000,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">UBS Securities LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">22,500,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">45,000,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">37,500,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">15,000,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">U.S. Bancorp Investments, Inc.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">22,500,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">45,000,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">37,500,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">15,000,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">BNY Mellon Capital Markets, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">15,000,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">30,000,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">25,000,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">10,000,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Fifth Third Securities, Inc.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">15,000,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">30,000,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">25,000,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">10,000,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Morgan Stanley&nbsp;&amp; Co. LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">15,000,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">30,000,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">25,000,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">10,000,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">PNC Capital Markets LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">15,000,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">30,000,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">25,000,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">10,000,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">SMBC Nikko Securities America, Inc.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">15,000,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">30,000,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">25,000,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">10,000,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">ICBC Standard Bank Plc</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">7,500,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">15,000,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">12,500,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">5,000,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">TD Securities (USA) LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">7,500,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">15,000,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">12,500,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">5,000,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">KeyBanc Capital Markets Inc.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">7,500,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">15,000,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">12,500,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">5,000,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Loop Capital Markets LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">7,500,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">15,000,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">12,500,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">5,000,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Academy Securities, Inc.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">7,500,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">15,000,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">12,500,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">5,000,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Samuel A. Ramirez&nbsp;&amp; Company, Inc.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">7,500,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">15,000,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">12,500,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">5,000,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Piper Sandler&nbsp;&amp; Co.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">5,625,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">11,250,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">9,375,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">3,750,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Total</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">750,000,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1,500,000,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1,250,000,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">500,000,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>SCHEDULE II </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>ISSUER FREE WRITING PROSPECTUSES </U></B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Final Term Sheet, dated August&nbsp;11, 2025, relating to the Notes, as filed pursuant to Rule 433 under the
Securities Act and attached as <U>Schedule III</U> hereto. </P></TD></TR></TABLE>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>SCHEDULE III </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>PRICING TERM SHEET </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><I>[Attached] </I></B></P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>CVS HEALTH CORPORATION </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><I>Pricing Term Sheet &#8212; August&nbsp;11, 2025 </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><I>$750,000,000 5.000% Senior Notes due 2032 </I></B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><I>$1,500,000,000 5.450% Senior Notes due 2035 </I></B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><I>$1,250,000,000 6.200% Senior Notes due 2055 </I></B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><I>$500,000,000 6.250% Senior Notes due 2065 </I></B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="28%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="71%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>Issuer:</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">CVS Health Corporation (the &#8220;<B>Issuer</B>&#8221;)</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>Description of Securities:</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">$750,000,000 5.000% Senior Notes due 2032 (the &#8220;<B>2032 Notes</B>&#8221;)</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">$1,500,000,000 5.450% Senior Notes due 2035 (the &#8220;<B>2035 Notes</B>&#8221;)</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">$1,250,000,000 6.200% Senior Notes due 2055 (the &#8220;<B>2055 Notes</B>&#8221;)</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">$500,000,000 6.250% Senior Notes due 2065 (the &#8220;<B>2065 Notes</B>&#8221; and, together with the 2032 Notes, the 2035 Notes and the 2055 Notes, the
&#8220;<B>Notes</B>&#8221;)</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>Maturity Date:</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">September&nbsp;15, 2032 for the 2032 Notes</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">September&nbsp;15, 2035 for the 2035 Notes</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">September&nbsp;15,
2055 for the 2055 Notes</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">September&nbsp;15, 2065 for the 2065 Notes</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>Settlement Date:</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">August&nbsp;15, 2025 (T+4)</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">We expect to deliver
the Notes against payment for the Notes on or about August&nbsp;15, 2025, which will be the fourth business day following the date of the pricing of the Notes. Under Rule <FONT STYLE="white-space:nowrap">15c6-1</FONT> of the Exchange Act, trades in
the secondary market generally are required to settle in one business day, unless the parties to a trade expressly agree otherwise. Accordingly, purchasers who wish to trade Notes prior to the business day before the delivery of the notes hereunder
will be required, by virtue of the fact that the Notes initially will settle in T+4, to specify alternative settlement arrangements to prevent a failed settlement.</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>Issue Price:</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">99.694% of principal amount for the 2032 Notes</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">99.970% of principal amount for the 2035 Notes</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">99.896% of
principal amount for the 2055 Notes</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">99.597% of principal amount for the 2065 Notes</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>Coupon:</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">5.000% for the 2032 Notes</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">5.450% for the 2035
Notes</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">6.200% for the 2055 Notes</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">6.250% for the 2065
Notes</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>Benchmark Treasury:</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">2032 Notes: 4.000% UST due July&nbsp;31, 2032</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">2035 Notes: 4.250% UST due August&nbsp;15, 2035</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">2055 Notes:
4.750% UST due May&nbsp;15, 2055</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">2065 Notes: 4.750% UST due May&nbsp;15, 2055</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>Benchmark Treasury Price and Yield:</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">2032 Notes: <FONT STYLE="white-space:nowrap">99-26;</FONT> 4.031%</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">2035 Notes: <FONT STYLE="white-space:nowrap">99-23+;</FONT> 4.283%</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">2055 Notes: <FONT STYLE="white-space:nowrap">98-10;</FONT> 4.857%</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">2065 Notes: <FONT STYLE="white-space:nowrap">98-10;</FONT> 4.857%</P></TD></TR>
</TABLE>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="28%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="71%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>Spread to Benchmark Treasury:</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">2032 Notes: +102 basis points (1.02%)</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">2035
Notes: +117 basis points (1.17%)</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">2055 Notes: +135 basis points (1.35%)</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">2065 Notes: +142 basis points (1.42%)</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>Yield to Maturity:</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">2032 Notes: 5.051%</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">2035 Notes: 5.453%</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">2055 Notes: 6.207%</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">2065 Notes: 6.277%</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>Interest Payment Dates:</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">2032 Notes: Semiannually on September&nbsp;15 and March&nbsp;15, commencing on March&nbsp;15, 2026</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">2035 Notes: Semiannually on September&nbsp;15 and March&nbsp;15, commencing on March&nbsp;15, 2026</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">2055 Notes: Semiannually on September&nbsp;15 and March&nbsp;15, commencing on March&nbsp;15, 2026</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">2065 Notes: Semiannually on September&nbsp;15 and March&nbsp;15, commencing on March&nbsp;15, 2026</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>Record Dates:</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">2032 Notes: September 1 and March 1</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">2035 Notes:
September 1 and March 1</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">2055 Notes: September 1 and March 1</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">2065 Notes: September 1 and March 1</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>Optional Redemption Provisions:</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">2032 Notes: Prior to July&nbsp;15, 2032 (two months prior to the maturity date), make-whole call at any time at the greater of 100% or
discounted present value at Treasury Yield plus 20 basis points. On or after July&nbsp;15, 2032, redeemable at a redemption price equal to 100% of the aggregate principal amount of the Notes being redeemed.</P>
<P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">2035 Notes: Prior to June&nbsp;15, 2035 (three months prior to the maturity date),
make-whole call at any time at the greater of 100% or discounted present value at Treasury Yield plus 20 basis points. On or after June&nbsp;15, 2035, redeemable at a redemption price equal to 100% of the aggregate principal amount of the Notes
being redeemed.</P> <P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">2055 Notes: Prior to March&nbsp;15, 2055 (six months prior to the
maturity date), make-whole call at any time at the greater of 100% or discounted present value at Treasury Yield plus 25 basis points. On or after March&nbsp;15, 2055, redeemable at a redemption price equal to 100% of the aggregate principal amount
of the Notes being redeemed.</P> <P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">2065 Notes: Prior to March&nbsp;15, 2065 (six months
prior to the maturity date), make-whole call at any time at the greater of 100% or discounted present value at Treasury Yield plus 25 basis points. On or after March&nbsp;15, 2065, redeemable at a redemption price equal to 100% of the aggregate
principal amount of the Notes being redeemed.</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>Change of Control:</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Upon certain change of control events, the Issuer will be required to make an offer to purchase the Notes in cash at a price equal to 101% of their aggregate principal amount.</TD></TR>
</TABLE>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="28%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="71%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>Joint Book-Running Managers:</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">BARCLAYS CAPITAL INC.</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">J.P. MORGAN SECURITIES
LLC</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">WELLS FARGO SECURITIES, LLC</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">BOFA SECURITIES, INC.</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">CITIGROUP GLOBAL MARKETS INC.</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">GOLDMAN SACHS&nbsp;&amp; CO.
LLC</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B><FONT STYLE="white-space:nowrap">Co-Managers:</FONT></B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">MIZUHO SECURITIES USA LLC</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">RBC CAPITAL MARKETS,
LLC</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">TRUIST SECURITIES, INC.</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">UBS SECURITIES LLC</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">U.S. BANCORP INVESTMENTS, INC.</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">BNY MELLON CAPITAL MARKETS,
LLC</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">FIFTH THIRD SECURITIES, INC.</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">MORGAN STANLEY&nbsp;&amp;
CO. LLC</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">PNC CAPITAL MARKETS LLC</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">SMBC NIKKO SECURITIES
AMERICA, INC.</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">ICBC STANDARD BANK PLC<SUB STYLE="font-size:75%; vertical-align:bottom">1</SUB></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">TD SECURITIES (USA) LLC</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">KEYBANC CAPITAL MARKETS INC.</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">LOOP CAPITAL MARKETS LLC</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">ACADEMY SECURITIES, INC.</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">SAMUEL A. RAMIREZ&nbsp;&amp; COMPANY, INC.</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">PIPER
SANDLER&nbsp;&amp; CO.</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>CUSIP Number:</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">2032 Notes: 126650EJ5</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">2035 Notes: 126650EK2</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">2055 Notes: 126650EL0</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">2065 Notes: 126650EM8</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>Ratings*:</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">[Reserved]</TD></TR>
</TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>*</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Note: A securities rating is not a recommendation to buy, sell or hold securities and may be subject to
revision or withdrawal at any time. </B></P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><SUB STYLE="font-size:75%; vertical-align:bottom">1</SUB></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">ICBC Standard Bank Plc is restricted in its U.S. securities dealings under the United States Bank Holding
Company Act and may not underwrite, subscribe, agree to purchase or procure purchasers to purchase notes that are offered or sold in the United States. Accordingly, ICBC Standard Bank Plc shall not be obligated to, and shall not, underwrite,
subscribe, agree to purchase or procure purchasers to purchase notes that may be offered or sold by other underwriters in the United States. ICBC Standard Bank Plc shall offer and sell the Notes constituting part of its allotment solely outside the
United States. </P></TD></TR></TABLE> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>Changes to Preliminary Prospectus Supplement </U></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Other Relationships </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The following paragraph shall
replace the second paragraph under the heading &#8220;Underwriting&#8212;Other Relationships&#8221; in the Preliminary Prospectus Supplement: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In the ordinary course of their business activities, the underwriters and their affiliates may make or hold a broad array of investments and
actively trade debt and equity securities (or related derivative securities) and financial instruments (including bank loans) for their own account and for the accounts of their customers. Such investments and securities activities may involve
securities and/or instruments of ours or our affiliates. If any of the underwriters or their affiliates have a lending relationship with us, certain of those underwriters or their affiliates routinely hedge, certain other of those underwriters or
their affiliates have hedged and are likely in the future to hedge, and certain other of those underwriters or their affiliates may hedge, or otherwise reduce their credit exposure to us consistent with their customary risk management policies.
Typically, these underwriters and their affiliates would hedge or otherwise reduce such exposure by entering into transactions which consist of either the purchase of </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
credit default swaps or the creation of short positions in our securities, including potentially the notes offered hereby. Any such credit default swaps or short positions could adversely affect
future trading prices of the notes offered hereby. The underwriters and their affiliates may also make investment recommendations and/or publish or express independent research views in respect of such securities or financial instruments and may
hold, or recommend to clients that they acquire, long and/or short positions in such securities and instruments. An affiliate of one of the underwriters, BNY Mellon Capital Markets, LLC, is acting as Trustee, Registrar and Paying Agent in the
offering. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">This pricing term sheet should be read together with the Issuer&#8217;s preliminary prospectus supplement dated August&nbsp;11, 2025, the
accompanying prospectus dated May&nbsp;25, 2023 and the other documents incorporated by reference therein. Capitalized terms used but not defined herein have the meanings given to them in the Preliminary Prospectus Supplement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>The Issuer has filed a registration statement (including a prospectus and preliminary prospectus supplement) with the SEC for the offering to which this
communication relates. Before you invest, you should read the prospectus and preliminary prospectus supplement in that registration statement, and other documents the Issuer has filed with the SEC for more complete information about the Issuer and
this offering. You may get these documents for free by visiting EDGAR on the SEC website at </B>www.sec.gov<B>. Alternatively, you may obtain a copy of the prospectus and the preliminary prospectus supplement from Barclays Capital Inc. by calling
toll-free at <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">1-888-603-5847,</FONT></FONT></FONT> J.P. Morgan Securities LLC by calling collect at <FONT STYLE="white-space:nowrap"><FONT
STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">1-212-834-4533</FONT></FONT></FONT> and Wells Fargo Securities, LLC by calling toll-free at
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">1-800-645-3751</FONT></FONT></FONT> or emailing </B>wfscustomerservice@wellsfargo.com<B>. </B> </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>ANY DISCLAIMERS OR OTHER NOTICES THAT MAY APPEAR BELOW ARE NOT APPLICABLE TO THIS COMMUNICATION AND SHOULD BE DISREGARDED. SUCH DISCLAIMERS OR OTHER
NOTICES WERE AUTOMATICALLY GENERATED AS A RESULT OF THIS COMMUNICATION BEING SENT VIA BLOOMBERG OR ANOTHER EMAIL SYSTEM. </B></P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>EXHIBIT A </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>SIGNIFICANT SUBSIDIARIES </U></B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">As used
in the Underwriting Agreement, the &#8220;Significant Subsidiaries&#8221; of the Company are as follows: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="63%"></TD>

<TD VALIGN="bottom" WIDTH="7%"></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="7%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="7%"></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; ">Name</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000">Jurisdiction&nbsp;of&nbsp;Organization</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000">%&nbsp;Owned</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000">Liens/Encumbrances</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Aetna Inc.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Pennsylvania</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">100</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>None</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">CVS Pharmacy, Inc.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Rhode Island</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">100</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>None</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Caremark, L.L.C.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>California</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">100</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>None</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">CaremarkPCS Health, L.L.C.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Delaware</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">100</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>None</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Caremark Rx, L.L.C.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Delaware</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">100</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>None</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">CVS Caremark Part D Services, L.L.C.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Delaware</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">100</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>None</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">SilverScript Insurance Company</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Tennessee</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">100</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>None</TD></TR>
</TABLE>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-4.1
<SEQUENCE>3
<FILENAME>d32562dex41.htm
<DESCRIPTION>EX-4.1
<TEXT>
<HTML><HEAD>
<TITLE>EX-4.1</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE" STYLE="line-height:Normal">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 4.1 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">UNLESS THIS CERTIFICATE IS PRESENTED BY AN AUTHORIZED REPRESENTATIVE OF THE DEPOSITORY TRUST COMPANY (&#147;DTC&#148;) TO THE
COMPANY OR ITS AGENT FOR REGISTRATION OF TRANSFER, EXCHANGE OR PAYMENT, AND ANY CERTIFICATE ISSUED IS REGISTERED IN THE NAME OF CEDE&nbsp;&amp; CO. OR SUCH OTHER NAME AS IS REQUESTED BY AN AUTHORIZED REPRESENTATIVE OF DTC (AND ANY PAYMENT IS MADE TO
CEDE&nbsp;&amp; CO., OR TO SUCH OTHER ENTITY AS IS REQUESTED BY AN AUTHORIZED REPRESENTATIVE OF DTC), ANY TRANSFER, PLEDGE OR OTHER USE HEREOF FOR VALUE OR OTHERWISE BY OR TO ANY PERSON IS WRONGFUL INASMUCH AS THE REGISTERED OWNER HEREOF,
CEDE&nbsp;&amp; CO., HAS AN INTEREST HEREIN. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">UNLESS AND UNTIL THIS GLOBAL NOTE IS EXCHANGED IN WHOLE OR IN PART FOR A
GLOBAL NOTE IN DEFINITIVE REGISTERED FORM, THIS GLOBAL NOTE MAY NOT BE TRANSFERRED EXCEPT AS A WHOLE BY DTC TO A NOMINEE OF DTC OR BY A NOMINEE OF DTC TO DTC OR ANOTHER NOMINEE OF DTC OR BY DTC OR ANY SUCH NOMINEE TO A SUCCESSOR DEPOSITARY OR A
NOMINEE OF SUCH SUCCESSOR DEPOSITARY. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">CVS HEALTH CORPORATION </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="51%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="48%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">No.&nbsp;[&#149;]</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">$[&#149;]</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">CUSIP No.&nbsp;126650 EJ5 </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">ISIN
No. US126650EJ50 </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">5.000% Senior Note due 2032 </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">CVS HEALTH CORPORATION, a Delaware corporation (such corporation, and its successors and assigns under the Indenture
hereinafter referred to, being herein called the &#147;<B>Company</B>&#148;), for value received promises to pay to CEDE&nbsp;&amp; CO., or registered assigns, the principal sum of $[&#149;] on September&nbsp;15, 2032. If such maturity date is not a
Business Day, then payment of principal will be made on the next succeeding Business Day and no interest will accrue on the amount so payable for the period from such maturity date to the date payment is made. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Interest Payment Dates: March&nbsp;15 and September 15. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Record Dates: Each March&nbsp;1 and September&nbsp;1, immediately preceding each Interest Payment Date. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Additional provisions of this Note are set forth on the reverse side of this Note. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[<I>Remainder of page intentionally left blank</I>] </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">IN WITNESS WHEREOF, the Company has caused this Note to be duly executed. </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="7%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="92%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B>CVS HEALTH CORPORATION</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Name:</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Title:</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Name:</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Title:</TD></TR>
</TABLE></DIV> <P STYLE="font-size:12pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[<I>Signature Page to
Note No. [&#8195;] of 2032 Notes</I>] </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Dated: August&nbsp;15, 2025 </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">TRUSTEE&#146;S CERTIFICATE OF AUTHENTICATION </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">THE BANK OF NEW
YORK MELLON TRUST COMPANY, N.A., </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">as Trustee, certifies that this is one of the Debt Securities referred to </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">in the Indenture. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="6%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="93%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Authorized Signatory</TD></TR>
</TABLE> <P STYLE="font-size:12pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[<I>Signature Page to
Note No. [&#8195;] of 2032 Notes</I>] </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">5.000% Senior Note due 2032 </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">This Note is one of a duly authorized series of Notes of the Company, designated as its 5.000% Senior Notes due 2032
(hereinafter referred to as the &#147;<B>Notes</B>&#148;). </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(a)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">Interest </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The Company promises to pay interest on the principal amount of this Note at the rate per annum shown above. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The Company will pay interest on the Notes semi-annually on March&nbsp;15 and September&nbsp;15 of each year, commencing
March&nbsp;15, 2026. Interest on the Notes will accrue from the most recent date to which interest has been paid or provided for, or, if no interest has been paid or provided for, from August&nbsp;15, 2025. Interest will be computed on the basis of
a <FONT STYLE="white-space:nowrap">360-day</FONT> year of twelve <FONT STYLE="white-space:nowrap">30-day&nbsp;months.</FONT> The Company shall pay interest on overdue principal at the rate borne by the Notes. If any interest payment date is not a
Business Day, then payment of interest will be made on the next succeeding Business Day and no interest will accrue on the amount so payable for the period from such interest payment date to the date payment is made. </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(b)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">Method of Payment </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The Company will pay interest on the Notes (except defaulted interest) to the Persons who are registered Holders thereof at
the close of business on the March&nbsp;1 and September&nbsp;1 (whether or not a Business Day) immediately preceding the interest payment date even if the Notes are canceled after the record date and on or before the interest payment date. Holders
must surrender Notes to a Paying Agent to collect principal payments. The Company will pay principal, premium, if any, and interest in money of the United States that at the time of payment is legal tender for payment of public and private debts by
wire transfer of immediately available funds to the accounts specified by the Holders, or, if no such account is specified, the Company may pay principal and interest by check payable in such money. It may mail an interest check to a Holder&#146;s
registered address. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(c)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">Paying Agent and Registrar </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Initially, The Bank of New York Mellon Trust Company, N.A., a national banking association (the &#147;<B>Trustee</B>&#148;),
will act as Paying Agent and Registrar. The Company may appoint and change any Paying Agent, Registrar or <FONT STYLE="white-space:nowrap">co-registrar</FONT> without notice. The Company or any of its domestically incorporated Wholly Owned
Subsidiaries may act as Paying Agent, Registrar or <FONT STYLE="white-space:nowrap">co-registrar.</FONT> </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(d)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">Indenture </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The Company issued the Notes under an Indenture dated as of August&nbsp;15, 2006 (the &#147;<B>Indenture</B>&#148;), between
the Company and the Trustee. The terms of the Notes include those stated in the Indenture and those made part of the Indenture by reference to the Trust Indenture Act of 1939 (15 U.S.C. ss.ss. 77aaa-77bbbb) as in effect on the date of the Indenture
(the &#147;<B>TIA</B>&#148;). Terms defined in the Indenture and not otherwise defined herein have the respective meanings ascribed thereto in the Indenture. The Notes are subject to all such terms, and Holders of Notes are referred to the Indenture
and the TIA for a statement of those terms. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The Notes are general unsecured senior obligations of the Company initially
limited to $750,000,000 aggregate principal amount (subject to Section&nbsp;2.08 of the Indenture). The Company may at any time issue additional Notes under the Indenture in unlimited amounts having the same terms as and treated as a single class
with the Notes for all purposes under the Indenture and that will vote together as one class with respect to the Notes; provided that, if such additional Notes are not fungible, for U.S. federal income tax purposes, with the Notes, such additional
Notes will have a different CUSIP, ISIN and/or other identifying number. The Indenture imposes certain limitations on the incurrence of certain additional indebtedness by the Company and certain of its subsidiaries and the entry into certain sale
and leaseback arrangements by the Company and certain of its subsidiaries. The Indenture also restricts the ability of the Company to consolidate or merge with or into, or to transfer all or substantially all its assets to, another person. </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(e)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">Optional Redemption </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Prior to the Applicable Par Call Date, the Company may redeem the Notes at its option, in whole or in part, at any time and
from time to time, at a redemption price (expressed as a percentage of principal amount and rounded to three decimal places) equal to the greater of (i) (a)&nbsp;the sum of the present values of the remaining scheduled payments of principal and
interest thereon discounted to the redemption date (assuming such Notes matured on the Applicable Par Call Date) on a semi-annual basis (assuming a <FONT STYLE="white-space:nowrap">360-day</FONT> year consisting of twelve <FONT
STYLE="white-space:nowrap">30-day&nbsp;months)</FONT> at the Treasury Rate plus the Applicable Spread for the Notes less (b)&nbsp;interest accrued to, but excluding, the redemption date, and (ii)&nbsp;100% of the principal amount of the Notes to be
redeemed, plus, in either case, accrued and unpaid interest thereon to, but excluding, the redemption date. On or after the Applicable Par Call Date, the Company may redeem the Notes, in whole or in part, at any time and from time to time, at a
redemption price equal to 100% of the principal amount of the Notes being redeemed plus accrued and unpaid interest thereon to, but excluding, the redemption date. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">&#147;<B>Applicable Par Call Date</B>&#148; means July&nbsp;15, 2032 (two months prior to the maturity date of the Notes).
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">&#147;<B>Applicable Spread</B>&#148; means 20 basis points. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">&#147;<B>Treasury Rate</B>&#148; means, with respect to any redemption date, the yield determined by the Company in accordance
with the following two paragraphs. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The Treasury Rate shall be determined by the Company after 4:15 p.m., New York City
time (or after such time as yields on U.S. government securities are posted daily by the Board of Governors of the Federal Reserve System), on the third Business Day preceding the redemption date based upon the yield or yields for the most recent
day that appear after such time on such day in the most recent statistical release published by the Board of Governors of the Federal Reserve System designated as &#147;Selected Interest Rates (Daily) - H.15&#148; (or any successor designation or
publication) (&#147;H.15&#148;) under the caption &#147;U.S. government securities&#150;Treasury constant maturities&#150;Nominal&#148; (or any successor caption or heading) (&#147;H.15 TCM&#148;). In determining the Treasury Rate, the Company shall
select, as applicable: (1)&nbsp;the yield for the Treasury constant </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">
maturity on H.15 exactly equal to the period from the redemption date to the Applicable Par Call Date (the &#147;Remaining Life&#148;); or (2)&nbsp;if there is no such Treasury constant maturity
on H.15 exactly equal to the Remaining Life, the two yields &#150; one yield corresponding to the Treasury constant maturity on H.15 immediately shorter than and one yield corresponding to the Treasury constant maturity on H.15 immediately longer
than the Remaining Life &#150; and shall interpolate to the Applicable Par Call Date on a straight-line basis (using the actual number of days) using such yields and rounding the result to three decimal places; or (3)&nbsp;if there is no such
Treasury constant maturity on H.15 shorter than or longer than the Remaining Life, the yield for the single Treasury constant maturity on H.15 closest to the Remaining Life. For purposes of this paragraph, the applicable Treasury constant maturity
or maturities on H.15 shall be deemed to have a maturity date equal to the relevant number of months or years, as applicable, of such Treasury constant maturity from the redemption date. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">If on the third Business Day preceding the redemption date H.15 TCM is no longer published, the Company shall calculate the
Treasury Rate based on the rate per annum equal to the semi-annual equivalent yield to maturity at 11:00 a.m., New York City time, on the second Business Day preceding such redemption date of the United States Treasury security maturing on, or with
a maturity that is closest to, the Applicable Par Call Date, as applicable. If there is no United States Treasury security maturing on the Applicable Par Call Date but there are two or more United States Treasury securities with a maturity date
equally distant from the Applicable Par Call Date, one with a maturity date preceding the Applicable Par Call Date and one with a maturity date following the Applicable Par Call Date, the Company shall select the United States Treasury security with
a maturity date preceding the Applicable Par Call Date. If there are two or more United States Treasury securities maturing on the Applicable Par Call Date or two or more United States Treasury securities meeting the criteria of the preceding
sentence, the Company shall select from among these two or more United States Treasury securities the United States Treasury security that is trading closest to par based upon the average of the bid and asked prices for such United States Treasury
securities at 11:00 a.m., New York City time. In determining the Treasury Rate in accordance with the terms of this paragraph, the semi-annual yield to maturity of the applicable United States Treasury security shall be based upon the average of the
bid and asked prices (expressed as a percentage of principal amount) at 11:00 a.m., New York City time, of such United States Treasury security, and rounded to three decimal places. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The Company&#146;s actions and determinations in determining the redemption price shall be conclusive and binding for all
purposes, absent manifest error. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Notice of any redemption will be mailed or electronically delivered (or otherwise
transmitted in accordance with the depositary&#146;s procedures) at least 10 days but not more than 60 days before the redemption date to each Holder of the Notes to be redeemed. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">In the case of a partial redemption, selection of the Notes for redemption will be made in accordance with the procedures of
DTC. No Notes of a principal amount of $2,000 or less will be redeemed in part. If any Note is to be redeemed in part only, the notice of redemption that relates to the Note will state the portion of the principal amount of the Note to be redeemed.
A new Note in a principal amount equal to the unredeemed portion of the Note will be issued in the name of the holder of the Note upon surrender for cancellation of the original Note. For so long as the Notes are held by DTC (or another Depositary),
the redemption of the Notes shall be done in accordance with the policies and procedures of the Depositary. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Unless the Company defaults in payment of the redemption price, on and after
the redemption date, interest will cease to accrue on the Notes or portions thereof called for redemption. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(f)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">Repurchase of the Notes Upon a Change of Control Triggering Event </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">If a Change of Control Triggering Event (as defined below) occurs, Holders of the Notes will have the right to require the
Company to repurchase all or any part (in integral multiples of $1,000 up to the original principal amount) of their Notes pursuant to the offer described below (the &#147;<B>Change of Control Offer</B>&#148;) on the terms set forth in this Note. In
the Change of Control Offer, the Company will be required to offer payment in cash equal to 101% of the aggregate principal amount of Notes repurchased plus accrued and unpaid interest, if any, on the Notes repurchased, to, but excluding, the date
of purchase (the &#147;<B>Change of Control Payment</B>&#148;). Within 30 days following any Change of Control Triggering Event, the Company will be required to mail a notice to Holders of Notes describing the transaction or transactions that
constitute the Change of Control Triggering Event and offering to repurchase the Notes on the date specified in the notice, which date will be no earlier than 30 days and no later than 60 days from the date such notice is mailed (the &#147;<B>Change
of Control Payment Date</B>&#148;), pursuant to the procedures required by this Note and described in such notice. The Company must comply with the requirements of Rule <FONT STYLE="white-space:nowrap">14e-1</FONT> under the Exchange Act and any
other securities laws and regulations thereunder to the extent those laws and regulations are applicable in connection with the repurchase of the Notes as a result of a Change of Control Triggering Event. To the extent that the provisions of any
securities laws or regulations conflict with the Change of Control provisions of the Notes, the Company will be required to comply with the applicable securities laws and regulations and will not be deemed to have breached its obligations under the
Change of Control provisions of the Notes by virtue of such conflicts and compliance with law. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">On the Change of Control
Payment Date, the Company will be required, to the extent lawful, to: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">accept for payment all Notes properly tendered pursuant to the Change of Control Offer; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">deposit with the Paying Agent an amount equal to the Change of Control Payment in respect of all Notes or
portions of Notes properly tendered; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">deliver or cause to be delivered to the Trustee the Notes properly accepted together with an Officers&#146;
Certificate stating the aggregate principal amount of Notes or portions of Notes being purchased. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The
Company will not be required to make a Change of Control Offer upon the occurrence of a Change of Control Triggering Event if a third party makes such an offer in the manner, at the times and otherwise in compliance with the requirements for an
offer made by the Company and the third party repurchases all Notes properly tendered and not withdrawn under its offer. In addition, the Company will not repurchase any Notes if there has occurred and is continuing on the Change of Control Payment
Date an event of default under the Indenture, other than a default in the payment of the Change of Control Payment upon a Change of Control Triggering Event. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">For purposes of the foregoing, the following definitions are applicable:
</P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">&#147;<B>Below Investment Grade Rating Event</B>&#148; means that the Notes are rated below an Investment Grade Rating by
each of the Rating Agencies (as defined below) on any date from the date of the public notice of an arrangement that could result in a Change of Control until the end of the <FONT STYLE="white-space:nowrap">60-day</FONT> period following public
notice of the occurrence of the Change of Control (which <FONT STYLE="white-space:nowrap">60-day</FONT> period shall be extended so long as the rating of the Notes is under publicly announced consideration for possible downgrade by any of the Rating
Agencies); <I>provided</I>, <I>however</I>, that a Below Investment Grade Rating Event otherwise arising by virtue of a particular reduction in rating will not be deemed to have occurred in respect of a particular Change of Control (and thus will
not be deemed a Below Investment Grade Rating Event for purposes of the definition of Change of Control Triggering Event) if the Rating Agencies making the reduction in rating to which this definition would otherwise apply do not announce or
publicly confirm or inform the Trustee in writing at the Company&#146;s or the Trustee&#146;s request that the reduction was the result, in whole or in part, of any event or circumstance comprised of or arising as a result of, or in respect of, the
applicable Change of Control (whether or not the applicable Change of Control has occurred at the time of the Below Investment Grade Rating Event). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">&#147;<B>Change of Control</B>&#148; means the occurrence of any of the following: (1)&nbsp;any event requiring the filing of
any report under or in response to Schedule 13D or <FONT STYLE="white-space:nowrap">14D-1</FONT> pursuant to the Exchange Act disclosing beneficial ownership of either 50% or more of the Company&#146;s common stock then outstanding or 50% or more of
the Company&#146;s voting power or the Company&#146;s voting stock then outstanding; (2)&nbsp;the direct or indirect sale, transfer, conveyance or other disposition (other than by way of merger or consolidation), in one or a series of related
transactions, of all or substantially all of the Company&#146;s properties or the Company&#146;s assets and the assets of its respective subsidiaries taken as a whole to one or more persons (as defined in the Indenture) other than the Company or one
of its subsidiaries; or (3)&nbsp;the first day on which a majority of the members of the Company&#146;s Board of Directors are not Continuing Directors. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Notwithstanding the foregoing, a transaction will not be deemed to involve a Change of Control if (1)&nbsp;the Company becomes
a direct or indirect wholly-owned subsidiary of a holding company and (2)(A) the direct or indirect holders of the voting stock of such holding company immediately following that transaction are substantially the same as the holders of the
Company&#146;s voting stock immediately prior to that transaction or (B)&nbsp;immediately following that transaction no person (other than a holding company satisfying the requirements of this sentence) is the beneficial owner, directly or
indirectly, of more than 50% of the voting stock of such holding company. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">&#147;<B>Change of Control Triggering
Event</B>&#148; means the occurrence of both a Change of Control and a Below Investment Grade Rating Event. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">&#147;<B>Continuing Director</B>&#148; means, as of any date of
determination, any member of the Company&#146;s Board of Directors who (1)&nbsp;was a member of such Board of Directors on the date of the issuance of the Notes; or (2)&nbsp;was nominated for election or elected to such Board of Directors with the
approval of a majority of the Continuing Directors who were members of such Board of Directors at the time of such nomination or election (either by a specific vote or by approval of the Company&#146;s proxy statement in which such member was named
as a nominee for election as a director, without objection to such nomination). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">&#147;<B>Fitch</B>&#148; mean Fitch
Ratings Inc. and its successors. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">&#147;<B>Investment Grade Rating</B>&#148; means a rating equal to or higher than Baa3
(or the equivalent) by Moody&#146;s and <FONT STYLE="white-space:nowrap">BBB-</FONT> (or the equivalent) by S&amp;P. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">&#147;<B>Moody&#146;s</B>&#148; means Moody&#146;s Investors Service, Inc., or its successor. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">&#147;<B>Rating Agencies</B>&#148; means (1)&nbsp;each of Moody&#146;s, S&amp;P and Fitch; and (2)&nbsp;if any of
Moody&#146;s, S&amp;P or Fitch ceases to rate the Notes or fails to make a rating of the Notes publicly available for reasons outside of the Company&#146;s control, a &#147;nationally recognized statistical rating organization&#148; within the
meaning of Rule 3(a)(62) under the Exchange Act selected by the Company (as certified by a resolution of the Company&#146;s Board of Directors) as a replacement agency for Moody&#146;s, S&amp;P or Fitch or all of them, as the case may be. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">&#147;<B>S&amp;P</B>&#148; means S&amp;P Global Ratings, a division of S&amp;P Global Inc., or its successor. </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(g)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">Denominations; Transfer; Exchange </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The Notes are in registered form without coupons in denominations of $2,000 and integral multiples of $1,000 in excess
thereof. Holders of Notes may transfer or exchange Notes in accordance with the Indenture. The Registrar may require a Holder of Notes, among other things, to furnish appropriate endorsements or transfer documents and to pay any taxes and fees
required by law or permitted by the Indenture. The Registrar need not register the transfer of or exchange any Notes selected for redemption (except, in the case of a Note to be redeemed in part, the portion of the Note not to be redeemed) or any
Notes for a period of 15&nbsp;days before a selection of Notes to be redeemed or 15&nbsp;days before an interest payment date. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(h)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">Persons Deemed Owners </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The registered Holder of this Note may be treated as the sole owner of such Note for all purposes. </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(i)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">Unclaimed Money </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Subject to applicable abandoned property law, if money for the payment of principal or interest remains unclaimed for two
years, the Trustee or Paying Agent shall pay the money back to the Company at its request unless an abandoned property law designates another Person. After any such payment, Holders entitled to the money must look only to the Company and not to the
Trustee or Paying Agent for payment. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(j)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">Discharge and Defeasance </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Subject to certain conditions, the Company at any time may terminate some or all of its obligations under the Notes and the
Indenture if the Company deposits with the Trustee money or U.S. Government Obligations for the payment of principal and interest on the Notes to redemption or maturity, as the case may be. </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(k)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">Amendment; Waiver </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Subject to certain exceptions set forth in the Indenture, (i)&nbsp;the Indenture or the Notes may be amended with the written
consent of the Holders of at least a majority in principal amount outstanding of the Notes; and (ii)&nbsp;any default or compliance with any provision may be waived with the written consent of the Holders of a majority in principal amount of the
Notes then outstanding. Subject to certain exceptions set forth in the Indenture, without the consent of any Holder of a Note, the Company and the Trustee may amend the Indenture or the Notes to cure any ambiguity, omission, defect or inconsistency
that does not materially and adversely affect the rights of any Holder of a Note, or to comply with Article&nbsp;5 of the Indenture or to comply with requirements of the SEC in connection with the qualification of the Indenture under the TIA. </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(l)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">Defaults and Remedies </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">If an Event of Default occurs and is continuing, the Trustee or the Holders of at least 25% in aggregate principal amount of
the Notes may declare all the Notes to be due and payable immediately. Certain events of bankruptcy or insolvency are Events of Default which will result in the Notes being due and payable immediately upon the occurrence of such Events of Default.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Holders of Notes may not enforce the Indenture or the Notes except as provided in the Indenture. The Trustee may refuse
to enforce the Indenture or the Notes unless it receives indemnity or security satisfactory to it. Subject to certain limitations, Holders of a majority in principal amount of the Notes may direct the Trustee in its exercise of any trust or power.
The Trustee may withhold from Holders of Notes notice of any continuing Default (except a Default in payment of principal or interest) if it determines that withholding such notice is in the interest of the Holders of Notes. </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(m)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">Trustee Dealings with the Company </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Subject to certain limitations imposed by the TIA, the Trustee under the Indenture, in its individual or any other capacity,
may become the owner or pledgee of Notes and may otherwise deal with and collect obligations owed to it by the Company or its Affiliates and may otherwise deal with the Company or its Affiliates with the same rights it would have if it were not
Trustee. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(n)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">No Recourse Against Others </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">A director, officer, employee or stockholder, as such, of the Company or the Trustee shall not have any liability for any
obligations of the Company under the Notes or the Indenture or for any claim based on, in respect of or by reason of such obligations. By accepting a Note, each Holder of a Note waives and releases all such liability. The waiver and release are part
of the consideration for the issue of the Notes. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(o)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">Authentication </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">This Note shall not be valid until an authorized signatory of the Trustee (or an authenticating agent) manually signs the
certificate of authentication on the face of this Note. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(p)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">Abbreviations </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Customary abbreviations may be used in the name of a Holder of a Note or an assignee, such as TEN COM (=tenants in common),
TEN ENT (=tenants by the entireties), JT TEN (=joint tenants with rights of survivorship and not as tenants in common), CUST (=custodian), and U/G/M/A (=Uniform Gift to Minors Act). </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(q)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">Governing Law </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">This Note shall be governed by, and construed in accordance with, the laws of the State of New York. </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(r)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">CUSIP Numbers </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Pursuant to the recommendation promulgated by the Committee on Uniform Security Identification Procedures, the Company has
caused CUSIP numbers to be printed on the Notes and has directed the Trustee to use such CUSIP numbers in notices of redemption as a convenience to Holders of Notes. No representation is made as to the accuracy of such numbers either as printed on
the Notes or as contained in any notice of redemption and reliance may be placed only on the other identification numbers placed thereon. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">------------------------------------------- </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The Company will furnish to any Holder of a Note upon written request and
without charge to such Holder of a Note a copy of the Indenture. Requests may be made to: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">CVS Health Corporation </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">One CVS Drive &#151; MC 1008 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Woonsocket, Rhode Island 02895 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Attention: Tom Cowhey </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">ASSIGNMENT FORM </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">To assign this Note, complete the form below: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">I or we assign and transfer this Note to: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[Print or type assignee&#146;s name, address and zip code] </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[Insert assignee&#146;s soc. sec. or tax I.D. No.] </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:30%; text-indent:4%; font-size:10pt; font-family:Times New Roman">and irrevocably appoint ___________ as agent to </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:30%; text-indent:4%; font-size:10pt; font-family:Times New Roman">transfer this Note on the books of CVS Health Corporation. </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:30%; text-indent:4%; font-size:10pt; font-family:Times New Roman">The agent may substitute another to act for him. </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</DIV> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="4%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="37%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="4%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="12%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="34%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="4%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Date:</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">&#8195;&#8195;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Your&nbsp;Signature:</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">&#8195;&#8195;</TD></TR>
</TABLE> <P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</DIV>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Sign exactly as your name appears on the face of this Note. </P>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-4.2
<SEQUENCE>4
<FILENAME>d32562dex42.htm
<DESCRIPTION>EX-4.2
<TEXT>
<HTML><HEAD>
<TITLE>EX-4.2</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE" STYLE="line-height:Normal">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 4.2 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">UNLESS THIS CERTIFICATE IS PRESENTED BY AN AUTHORIZED REPRESENTATIVE OF THE DEPOSITORY TRUST COMPANY (&#147;DTC&#148;) TO THE
COMPANY OR ITS AGENT FOR REGISTRATION OF TRANSFER, EXCHANGE OR PAYMENT, AND ANY CERTIFICATE ISSUED IS REGISTERED IN THE NAME OF CEDE&nbsp;&amp; CO. OR SUCH OTHER NAME AS IS REQUESTED BY AN AUTHORIZED REPRESENTATIVE OF DTC (AND ANY PAYMENT IS MADE TO
CEDE&nbsp;&amp; CO., OR TO SUCH OTHER ENTITY AS IS REQUESTED BY AN AUTHORIZED REPRESENTATIVE OF DTC), ANY TRANSFER, PLEDGE OR OTHER USE HEREOF FOR VALUE OR OTHERWISE BY OR TO ANY PERSON IS WRONGFUL INASMUCH AS THE REGISTERED OWNER HEREOF,
CEDE&nbsp;&amp; CO., HAS AN INTEREST HEREIN. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">UNLESS AND UNTIL THIS GLOBAL NOTE IS EXCHANGED IN WHOLE OR IN PART FOR A
GLOBAL NOTE IN DEFINITIVE REGISTERED FORM, THIS GLOBAL NOTE MAY NOT BE TRANSFERRED EXCEPT AS A WHOLE BY DTC TO A NOMINEE OF DTC OR BY A NOMINEE OF DTC TO DTC OR ANOTHER NOMINEE OF DTC OR BY DTC OR ANY SUCH NOMINEE TO A SUCCESSOR DEPOSITARY OR A
NOMINEE OF SUCH SUCCESSOR DEPOSITARY. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">CVS HEALTH CORPORATION </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="51%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="48%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">No.&nbsp;[&#149;]</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">$[&#149;]</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">CUSIP No.&nbsp;126650 EK2 </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">ISIN
No. US126650EK24 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">5.450% Senior Note due 2035 </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">CVS HEALTH CORPORATION, a Delaware corporation (such corporation, and its successors and assigns under the Indenture
hereinafter referred to, being herein called the &#147;<B>Company</B>&#148;), for value received promises to pay to CEDE&nbsp;&amp; CO., or registered assigns, the principal sum of $[&#149;] on September&nbsp;15, 2035. If such maturity date is not a
Business Day, then payment of principal will be made on the next succeeding Business Day and no interest will accrue on the amount so payable for the period from such maturity date to the date payment is made. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Interest Payment Dates: March&nbsp;15 and September 15. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Record Dates: Each March&nbsp;1 and September&nbsp;1, immediately preceding each Interest Payment Date. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Additional provisions of this Note are set forth on the reverse side of this Note. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[<I>Remainder of page intentionally left blank</I>] </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">IN WITNESS WHEREOF, the Company has caused this Note to be duly executed. </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="7%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="92%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B>CVS HEALTH CORPORATION</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Name:</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Title:</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Name:</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Title:</P></TD></TR>
</TABLE></DIV>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[<I>Signature Page to
Note No. [&#8195;] of 2035 Notes</I>] </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Dated: August&nbsp;15, 2025 </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">TRUSTEE&#146;S CERTIFICATE OF AUTHENTICATION </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">THE BANK OF NEW
YORK MELLON TRUST COMPANY, N.A., </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">as Trustee, certifies that this is one of the Debt Securities referred to </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">in the Indenture. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="6%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="93%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Authorized Signatory</P></TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[<I>Signature Page to
Note No. [&#8195;] of 2035 Notes</I>] </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">5.450% Senior Note due 2035 </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">This Note is one of a duly authorized series of Notes of the Company, designated as its 5.450% Senior Notes due 2035
(hereinafter referred to as the &#147;<B>Notes</B>&#148;). </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(a)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">Interest </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The Company promises to pay interest on the principal amount of this Note at the rate per annum shown above. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The Company will pay interest on the Notes semi-annually on March&nbsp;15 and September&nbsp;15 of each year, commencing
March&nbsp;15, 2026. Interest on the Notes will accrue from the most recent date to which interest has been paid or provided for, or, if no interest has been paid or provided for, from August&nbsp;15, 2025. Interest will be computed on the basis of
a <FONT STYLE="white-space:nowrap">360-day</FONT> year of twelve <FONT STYLE="white-space:nowrap">30-day&nbsp;months.</FONT> The Company shall pay interest on overdue principal at the rate borne by the Notes. If any interest payment date is not a
Business Day, then payment of interest will be made on the next succeeding Business Day and no interest will accrue on the amount so payable for the period from such interest payment date to the date payment is made. </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(b)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">Method of Payment </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The Company will pay interest on the Notes (except defaulted interest) to the Persons who are registered Holders thereof at
the close of business on the March&nbsp;1 and September&nbsp;1 (whether or not a Business Day) immediately preceding the interest payment date even if the Notes are canceled after the record date and on or before the interest payment date. Holders
must surrender Notes to a Paying Agent to collect principal payments. The Company will pay principal, premium, if any, and interest in money of the United States that at the time of payment is legal tender for payment of public and private debts by
wire transfer of immediately available funds to the accounts specified by the Holders, or, if no such account is specified, the Company may pay principal and interest by check payable in such money. It may mail an interest check to a Holder&#146;s
registered address. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(c)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">Paying Agent and Registrar </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Initially, The Bank of New York Mellon Trust Company, N.A., a national banking association (the &#147;<B>Trustee</B>&#148;),
will act as Paying Agent and Registrar. The Company may appoint and change any Paying Agent, Registrar or <FONT STYLE="white-space:nowrap">co-registrar</FONT> without notice. The Company or any of its domestically incorporated Wholly Owned
Subsidiaries may act as Paying Agent, Registrar or <FONT STYLE="white-space:nowrap">co-registrar.</FONT> </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(d)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">Indenture </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The Company issued the Notes under an Indenture dated as of August&nbsp;15, 2006 (the &#147;<B>Indenture</B>&#148;), between
the Company and the Trustee. The terms of the Notes include those stated in the Indenture and those made part of the Indenture by reference to the Trust Indenture Act of 1939 (15 U.S.C. ss.ss. 77aaa-77bbbb) as in effect on the date of the Indenture
(the &#147;<B>TIA</B>&#148;). Terms defined in the Indenture and not otherwise defined herein have the respective meanings ascribed thereto in the Indenture. The Notes are subject to all such terms, and Holders of Notes are referred to the Indenture
and the TIA for a statement of those terms. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The Notes are general unsecured senior obligations of the Company initially
limited to $1,500,000,000 aggregate principal amount (subject to Section&nbsp;2.08 of the Indenture). The Company may at any time issue additional Notes under the Indenture in unlimited amounts having the same terms as and treated as a single class
with the Notes for all purposes under the Indenture and that will vote together as one class with respect to the Notes; provided that, if such additional Notes are not fungible, for U.S. federal income tax purposes, with the Notes, such additional
Notes will have a different CUSIP, ISIN and/or other identifying number. The Indenture imposes certain limitations on the incurrence of certain additional indebtedness by the Company and certain of its subsidiaries and the entry into certain sale
and leaseback arrangements by the Company and certain of its subsidiaries. The Indenture also restricts the ability of the Company to consolidate or merge with or into, or to transfer all or substantially all its assets to, another person. </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(e)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">Optional Redemption </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Prior to the Applicable Par Call Date, the Company may redeem the Notes at its option, in whole or in part, at any time and
from time to time, at a redemption price (expressed as a percentage of principal amount and rounded to three decimal places) equal to the greater of (i) (a)&nbsp;the sum of the present values of the remaining scheduled payments of principal and
interest thereon discounted to the redemption date (assuming such Notes matured on the Applicable Par Call Date) on a semi-annual basis (assuming a <FONT STYLE="white-space:nowrap">360-day</FONT> year consisting of twelve <FONT
STYLE="white-space:nowrap">30-day&nbsp;months)</FONT> at the Treasury Rate plus the Applicable Spread for the Notes less (b)&nbsp;interest accrued to, but excluding, the redemption date, and (ii)&nbsp;100% of the principal amount of the Notes to be
redeemed, plus, in either case, accrued and unpaid interest thereon to, but excluding, the redemption date. On or after the Applicable Par Call Date, the Company may redeem the Notes, in whole or in part, at any time and from time to time, at a
redemption price equal to 100% of the principal amount of the Notes being redeemed plus accrued and unpaid interest thereon to, but excluding, the redemption date. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">&#147;<B>Applicable Par Call Date</B>&#148; means June&nbsp;15, 2035 (three months prior to the maturity date of the Notes).
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">&#147;<B>Applicable Spread</B>&#148; means 20 basis points. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">&#147;<B>Treasury Rate</B>&#148; means, with respect to any redemption date, the yield determined by the Company in accordance
with the following two paragraphs. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The Treasury Rate shall be determined by the Company after 4:15 p.m., New York City
time (or after such time as yields on U.S. government securities are posted daily by the Board of Governors of the Federal Reserve System), on the third Business Day preceding the redemption date based upon the yield or yields for the most recent
day that appear after such time on such day in the most recent statistical release published by the Board of Governors of the Federal Reserve System designated as &#147;Selected Interest Rates (Daily) - H.15&#148; (or any successor designation or
publication) (&#147;H.15&#148;) under the caption &#147;U.S. government securities&#150;Treasury constant maturities&#150;Nominal&#148; (or any successor caption or heading) (&#147;H.15 TCM&#148;). In determining the Treasury Rate, the Company shall
select, as applicable: (1)&nbsp;the yield for the Treasury constant </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">
maturity on H.15 exactly equal to the period from the redemption date to the Applicable Par Call Date (the &#147;Remaining Life&#148;); or (2)&nbsp;if there is no such Treasury constant maturity
on H.15 exactly equal to the Remaining Life, the two yields &#150; one yield corresponding to the Treasury constant maturity on H.15 immediately shorter than and one yield corresponding to the Treasury constant maturity on H.15 immediately longer
than the Remaining Life &#150; and shall interpolate to the Applicable Par Call Date on a straight-line basis (using the actual number of days) using such yields and rounding the result to three decimal places; or (3)&nbsp;if there is no such
Treasury constant maturity on H.15 shorter than or longer than the Remaining Life, the yield for the single Treasury constant maturity on H.15 closest to the Remaining Life. For purposes of this paragraph, the applicable Treasury constant maturity
or maturities on H.15 shall be deemed to have a maturity date equal to the relevant number of months or years, as applicable, of such Treasury constant maturity from the redemption date. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">If on the third Business Day preceding the redemption date H.15 TCM is no longer published, the Company shall calculate the
Treasury Rate based on the rate per annum equal to the semi-annual equivalent yield to maturity at 11:00 a.m., New York City time, on the second Business Day preceding such redemption date of the United States Treasury security maturing on, or with
a maturity that is closest to, the Applicable Par Call Date, as applicable. If there is no United States Treasury security maturing on the Applicable Par Call Date but there are two or more United States Treasury securities with a maturity date
equally distant from the Applicable Par Call Date, one with a maturity date preceding the Applicable Par Call Date and one with a maturity date following the Applicable Par Call Date, the Company shall select the United States Treasury security with
a maturity date preceding the Applicable Par Call Date. If there are two or more United States Treasury securities maturing on the Applicable Par Call Date or two or more United States Treasury securities meeting the criteria of the preceding
sentence, the Company shall select from among these two or more United States Treasury securities the United States Treasury security that is trading closest to par based upon the average of the bid and asked prices for such United States Treasury
securities at 11:00 a.m., New York City time. In determining the Treasury Rate in accordance with the terms of this paragraph, the semi-annual yield to maturity of the applicable United States Treasury security shall be based upon the average of the
bid and asked prices (expressed as a percentage of principal amount) at 11:00 a.m., New York City time, of such United States Treasury security, and rounded to three decimal places. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The Company&#146;s actions and determinations in determining the redemption price shall be conclusive and binding for all
purposes, absent manifest error. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Notice of any redemption will be mailed or electronically delivered (or otherwise
transmitted in accordance with the depositary&#146;s procedures) at least 10 days but not more than 60 days before the redemption date to each Holder of the Notes to be redeemed. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">In the case of a partial redemption, selection of the Notes for redemption will be made in accordance with the procedures of
DTC. No Notes of a principal amount of $2,000 or less will be redeemed in part. If any Note is to be redeemed in part only, the notice of redemption that relates to the Note will state the portion of the principal amount of the Note to be redeemed.
A new Note in a principal amount equal to the unredeemed portion of the Note will be issued in the name of the holder of the Note upon surrender for cancellation of the original Note. For so long as the Notes are held by DTC (or another Depositary),
the redemption of the Notes shall be done in accordance with the policies and procedures of the Depositary. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Unless the Company defaults in payment of the redemption price, on and after
the redemption date, interest will cease to accrue on the Notes or portions thereof called for redemption. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(f)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">Repurchase of the Notes Upon a Change of Control Triggering Event </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">If a Change of Control Triggering Event (as defined below) occurs, Holders of the Notes will have the right to require the
Company to repurchase all or any part (in integral multiples of $1,000 up to the original principal amount) of their Notes pursuant to the offer described below (the &#147;<B>Change of Control Offer</B>&#148;) on the terms set forth in this Note. In
the Change of Control Offer, the Company will be required to offer payment in cash equal to 101% of the aggregate principal amount of Notes repurchased plus accrued and unpaid interest, if any, on the Notes repurchased, to, but excluding, the date
of purchase (the &#147;<B>Change of Control Payment</B>&#148;). Within 30 days following any Change of Control Triggering Event, the Company will be required to mail a notice to Holders of Notes describing the transaction or transactions that
constitute the Change of Control Triggering Event and offering to repurchase the Notes on the date specified in the notice, which date will be no earlier than 30 days and no later than 60 days from the date such notice is mailed (the &#147;<B>Change
of Control Payment Date</B>&#148;), pursuant to the procedures required by this Note and described in such notice. The Company must comply with the requirements of Rule <FONT STYLE="white-space:nowrap">14e-1</FONT> under the Exchange Act and any
other securities laws and regulations thereunder to the extent those laws and regulations are applicable in connection with the repurchase of the Notes as a result of a Change of Control Triggering Event. To the extent that the provisions of any
securities laws or regulations conflict with the Change of Control provisions of the Notes, the Company will be required to comply with the applicable securities laws and regulations and will not be deemed to have breached its obligations under the
Change of Control provisions of the Notes by virtue of such conflicts and compliance with law. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">On the Change of Control
Payment Date, the Company will be required, to the extent lawful, to: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">accept for payment all Notes properly tendered pursuant to the Change of Control Offer; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">deposit with the Paying Agent an amount equal to the Change of Control Payment in respect of all Notes or
portions of Notes properly tendered; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">deliver or cause to be delivered to the Trustee the Notes properly accepted together with an Officers&#146;
Certificate stating the aggregate principal amount of Notes or portions of Notes being purchased. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The
Company will not be required to make a Change of Control Offer upon the occurrence of a Change of Control Triggering Event if a third party makes such an offer in the manner, at the times and otherwise in compliance with the requirements for an
offer made by the Company and the third party repurchases all Notes properly tendered and not withdrawn under its offer. In addition, the Company will not repurchase any Notes if there has occurred and is continuing on the Change of Control Payment
Date an event of default under the Indenture, other than a default in the payment of the Change of Control Payment upon a Change of Control Triggering Event. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">For purposes of the foregoing, the following definitions are applicable:
</P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">&#147;<B>Below Investment Grade Rating Event</B>&#148; means that the Notes are rated below an Investment Grade Rating by
each of the Rating Agencies (as defined below) on any date from the date of the public notice of an arrangement that could result in a Change of Control until the end of the <FONT STYLE="white-space:nowrap">60-day</FONT> period following public
notice of the occurrence of the Change of Control (which <FONT STYLE="white-space:nowrap">60-day</FONT> period shall be extended so long as the rating of the Notes is under publicly announced consideration for possible downgrade by any of the Rating
Agencies); <I>provided</I>, <I>however</I>, that a Below Investment Grade Rating Event otherwise arising by virtue of a particular reduction in rating will not be deemed to have occurred in respect of a particular Change of Control (and thus will
not be deemed a Below Investment Grade Rating Event for purposes of the definition of Change of Control Triggering Event) if the Rating Agencies making the reduction in rating to which this definition would otherwise apply do not announce or
publicly confirm or inform the Trustee in writing at the Company&#146;s or the Trustee&#146;s request that the reduction was the result, in whole or in part, of any event or circumstance comprised of or arising as a result of, or in respect of, the
applicable Change of Control (whether or not the applicable Change of Control has occurred at the time of the Below Investment Grade Rating Event). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">&#147;<B>Change of Control</B>&#148; means the occurrence of any of the following: (1)&nbsp;any event requiring the filing of
any report under or in response to Schedule 13D or <FONT STYLE="white-space:nowrap">14D-1</FONT> pursuant to the Exchange Act disclosing beneficial ownership of either 50% or more of the Company&#146;s common stock then outstanding or 50% or more of
the Company&#146;s voting power or the Company&#146;s voting stock then outstanding; (2)&nbsp;the direct or indirect sale, transfer, conveyance or other disposition (other than by way of merger or consolidation), in one or a series of related
transactions, of all or substantially all of the Company&#146;s properties or the Company&#146;s assets and the assets of its respective subsidiaries taken as a whole to one or more persons (as defined in the Indenture) other than the Company or one
of its subsidiaries; or (3)&nbsp;the first day on which a majority of the members of the Company&#146;s Board of Directors are not Continuing Directors. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Notwithstanding the foregoing, a transaction will not be deemed to involve a Change of Control if (1)&nbsp;the Company becomes
a direct or indirect wholly-owned subsidiary of a holding company and (2)(A) the direct or indirect holders of the voting stock of such holding company immediately following that transaction are substantially the same as the holders of the
Company&#146;s voting stock immediately prior to that transaction or (B)&nbsp;immediately following that transaction no person (other than a holding company satisfying the requirements of this sentence) is the beneficial owner, directly or
indirectly, of more than 50% of the voting stock of such holding company. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">&#147;<B>Change of Control Triggering
Event</B>&#148; means the occurrence of both a Change of Control and a Below Investment Grade Rating Event. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">&#147;<B>Continuing Director</B>&#148; means, as of any date of
determination, any member of the Company&#146;s Board of Directors who (1)&nbsp;was a member of such Board of Directors on the date of the issuance of the Notes; or (2)&nbsp;was nominated for election or elected to such Board of Directors with the
approval of a majority of the Continuing Directors who were members of such Board of Directors at the time of such nomination or election (either by a specific vote or by approval of the Company&#146;s proxy statement in which such member was named
as a nominee for election as a director, without objection to such nomination). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">&#147;<B>Fitch</B>&#148; mean Fitch
Ratings Inc. and its successors. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">&#147;<B>Investment Grade Rating</B>&#148; means a rating equal to or higher than Baa3
(or the equivalent) by Moody&#146;s and <FONT STYLE="white-space:nowrap">BBB-</FONT> (or the equivalent) by S&amp;P. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">&#147;<B>Moody&#146;s</B>&#148; means Moody&#146;s Investors Service, Inc., or its successor. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">&#147;<B>Rating Agencies</B>&#148; means (1)&nbsp;each of Moody&#146;s, S&amp;P and Fitch; and (2)&nbsp;if any of
Moody&#146;s, S&amp;P or Fitch ceases to rate the Notes or fails to make a rating of the Notes publicly available for reasons outside of the Company&#146;s control, a &#147;nationally recognized statistical rating organization&#148; within the
meaning of Rule 3(a)(62) under the Exchange Act selected by the Company (as certified by a resolution of the Company&#146;s Board of Directors) as a replacement agency for Moody&#146;s, S&amp;P or Fitch or all of them, as the case may be. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">&#147;<B>S&amp;P</B>&#148; means S&amp;P Global Ratings, a division of S&amp;P Global Inc., or its successor. </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(g)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">Denominations; Transfer; Exchange </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The Notes are in registered form without coupons in denominations of $2,000 and integral multiples of $1,000 in excess
thereof. Holders of Notes may transfer or exchange Notes in accordance with the Indenture. The Registrar may require a Holder of Notes, among other things, to furnish appropriate endorsements or transfer documents and to pay any taxes and fees
required by law or permitted by the Indenture. The Registrar need not register the transfer of or exchange any Notes selected for redemption (except, in the case of a Note to be redeemed in part, the portion of the Note not to be redeemed) or any
Notes for a period of 15&nbsp;days before a selection of Notes to be redeemed or 15&nbsp;days before an interest payment date. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(h)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">Persons Deemed Owners </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The registered Holder of this Note may be treated as the sole owner of such Note for all purposes. </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(i)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">Unclaimed Money </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Subject to applicable abandoned property law, if money for the payment of principal or interest remains unclaimed for two
years, the Trustee or Paying Agent shall pay the money back to the Company at its request unless an abandoned property law designates another Person. After any such payment, Holders entitled to the money must look only to the Company and not to the
Trustee or Paying Agent for payment. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(j)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">Discharge and Defeasance </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Subject to certain conditions, the Company at any time may terminate some or all of its obligations under the Notes and the
Indenture if the Company deposits with the Trustee money or U.S. Government Obligations for the payment of principal and interest on the Notes to redemption or maturity, as the case may be. </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(k)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">Amendment; Waiver </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Subject to certain exceptions set forth in the Indenture, (i)&nbsp;the Indenture or the Notes may be amended with the written
consent of the Holders of at least a majority in principal amount outstanding of the Notes; and (ii)&nbsp;any default or compliance with any provision may be waived with the written consent of the Holders of a majority in principal amount of the
Notes then outstanding. Subject to certain exceptions set forth in the Indenture, without the consent of any Holder of a Note, the Company and the Trustee may amend the Indenture or the Notes to cure any ambiguity, omission, defect or inconsistency
that does not materially and adversely affect the rights of any Holder of a Note, or to comply with Article&nbsp;5 of the Indenture or to comply with requirements of the SEC in connection with the qualification of the Indenture under the TIA. </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(l)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">Defaults and Remedies </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">If an Event of Default occurs and is continuing, the Trustee or the Holders of at least 25% in aggregate principal amount of
the Notes may declare all the Notes to be due and payable immediately. Certain events of bankruptcy or insolvency are Events of Default which will result in the Notes being due and payable immediately upon the occurrence of such Events of Default.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Holders of Notes may not enforce the Indenture or the Notes except as provided in the Indenture. The Trustee may refuse
to enforce the Indenture or the Notes unless it receives indemnity or security satisfactory to it. Subject to certain limitations, Holders of a majority in principal amount of the Notes may direct the Trustee in its exercise of any trust or power.
The Trustee may withhold from Holders of Notes notice of any continuing Default (except a Default in payment of principal or interest) if it determines that withholding such notice is in the interest of the Holders of Notes. </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(m)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">Trustee Dealings with the Company </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Subject to certain limitations imposed by the TIA, the Trustee under the Indenture, in its individual or any other capacity,
may become the owner or pledgee of Notes and may otherwise deal with and collect obligations owed to it by the Company or its Affiliates and may otherwise deal with the Company or its Affiliates with the same rights it would have if it were not
Trustee. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(n)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">No Recourse Against Others </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">A director, officer, employee or stockholder, as such, of the Company or the Trustee shall not have any liability for any
obligations of the Company under the Notes or the Indenture or for any claim based on, in respect of or by reason of such obligations. By accepting a Note, each Holder of a Note waives and releases all such liability. The waiver and release are part
of the consideration for the issue of the Notes. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(o)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">Authentication </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">This Note shall not be valid until an authorized signatory of the Trustee (or an authenticating agent) manually signs the
certificate of authentication on the face of this Note. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(p)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">Abbreviations </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Customary abbreviations may be used in the name of a Holder of a Note or an assignee, such as TEN COM (=tenants in common),
TEN ENT (=tenants by the entireties), JT TEN (=joint tenants with rights of survivorship and not as tenants in common), CUST (=custodian), and U/G/M/A (=Uniform Gift to Minors Act). </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(q)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">Governing Law </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">This Note shall be governed by, and construed in accordance with, the laws of the State of New York. </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(r)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">CUSIP Numbers </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Pursuant to the recommendation promulgated by the Committee on Uniform Security Identification Procedures, the Company has
caused CUSIP numbers to be printed on the Notes and has directed the Trustee to use such CUSIP numbers in notices of redemption as a convenience to Holders of Notes. No representation is made as to the accuracy of such numbers either as printed on
the Notes or as contained in any notice of redemption and reliance may be placed only on the other identification numbers placed thereon. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">------------------------------------------- </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The Company will furnish to any Holder of a Note upon written request and
without charge to such Holder of a Note a copy of the Indenture. Requests may be made to: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">CVS Health Corporation </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">One CVS Drive &#151; MC 1008 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Woonsocket, Rhode Island 02895 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Attention: Tom Cowhey </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">ASSIGNMENT FORM </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">To assign this Note, complete the form below: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">I or we assign and transfer this Note to: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[Print or type assignee&#146;s name, address and zip code] </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[Insert assignee&#146;s soc. sec. or tax I.D. No.] </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:30%; text-indent:4%; font-size:10pt; font-family:Times New Roman">and irrevocably appoint ___________ as agent to </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:30%; text-indent:4%; font-size:10pt; font-family:Times New Roman">transfer this Note on the books of CVS Health Corporation. </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:30%; text-indent:4%; font-size:10pt; font-family:Times New Roman">The agent may substitute another to act for him. </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</DIV> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="4%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="37%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="4%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="12%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="34%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="4%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Date:</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">&#8195;&#8195;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Your&nbsp;Signature:</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">&#8195;&#8195;</TD></TR>
</TABLE> <P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</DIV>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Sign exactly as your name appears on the face of this Note. </P>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-4.3
<SEQUENCE>5
<FILENAME>d32562dex43.htm
<DESCRIPTION>EX-4.3
<TEXT>
<HTML><HEAD>
<TITLE>EX-4.3</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE" STYLE="line-height:Normal">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 4.3 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">UNLESS THIS CERTIFICATE IS PRESENTED BY AN AUTHORIZED REPRESENTATIVE OF THE DEPOSITORY TRUST COMPANY (&#147;DTC&#148;) TO THE
COMPANY OR ITS AGENT FOR REGISTRATION OF TRANSFER, EXCHANGE OR PAYMENT, AND ANY CERTIFICATE ISSUED IS REGISTERED IN THE NAME OF CEDE&nbsp;&amp; CO. OR SUCH OTHER NAME AS IS REQUESTED BY AN AUTHORIZED REPRESENTATIVE OF DTC (AND ANY PAYMENT IS MADE TO
CEDE&nbsp;&amp; CO., OR TO SUCH OTHER ENTITY AS IS REQUESTED BY AN AUTHORIZED REPRESENTATIVE OF DTC), ANY TRANSFER, PLEDGE OR OTHER USE HEREOF FOR VALUE OR OTHERWISE BY OR TO ANY PERSON IS WRONGFUL INASMUCH AS THE REGISTERED OWNER HEREOF,
CEDE&nbsp;&amp; CO., HAS AN INTEREST HEREIN. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">UNLESS AND UNTIL THIS GLOBAL NOTE IS EXCHANGED IN WHOLE OR IN PART FOR A
GLOBAL NOTE IN DEFINITIVE REGISTERED FORM, THIS GLOBAL NOTE MAY NOT BE TRANSFERRED EXCEPT AS A WHOLE BY DTC TO A NOMINEE OF DTC OR BY A NOMINEE OF DTC TO DTC OR ANOTHER NOMINEE OF DTC OR BY DTC OR ANY SUCH NOMINEE TO A SUCCESSOR DEPOSITARY OR A
NOMINEE OF SUCH SUCCESSOR DEPOSITARY. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">CVS HEALTH CORPORATION </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="51%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="48%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">No.&nbsp;[&#149;]</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">$[&#149;]</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">CUSIP No.&nbsp;126650 EL0 </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">ISIN
No. US126650EL07 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">6.200% Senior Note due 2055 </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">CVS HEALTH CORPORATION, a Delaware corporation (such corporation, and its successors and assigns under the Indenture
hereinafter referred to, being herein called the &#147;<B>Company</B>&#148;), for value received promises to pay to CEDE&nbsp;&amp; CO., or registered assigns, the principal sum of $[&#149;] on September&nbsp;15, 2055. If such maturity date is not a
Business Day, then payment of principal will be made on the next succeeding Business Day and no interest will accrue on the amount so payable for the period from such maturity date to the date payment is made. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Interest Payment Dates: March&nbsp;15 and September 15. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Record Dates: Each March&nbsp;1 and September&nbsp;1, immediately preceding each Interest Payment Date. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Additional provisions of this Note are set forth on the reverse side of this Note. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[<I>Remainder of page intentionally left blank</I>] </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">IN WITNESS WHEREOF, the Company has caused this Note to be duly executed. </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="7%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="92%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B>CVS HEALTH CORPORATION</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Name:</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Title:</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Name:</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Title:</TD></TR>
</TABLE></DIV>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[<I>Signature Page to
Note No. [&#8195;] of 2055 Notes</I>] </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Dated: August&nbsp;15, 2025 </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">TRUSTEE&#146;S CERTIFICATE OF AUTHENTICATION </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">THE BANK OF NEW
YORK MELLON TRUST COMPANY, N.A., </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">as Trustee, certifies that this is one of the Debt Securities referred to </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">in the Indenture. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="6%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="93%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Authorized Signatory</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[<I>Signature Page to
Note No. [&#8195;] of 2055 Notes</I>] </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">6.200% Senior Note due 2055 </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">This Note is one of a duly authorized series of Notes of the Company, designated as its 6.200% Senior Notes due 2055
(hereinafter referred to as the &#147;<B>Notes</B>&#148;). </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(a)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">Interest </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The Company promises to pay interest on the principal amount of this Note at the rate per annum shown above. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The Company will pay interest on the Notes semi-annually on March&nbsp;15 and September&nbsp;15 of each year, commencing
March&nbsp;15, 2026. Interest on the Notes will accrue from the most recent date to which interest has been paid or provided for, or, if no interest has been paid or provided for, from August&nbsp;15, 2025. Interest will be computed on the basis of
a <FONT STYLE="white-space:nowrap">360-day</FONT> year of twelve <FONT STYLE="white-space:nowrap">30-day&nbsp;months.</FONT> The Company shall pay interest on overdue principal at the rate borne by the Notes. If any interest payment date is not a
Business Day, then payment of interest will be made on the next succeeding Business Day and no interest will accrue on the amount so payable for the period from such interest payment date to the date payment is made. </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(b)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">Method of Payment </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The Company will pay interest on the Notes (except defaulted interest) to the Persons who are registered Holders thereof at
the close of business on the March&nbsp;1 and September&nbsp;1 (whether or not a Business Day) immediately preceding the interest payment date even if the Notes are canceled after the record date and on or before the interest payment date. Holders
must surrender Notes to a Paying Agent to collect principal payments. The Company will pay principal, premium, if any, and interest in money of the United States that at the time of payment is legal tender for payment of public and private debts by
wire transfer of immediately available funds to the accounts specified by the Holders, or, if no such account is specified, the Company may pay principal and interest by check payable in such money. It may mail an interest check to a Holder&#146;s
registered address. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(c)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">Paying Agent and Registrar </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Initially, The Bank of New York Mellon Trust Company, N.A., a national banking association (the &#147;<B>Trustee</B>&#148;),
will act as Paying Agent and Registrar. The Company may appoint and change any Paying Agent, Registrar or <FONT STYLE="white-space:nowrap">co-registrar</FONT> without notice. The Company or any of its domestically incorporated Wholly Owned
Subsidiaries may act as Paying Agent, Registrar or <FONT STYLE="white-space:nowrap">co-registrar.</FONT> </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(d)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">Indenture </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The Company issued the Notes under an Indenture dated as of August&nbsp;15, 2006 (the &#147;<B>Indenture</B>&#148;), between
the Company and the Trustee. The terms of the Notes include those stated in the Indenture and those made part of the Indenture by reference to the Trust Indenture Act of 1939 (15 U.S.C. ss.ss. 77aaa-77bbbb) as in effect on the date of the Indenture
(the &#147;<B>TIA</B>&#148;). Terms defined in the Indenture and not otherwise defined herein have the respective meanings ascribed thereto in the Indenture. The Notes are subject to all such terms, and Holders of Notes are referred to the Indenture
and the TIA for a statement of those terms. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The Notes are general unsecured senior obligations of the Company initially
limited to $1,250,000,000 aggregate principal amount (subject to Section&nbsp;2.08 of the Indenture). The Company may at any time issue additional Notes under the Indenture in unlimited amounts having the same terms as and treated as a single class
with the Notes for all purposes under the Indenture and that will vote together as one class with respect to the Notes; provided that, if such additional Notes are not fungible, for U.S. federal income tax purposes, with the Notes, such additional
Notes will have a different CUSIP, ISIN and/or other identifying number. The Indenture imposes certain limitations on the incurrence of certain additional indebtedness by the Company and certain of its subsidiaries and the entry into certain sale
and leaseback arrangements by the Company and certain of its subsidiaries. The Indenture also restricts the ability of the Company to consolidate or merge with or into, or to transfer all or substantially all its assets to, another person. </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(e)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">Optional Redemption </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Prior to the Applicable Par Call Date, the Company may redeem the Notes at its option, in whole or in part, at any time and
from time to time, at a redemption price (expressed as a percentage of principal amount and rounded to three decimal places) equal to the greater of (i) (a)&nbsp;the sum of the present values of the remaining scheduled payments of principal and
interest thereon discounted to the redemption date (assuming such Notes matured on the Applicable Par Call Date) on a semi-annual basis (assuming a <FONT STYLE="white-space:nowrap">360-day</FONT> year consisting of twelve <FONT
STYLE="white-space:nowrap">30-day&nbsp;months)</FONT> at the Treasury Rate plus the Applicable Spread for the Notes less (b)&nbsp;interest accrued to, but excluding, the redemption date, and (ii)&nbsp;100% of the principal amount of the Notes to be
redeemed, plus, in either case, accrued and unpaid interest thereon to, but excluding, the redemption date. On or after the Applicable Par Call Date, the Company may redeem the Notes, in whole or in part, at any time and from time to time, at a
redemption price equal to 100% of the principal amount of the Notes being redeemed plus accrued and unpaid interest thereon to, but excluding, the redemption date. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">&#147;<B>Applicable Par Call Date</B>&#148; means March&nbsp;15, 2055 (six months prior to the maturity date of the Notes).
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">&#147;<B>Applicable Spread</B>&#148; means 25 basis points. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">&#147;<B>Treasury Rate</B>&#148; means, with respect to any redemption date, the yield determined by the Company in accordance
with the following two paragraphs. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The Treasury Rate shall be determined by the Company after 4:15 p.m., New York City
time (or after such time as yields on U.S. government securities are posted daily by the Board of Governors of the Federal Reserve System), on the third Business Day preceding the redemption date based upon the yield or yields for the most recent
day that appear after such time on such day in the most recent statistical release published by the Board of Governors of the Federal Reserve System designated as &#147;Selected Interest Rates (Daily) - H.15&#148; (or any successor designation or
publication) (&#147;H.15&#148;) under the caption &#147;U.S. government securities&#150;Treasury constant maturities&#150;Nominal&#148; (or any successor caption or heading) (&#147;H.15 TCM&#148;). In determining the Treasury Rate, the Company shall
select, as applicable: (1)&nbsp;the yield for the Treasury constant </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">
maturity on H.15 exactly equal to the period from the redemption date to the Applicable Par Call Date (the &#147;Remaining Life&#148;); or (2)&nbsp;if there is no such Treasury constant maturity
on H.15 exactly equal to the Remaining Life, the two yields &#150; one yield corresponding to the Treasury constant maturity on H.15 immediately shorter than and one yield corresponding to the Treasury constant maturity on H.15 immediately longer
than the Remaining Life &#150; and shall interpolate to the Applicable Par Call Date on a straight-line basis (using the actual number of days) using such yields and rounding the result to three decimal places; or (3)&nbsp;if there is no such
Treasury constant maturity on H.15 shorter than or longer than the Remaining Life, the yield for the single Treasury constant maturity on H.15 closest to the Remaining Life. For purposes of this paragraph, the applicable Treasury constant maturity
or maturities on H.15 shall be deemed to have a maturity date equal to the relevant number of months or years, as applicable, of such Treasury constant maturity from the redemption date. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">If on the third Business Day preceding the redemption date H.15 TCM is no longer published, the Company shall calculate the
Treasury Rate based on the rate per annum equal to the semi-annual equivalent yield to maturity at 11:00 a.m., New York City time, on the second Business Day preceding such redemption date of the United States Treasury security maturing on, or with
a maturity that is closest to, the Applicable Par Call Date, as applicable. If there is no United States Treasury security maturing on the Applicable Par Call Date but there are two or more United States Treasury securities with a maturity date
equally distant from the Applicable Par Call Date, one with a maturity date preceding the Applicable Par Call Date and one with a maturity date following the Applicable Par Call Date, the Company shall select the United States Treasury security with
a maturity date preceding the Applicable Par Call Date. If there are two or more United States Treasury securities maturing on the Applicable Par Call Date or two or more United States Treasury securities meeting the criteria of the preceding
sentence, the Company shall select from among these two or more United States Treasury securities the United States Treasury security that is trading closest to par based upon the average of the bid and asked prices for such United States Treasury
securities at 11:00 a.m., New York City time. In determining the Treasury Rate in accordance with the terms of this paragraph, the semi-annual yield to maturity of the applicable United States Treasury security shall be based upon the average of the
bid and asked prices (expressed as a percentage of principal amount) at 11:00 a.m., New York City time, of such United States Treasury security, and rounded to three decimal places. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The Company&#146;s actions and determinations in determining the redemption price shall be conclusive and binding for all
purposes, absent manifest error. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Notice of any redemption will be mailed or electronically delivered (or otherwise
transmitted in accordance with the depositary&#146;s procedures) at least 10 days but not more than 60 days before the redemption date to each Holder of the Notes to be redeemed. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">In the case of a partial redemption, selection of the Notes for redemption will be made in accordance with the procedures of
DTC. No Notes of a principal amount of $2,000 or less will be redeemed in part. If any Note is to be redeemed in part only, the notice of redemption that relates to the Note will state the portion of the principal amount of the Note to be redeemed.
A new Note in a principal amount equal to the unredeemed portion of the Note will be issued in the name of the holder of the Note upon surrender for cancellation of the original Note. For so long as the Notes are held by DTC (or another Depositary),
the redemption of the Notes shall be done in accordance with the policies and procedures of the Depositary. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Unless the Company defaults in payment of the redemption price, on and after
the redemption date, interest will cease to accrue on the Notes or portions thereof called for redemption. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(f)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">Repurchase of the Notes Upon a Change of Control Triggering Event </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">If a Change of Control Triggering Event (as defined below) occurs, Holders of the Notes will have the right to require the
Company to repurchase all or any part (in integral multiples of $1,000 up to the original principal amount) of their Notes pursuant to the offer described below (the &#147;<B>Change of Control Offer</B>&#148;) on the terms set forth in this Note. In
the Change of Control Offer, the Company will be required to offer payment in cash equal to 101% of the aggregate principal amount of Notes repurchased plus accrued and unpaid interest, if any, on the Notes repurchased, to, but excluding, the date
of purchase (the &#147;<B>Change of Control Payment</B>&#148;). Within 30 days following any Change of Control Triggering Event, the Company will be required to mail a notice to Holders of Notes describing the transaction or transactions that
constitute the Change of Control Triggering Event and offering to repurchase the Notes on the date specified in the notice, which date will be no earlier than 30 days and no later than 60 days from the date such notice is mailed (the &#147;<B>Change
of Control Payment Date</B>&#148;), pursuant to the procedures required by this Note and described in such notice. The Company must comply with the requirements of Rule <FONT STYLE="white-space:nowrap">14e-1</FONT> under the Exchange Act and any
other securities laws and regulations thereunder to the extent those laws and regulations are applicable in connection with the repurchase of the Notes as a result of a Change of Control Triggering Event. To the extent that the provisions of any
securities laws or regulations conflict with the Change of Control provisions of the Notes, the Company will be required to comply with the applicable securities laws and regulations and will not be deemed to have breached its obligations under the
Change of Control provisions of the Notes by virtue of such conflicts and compliance with law. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">On the Change of Control
Payment Date, the Company will be required, to the extent lawful, to: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">accept for payment all Notes properly tendered pursuant to the Change of Control Offer; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">deposit with the Paying Agent an amount equal to the Change of Control Payment in respect of all Notes or
portions of Notes properly tendered; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">deliver or cause to be delivered to the Trustee the Notes properly accepted together with an Officers&#146;
Certificate stating the aggregate principal amount of Notes or portions of Notes being purchased. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The
Company will not be required to make a Change of Control Offer upon the occurrence of a Change of Control Triggering Event if a third party makes such an offer in the manner, at the times and otherwise in compliance with the requirements for an
offer made by the Company and the third party repurchases all Notes properly tendered and not withdrawn under its offer. In addition, the Company will not repurchase any Notes if there has occurred and is continuing on the Change of Control Payment
Date an event of default under the Indenture, other than a default in the payment of the Change of Control Payment upon a Change of Control Triggering Event. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">For purposes of the foregoing, the following definitions are applicable:
</P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">&#147;<B>Below Investment Grade Rating Event</B>&#148; means that the Notes are rated below an Investment Grade Rating by
each of the Rating Agencies (as defined below) on any date from the date of the public notice of an arrangement that could result in a Change of Control until the end of the <FONT STYLE="white-space:nowrap">60-day</FONT> period following public
notice of the occurrence of the Change of Control (which <FONT STYLE="white-space:nowrap">60-day</FONT> period shall be extended so long as the rating of the Notes is under publicly announced consideration for possible downgrade by any of the Rating
Agencies); <I>provided</I>, <I>however</I>, that a Below Investment Grade Rating Event otherwise arising by virtue of a particular reduction in rating will not be deemed to have occurred in respect of a particular Change of Control (and thus will
not be deemed a Below Investment Grade Rating Event for purposes of the definition of Change of Control Triggering Event) if the Rating Agencies making the reduction in rating to which this definition would otherwise apply do not announce or
publicly confirm or inform the Trustee in writing at the Company&#146;s or the Trustee&#146;s request that the reduction was the result, in whole or in part, of any event or circumstance comprised of or arising as a result of, or in respect of, the
applicable Change of Control (whether or not the applicable Change of Control has occurred at the time of the Below Investment Grade Rating Event). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">&#147;<B>Change of Control</B>&#148; means the occurrence of any of the following: (1)&nbsp;any event requiring the filing of
any report under or in response to Schedule 13D or <FONT STYLE="white-space:nowrap">14D-1</FONT> pursuant to the Exchange Act disclosing beneficial ownership of either 50% or more of the Company&#146;s common stock then outstanding or 50% or more of
the Company&#146;s voting power or the Company&#146;s voting stock then outstanding; (2)&nbsp;the direct or indirect sale, transfer, conveyance or other disposition (other than by way of merger or consolidation), in one or a series of related
transactions, of all or substantially all of the Company&#146;s properties or the Company&#146;s assets and the assets of its respective subsidiaries taken as a whole to one or more persons (as defined in the Indenture) other than the Company or one
of its subsidiaries; or (3)&nbsp;the first day on which a majority of the members of the Company&#146;s Board of Directors are not Continuing Directors. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Notwithstanding the foregoing, a transaction will not be deemed to involve a Change of Control if (1)&nbsp;the Company becomes
a direct or indirect wholly-owned subsidiary of a holding company and (2)(A) the direct or indirect holders of the voting stock of such holding company immediately following that transaction are substantially the same as the holders of the
Company&#146;s voting stock immediately prior to that transaction or (B)&nbsp;immediately following that transaction no person (other than a holding company satisfying the requirements of this sentence) is the beneficial owner, directly or
indirectly, of more than 50% of the voting stock of such holding company. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">&#147;<B>Change of Control Triggering
Event</B>&#148; means the occurrence of both a Change of Control and a Below Investment Grade Rating Event. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">&#147;<B>Continuing Director</B>&#148; means, as of any date of
determination, any member of the Company&#146;s Board of Directors who (1)&nbsp;was a member of such Board of Directors on the date of the issuance of the Notes; or (2)&nbsp;was nominated for election or elected to such Board of Directors with the
approval of a majority of the Continuing Directors who were members of such Board of Directors at the time of such nomination or election (either by a specific vote or by approval of the Company&#146;s proxy statement in which such member was named
as a nominee for election as a director, without objection to such nomination). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">&#147;<B>Fitch</B>&#148; mean Fitch
Ratings Inc. and its successors. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">&#147;<B>Investment Grade Rating</B>&#148; means a rating equal to or higher than Baa3
(or the equivalent) by Moody&#146;s and <FONT STYLE="white-space:nowrap">BBB-</FONT> (or the equivalent) by S&amp;P. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">&#147;<B>Moody&#146;s</B>&#148; means Moody&#146;s Investors Service, Inc., or its successor. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">&#147;<B>Rating Agencies</B>&#148; means (1)&nbsp;each of Moody&#146;s, S&amp;P and Fitch; and (2)&nbsp;if any of
Moody&#146;s, S&amp;P or Fitch ceases to rate the Notes or fails to make a rating of the Notes publicly available for reasons outside of the Company&#146;s control, a &#147;nationally recognized statistical rating organization&#148; within the
meaning of Rule 3(a)(62) under the Exchange Act selected by the Company (as certified by a resolution of the Company&#146;s Board of Directors) as a replacement agency for Moody&#146;s, S&amp;P or Fitch or all of them, as the case may be. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">&#147;<B>S&amp;P</B>&#148; means S&amp;P Global Ratings, a division of S&amp;P Global Inc., or its successor. </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(g)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">Denominations; Transfer; Exchange </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The Notes are in registered form without coupons in denominations of $2,000 and integral multiples of $1,000 in excess
thereof. Holders of Notes may transfer or exchange Notes in accordance with the Indenture. The Registrar may require a Holder of Notes, among other things, to furnish appropriate endorsements or transfer documents and to pay any taxes and fees
required by law or permitted by the Indenture. The Registrar need not register the transfer of or exchange any Notes selected for redemption (except, in the case of a Note to be redeemed in part, the portion of the Note not to be redeemed) or any
Notes for a period of 15&nbsp;days before a selection of Notes to be redeemed or 15&nbsp;days before an interest payment date. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(h)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">Persons Deemed Owners </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The registered Holder of this Note may be treated as the sole owner of such Note for all purposes. </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(i)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">Unclaimed Money </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Subject to applicable abandoned property law, if money for the payment of principal or interest remains unclaimed for two
years, the Trustee or Paying Agent shall pay the money back to the Company at its request unless an abandoned property law designates another Person. After any such payment, Holders entitled to the money must look only to the Company and not to the
Trustee or Paying Agent for payment. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(j)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">Discharge and Defeasance </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Subject to certain conditions, the Company at any time may terminate some or all of its obligations under the Notes and the
Indenture if the Company deposits with the Trustee money or U.S. Government Obligations for the payment of principal and interest on the Notes to redemption or maturity, as the case may be. </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(k)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">Amendment; Waiver </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Subject to certain exceptions set forth in the Indenture, (i)&nbsp;the Indenture or the Notes may be amended with the written
consent of the Holders of at least a majority in principal amount outstanding of the Notes; and (ii)&nbsp;any default or compliance with any provision may be waived with the written consent of the Holders of a majority in principal amount of the
Notes then outstanding. Subject to certain exceptions set forth in the Indenture, without the consent of any Holder of a Note, the Company and the Trustee may amend the Indenture or the Notes to cure any ambiguity, omission, defect or inconsistency
that does not materially and adversely affect the rights of any Holder of a Note, or to comply with Article&nbsp;5 of the Indenture or to comply with requirements of the SEC in connection with the qualification of the Indenture under the TIA. </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(l)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">Defaults and Remedies </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">If an Event of Default occurs and is continuing, the Trustee or the Holders of at least 25% in aggregate principal amount of
the Notes may declare all the Notes to be due and payable immediately. Certain events of bankruptcy or insolvency are Events of Default which will result in the Notes being due and payable immediately upon the occurrence of such Events of Default.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Holders of Notes may not enforce the Indenture or the Notes except as provided in the Indenture. The Trustee may refuse
to enforce the Indenture or the Notes unless it receives indemnity or security satisfactory to it. Subject to certain limitations, Holders of a majority in principal amount of the Notes may direct the Trustee in its exercise of any trust or power.
The Trustee may withhold from Holders of Notes notice of any continuing Default (except a Default in payment of principal or interest) if it determines that withholding such notice is in the interest of the Holders of Notes. </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(m)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">Trustee Dealings with the Company </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Subject to certain limitations imposed by the TIA, the Trustee under the Indenture, in its individual or any other capacity,
may become the owner or pledgee of Notes and may otherwise deal with and collect obligations owed to it by the Company or its Affiliates and may otherwise deal with the Company or its Affiliates with the same rights it would have if it were not
Trustee. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(n)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">No Recourse Against Others </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">A director, officer, employee or stockholder, as such, of the Company or the Trustee shall not have any liability for any
obligations of the Company under the Notes or the Indenture or for any claim based on, in respect of or by reason of such obligations. By accepting a Note, each Holder of a Note waives and releases all such liability. The waiver and release are part
of the consideration for the issue of the Notes. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(o)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">Authentication </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">This Note shall not be valid until an authorized signatory of the Trustee (or an authenticating agent) manually signs the
certificate of authentication on the face of this Note. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(p)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">Abbreviations </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Customary abbreviations may be used in the name of a Holder of a Note or an assignee, such as TEN COM (=tenants in common),
TEN ENT (=tenants by the entireties), JT TEN (=joint tenants with rights of survivorship and not as tenants in common), CUST (=custodian), and U/G/M/A (=Uniform Gift to Minors Act). </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(q)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">Governing Law </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">This Note shall be governed by, and construed in accordance with, the laws of the State of New York. </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(r)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">CUSIP Numbers </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Pursuant to the recommendation promulgated by the Committee on Uniform Security Identification Procedures, the Company has
caused CUSIP numbers to be printed on the Notes and has directed the Trustee to use such CUSIP numbers in notices of redemption as a convenience to Holders of Notes. No representation is made as to the accuracy of such numbers either as printed on
the Notes or as contained in any notice of redemption and reliance may be placed only on the other identification numbers placed thereon. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">------------------------------------------- </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The Company will furnish to any Holder of a Note upon written request and
without charge to such Holder of a Note a copy of the Indenture. Requests may be made to: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">CVS Health Corporation </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">One CVS Drive &#151; MC 1008 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Woonsocket, Rhode Island 02895 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Attention: Tom Cowhey </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">ASSIGNMENT FORM </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">To assign this Note, complete the form below: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">I or we assign and transfer this Note to: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[Print or type assignee&#146;s name, address and zip code] </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[Insert assignee&#146;s soc. sec. or tax I.D. No.] </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:30%; text-indent:4%; font-size:10pt; font-family:Times New Roman">and irrevocably appoint ___________ as agent to </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:30%; text-indent:4%; font-size:10pt; font-family:Times New Roman">transfer this Note on the books of CVS Health Corporation. </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:30%; text-indent:4%; font-size:10pt; font-family:Times New Roman">The agent may substitute another to act for him. </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</DIV> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="4%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="37%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="4%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="12%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="34%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="4%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Date:</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">&#8195;&#8195;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Your&nbsp;Signature:</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">&#8195;&#8195;</TD></TR>
</TABLE> <P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</DIV>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Sign exactly as your name appears on the face of this Note. </P>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-4.4
<SEQUENCE>6
<FILENAME>d32562dex44.htm
<DESCRIPTION>EX-4.4
<TEXT>
<HTML><HEAD>
<TITLE>EX-4.4</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE" STYLE="line-height:Normal">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 4.4 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">UNLESS THIS CERTIFICATE IS PRESENTED BY AN AUTHORIZED REPRESENTATIVE OF THE DEPOSITORY TRUST COMPANY (&#147;DTC&#148;) TO THE
COMPANY OR ITS AGENT FOR REGISTRATION OF TRANSFER, EXCHANGE OR PAYMENT, AND ANY CERTIFICATE ISSUED IS REGISTERED IN THE NAME OF CEDE&nbsp;&amp; CO. OR SUCH OTHER NAME AS IS REQUESTED BY AN AUTHORIZED REPRESENTATIVE OF DTC (AND ANY PAYMENT IS MADE TO
CEDE&nbsp;&amp; CO., OR TO SUCH OTHER ENTITY AS IS REQUESTED BY AN AUTHORIZED REPRESENTATIVE OF DTC), ANY TRANSFER, PLEDGE OR OTHER USE HEREOF FOR VALUE OR OTHERWISE BY OR TO ANY PERSON IS WRONGFUL INASMUCH AS THE REGISTERED OWNER HEREOF,
CEDE&nbsp;&amp; CO., HAS AN INTEREST HEREIN. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">UNLESS AND UNTIL THIS GLOBAL NOTE IS EXCHANGED IN WHOLE OR IN PART FOR A
GLOBAL NOTE IN DEFINITIVE REGISTERED FORM, THIS GLOBAL NOTE MAY NOT BE TRANSFERRED EXCEPT AS A WHOLE BY DTC TO A NOMINEE OF DTC OR BY A NOMINEE OF DTC TO DTC OR ANOTHER NOMINEE OF DTC OR BY DTC OR ANY SUCH NOMINEE TO A SUCCESSOR DEPOSITARY OR A
NOMINEE OF SUCH SUCCESSOR DEPOSITARY. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">CVS HEALTH CORPORATION </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="51%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="48%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">No.&nbsp;[&#149;]</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">$[&#149;]</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">CUSIP No.&nbsp;126650 EM8 </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">ISIN
No. US126650EM89 </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">6.250% Senior Note due 2065 </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">CVS HEALTH CORPORATION, a Delaware corporation (such corporation, and its successors and assigns under the Indenture
hereinafter referred to, being herein called the &#147;<B>Company</B>&#148;), for value received promises to pay to CEDE&nbsp;&amp; CO., or registered assigns, the principal sum of $[&#149;] on September&nbsp;15, 2065. If such maturity date is not a
Business Day, then payment of principal will be made on the next succeeding Business Day and no interest will accrue on the amount so payable for the period from such maturity date to the date payment is made. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Interest Payment Dates: March&nbsp;15 and September 15. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Record Dates: Each March&nbsp;1 and September&nbsp;1, immediately preceding each Interest Payment Date. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Additional provisions of this Note are set forth on the reverse side of this Note. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[<I>Remainder of page intentionally left blank</I>] </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">IN WITNESS WHEREOF, the Company has caused this Note to be duly executed. </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="7%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="92%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B>CVS HEALTH CORPORATION</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Name:</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Title:</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Name:</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Title:</TD></TR>
</TABLE></DIV> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[<I>Signature Page to Note No. [&#8195;] of 2065 Notes</I>] </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Dated: August&nbsp;15, 2025 </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">TRUSTEE&#146;S CERTIFICATE OF AUTHENTICATION </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">THE BANK OF NEW
YORK MELLON TRUST COMPANY, N.A., </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">as Trustee, certifies that this is one of the Debt Securities referred to </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">in the Indenture. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="6%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="93%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">By</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Authorized Signatory</P></TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[<I>Signature Page to Note No. [&#8195;] of 2065 Notes</I>] </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">6.250% Senior Note due 2065 </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">This Note is one of a duly authorized series of Notes of the Company, designated as its 6.250% Senior Notes due 2065
(hereinafter referred to as the &#147;<B>Notes</B>&#148;). </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(a)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">Interest </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The Company promises to pay interest on the principal amount of this Note at the rate per annum shown above. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The Company will pay interest on the Notes semi-annually on March&nbsp;15 and September&nbsp;15 of each year, commencing
March&nbsp;15, 2026. Interest on the Notes will accrue from the most recent date to which interest has been paid or provided for, or, if no interest has been paid or provided for, from August&nbsp;15, 2025. Interest will be computed on the basis of
a <FONT STYLE="white-space:nowrap">360-day</FONT> year of twelve <FONT STYLE="white-space:nowrap">30-day&nbsp;months.</FONT> The Company shall pay interest on overdue principal at the rate borne by the Notes. If any interest payment date is not a
Business Day, then payment of interest will be made on the next succeeding Business Day and no interest will accrue on the amount so payable for the period from such interest payment date to the date payment is made. </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(b)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">Method of Payment </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The Company will pay interest on the Notes (except defaulted interest) to the Persons who are registered Holders thereof at
the close of business on the March&nbsp;1 and September&nbsp;1 (whether or not a Business Day) immediately preceding the interest payment date even if the Notes are canceled after the record date and on or before the interest payment date. Holders
must surrender Notes to a Paying Agent to collect principal payments. The Company will pay principal, premium, if any, and interest in money of the United States that at the time of payment is legal tender for payment of public and private debts by
wire transfer of immediately available funds to the accounts specified by the Holders, or, if no such account is specified, the Company may pay principal and interest by check payable in such money. It may mail an interest check to a Holder&#146;s
registered address. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(c)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">Paying Agent and Registrar </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Initially, The Bank of New York Mellon Trust Company, N.A., a national banking association (the &#147;<B>Trustee</B>&#148;),
will act as Paying Agent and Registrar. The Company may appoint and change any Paying Agent, Registrar or <FONT STYLE="white-space:nowrap">co-registrar</FONT> without notice. The Company or any of its domestically incorporated Wholly Owned
Subsidiaries may act as Paying Agent, Registrar or <FONT STYLE="white-space:nowrap">co-registrar.</FONT> </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(d)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">Indenture </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The Company issued the Notes under an Indenture dated as of August&nbsp;15, 2006 (the &#147;<B>Indenture</B>&#148;), between
the Company and the Trustee. The terms of the Notes include those stated in the Indenture and those made part of the Indenture by reference to the Trust Indenture Act of 1939 (15 U.S.C. ss.ss. 77aaa-77bbbb) as in effect on the date of the Indenture
(the &#147;<B>TIA</B>&#148;). Terms defined in the Indenture and not otherwise defined herein have the respective meanings ascribed thereto in the Indenture. The Notes are subject to all such terms, and Holders of Notes are referred to the Indenture
and the TIA for a statement of those terms. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The Notes are general unsecured senior obligations of the Company initially
limited to $500,000,000 aggregate principal amount (subject to Section&nbsp;2.08 of the Indenture). The Company may at any time issue additional Notes under the Indenture in unlimited amounts having the same terms as and treated as a single class
with the Notes for all purposes under the Indenture and that will vote together as one class with respect to the Notes; provided that, if such additional Notes are not fungible, for U.S. federal income tax purposes, with the Notes, such additional
Notes will have a different CUSIP, ISIN and/or other identifying number. The Indenture imposes certain limitations on the incurrence of certain additional indebtedness by the Company and certain of its subsidiaries and the entry into certain sale
and leaseback arrangements by the Company and certain of its subsidiaries. The Indenture also restricts the ability of the Company to consolidate or merge with or into, or to transfer all or substantially all its assets to, another person. </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(e)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">Optional Redemption </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Prior to the Applicable Par Call Date, the Company may redeem the Notes at its option, in whole or in part, at any time and
from time to time, at a redemption price (expressed as a percentage of principal amount and rounded to three decimal places) equal to the greater of (i) (a)&nbsp;the sum of the present values of the remaining scheduled payments of principal and
interest thereon discounted to the redemption date (assuming such Notes matured on the Applicable Par Call Date) on a semi-annual basis (assuming a <FONT STYLE="white-space:nowrap">360-day</FONT> year consisting of twelve <FONT
STYLE="white-space:nowrap">30-day&nbsp;months)</FONT> at the Treasury Rate plus the Applicable Spread for the Notes less (b)&nbsp;interest accrued to, but excluding, the redemption date, and (ii)&nbsp;100% of the principal amount of the Notes to be
redeemed, plus, in either case, accrued and unpaid interest thereon to, but excluding, the redemption date. On or after the Applicable Par Call Date, the Company may redeem the Notes, in whole or in part, at any time and from time to time, at a
redemption price equal to 100% of the principal amount of the Notes being redeemed plus accrued and unpaid interest thereon to, but excluding, the redemption date. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">&#147;<B>Applicable Par Call Date</B>&#148; means March&nbsp;15, 2065 (six months prior to the maturity date of the Notes).
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">&#147;<B>Applicable Spread</B>&#148; means 25 basis points. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">&#147;<B>Treasury Rate</B>&#148; means, with respect to any redemption date, the yield determined by the Company in accordance
with the following two paragraphs. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The Treasury Rate shall be determined by the Company after 4:15 p.m., New York City
time (or after such time as yields on U.S. government securities are posted daily by the Board of Governors of the Federal Reserve System), on the third Business Day preceding the redemption date based upon the yield or yields for the most recent
day that appear after such time on such day in the most recent statistical release published by the Board of Governors of the Federal Reserve System designated as &#147;Selected Interest Rates (Daily) - H.15&#148; (or any successor designation or
publication) (&#147;H.15&#148;) under the caption &#147;U.S. government securities&#150;Treasury constant maturities&#150;Nominal&#148; (or any successor caption or heading) (&#147;H.15 TCM&#148;). In determining the Treasury Rate, the Company shall
select, as applicable: (1)&nbsp;the yield for the Treasury constant </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">
maturity on H.15 exactly equal to the period from the redemption date to the Applicable Par Call Date (the &#147;Remaining Life&#148;); or (2)&nbsp;if there is no such Treasury constant maturity
on H.15 exactly equal to the Remaining Life, the two yields &#150; one yield corresponding to the Treasury constant maturity on H.15 immediately shorter than and one yield corresponding to the Treasury constant maturity on H.15 immediately longer
than the Remaining Life &#150; and shall interpolate to the Applicable Par Call Date on a straight-line basis (using the actual number of days) using such yields and rounding the result to three decimal places; or (3)&nbsp;if there is no such
Treasury constant maturity on H.15 shorter than or longer than the Remaining Life, the yield for the single Treasury constant maturity on H.15 closest to the Remaining Life. For purposes of this paragraph, the applicable Treasury constant maturity
or maturities on H.15 shall be deemed to have a maturity date equal to the relevant number of months or years, as applicable, of such Treasury constant maturity from the redemption date. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">If on the third Business Day preceding the redemption date H.15 TCM is no longer published, the Company shall calculate the
Treasury Rate based on the rate per annum equal to the semi-annual equivalent yield to maturity at 11:00 a.m., New York City time, on the second Business Day preceding such redemption date of the United States Treasury security maturing on, or with
a maturity that is closest to, the Applicable Par Call Date, as applicable. If there is no United States Treasury security maturing on the Applicable Par Call Date but there are two or more United States Treasury securities with a maturity date
equally distant from the Applicable Par Call Date, one with a maturity date preceding the Applicable Par Call Date and one with a maturity date following the Applicable Par Call Date, the Company shall select the United States Treasury security with
a maturity date preceding the Applicable Par Call Date. If there are two or more United States Treasury securities maturing on the Applicable Par Call Date or two or more United States Treasury securities meeting the criteria of the preceding
sentence, the Company shall select from among these two or more United States Treasury securities the United States Treasury security that is trading closest to par based upon the average of the bid and asked prices for such United States Treasury
securities at 11:00 a.m., New York City time. In determining the Treasury Rate in accordance with the terms of this paragraph, the semi-annual yield to maturity of the applicable United States Treasury security shall be based upon the average of the
bid and asked prices (expressed as a percentage of principal amount) at 11:00 a.m., New York City time, of such United States Treasury security, and rounded to three decimal places. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The Company&#146;s actions and determinations in determining the redemption price shall be conclusive and binding for all
purposes, absent manifest error. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Notice of any redemption will be mailed or electronically delivered (or otherwise
transmitted in accordance with the depositary&#146;s procedures) at least 10 days but not more than 60 days before the redemption date to each Holder of the Notes to be redeemed. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">In the case of a partial redemption, selection of the Notes for redemption will be made in accordance with the procedures of
DTC. No Notes of a principal amount of $2,000 or less will be redeemed in part. If any Note is to be redeemed in part only, the notice of redemption that relates to the Note will state the portion of the principal amount of the Note to be redeemed.
A new Note in a principal amount equal to the unredeemed portion of the Note will be issued in the name of the holder of the Note upon surrender for cancellation of the original Note. For so long as the Notes are held by DTC (or another Depositary),
the redemption of the Notes shall be done in accordance with the policies and procedures of the Depositary. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Unless the Company defaults in payment of the redemption price, on and after
the redemption date, interest will cease to accrue on the Notes or portions thereof called for redemption. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(f)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">Repurchase of the Notes Upon a Change of Control Triggering Event </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">If a Change of Control Triggering Event (as defined below) occurs, Holders of the Notes will have the right to require the
Company to repurchase all or any part (in integral multiples of $1,000 up to the original principal amount) of their Notes pursuant to the offer described below (the &#147;<B>Change of Control Offer</B>&#148;) on the terms set forth in this Note. In
the Change of Control Offer, the Company will be required to offer payment in cash equal to 101% of the aggregate principal amount of Notes repurchased plus accrued and unpaid interest, if any, on the Notes repurchased, to, but excluding, the date
of purchase (the &#147;<B>Change of Control Payment</B>&#148;). Within 30 days following any Change of Control Triggering Event, the Company will be required to mail a notice to Holders of Notes describing the transaction or transactions that
constitute the Change of Control Triggering Event and offering to repurchase the Notes on the date specified in the notice, which date will be no earlier than 30 days and no later than 60 days from the date such notice is mailed (the &#147;<B>Change
of Control Payment Date</B>&#148;), pursuant to the procedures required by this Note and described in such notice. The Company must comply with the requirements of Rule <FONT STYLE="white-space:nowrap">14e-1</FONT> under the Exchange Act and any
other securities laws and regulations thereunder to the extent those laws and regulations are applicable in connection with the repurchase of the Notes as a result of a Change of Control Triggering Event. To the extent that the provisions of any
securities laws or regulations conflict with the Change of Control provisions of the Notes, the Company will be required to comply with the applicable securities laws and regulations and will not be deemed to have breached its obligations under the
Change of Control provisions of the Notes by virtue of such conflicts and compliance with law. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">On the Change of Control
Payment Date, the Company will be required, to the extent lawful, to: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">accept for payment all Notes properly tendered pursuant to the Change of Control Offer; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">deposit with the Paying Agent an amount equal to the Change of Control Payment in respect of all Notes or
portions of Notes properly tendered; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">deliver or cause to be delivered to the Trustee the Notes properly accepted together with an Officers&#146;
Certificate stating the aggregate principal amount of Notes or portions of Notes being purchased. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The
Company will not be required to make a Change of Control Offer upon the occurrence of a Change of Control Triggering Event if a third party makes such an offer in the manner, at the times and otherwise in compliance with the requirements for an
offer made by the Company and the third party repurchases all Notes properly tendered and not withdrawn under its offer. In addition, the Company will not repurchase any Notes if there has occurred and is continuing on the Change of Control Payment
Date an event of default under the Indenture, other than a default in the payment of the Change of Control Payment upon a Change of Control Triggering Event. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">For purposes of the foregoing, the following definitions are applicable:
</P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">&#147;<B>Below Investment Grade Rating Event</B>&#148; means that the Notes are rated below an Investment Grade Rating by
each of the Rating Agencies (as defined below) on any date from the date of the public notice of an arrangement that could result in a Change of Control until the end of the <FONT STYLE="white-space:nowrap">60-day</FONT> period following public
notice of the occurrence of the Change of Control (which <FONT STYLE="white-space:nowrap">60-day</FONT> period shall be extended so long as the rating of the Notes is under publicly announced consideration for possible downgrade by any of the Rating
Agencies); <I>provided</I>, <I>however</I>, that a Below Investment Grade Rating Event otherwise arising by virtue of a particular reduction in rating will not be deemed to have occurred in respect of a particular Change of Control (and thus will
not be deemed a Below Investment Grade Rating Event for purposes of the definition of Change of Control Triggering Event) if the Rating Agencies making the reduction in rating to which this definition would otherwise apply do not announce or
publicly confirm or inform the Trustee in writing at the Company&#146;s or the Trustee&#146;s request that the reduction was the result, in whole or in part, of any event or circumstance comprised of or arising as a result of, or in respect of, the
applicable Change of Control (whether or not the applicable Change of Control has occurred at the time of the Below Investment Grade Rating Event). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">&#147;<B>Change of Control</B>&#148; means the occurrence of any of the following: (1)&nbsp;any event requiring the filing of
any report under or in response to Schedule 13D or <FONT STYLE="white-space:nowrap">14D-1</FONT> pursuant to the Exchange Act disclosing beneficial ownership of either 50% or more of the Company&#146;s common stock then outstanding or 50% or more of
the Company&#146;s voting power or the Company&#146;s voting stock then outstanding; (2)&nbsp;the direct or indirect sale, transfer, conveyance or other disposition (other than by way of merger or consolidation), in one or a series of related
transactions, of all or substantially all of the Company&#146;s properties or the Company&#146;s assets and the assets of its respective subsidiaries taken as a whole to one or more persons (as defined in the Indenture) other than the Company or one
of its subsidiaries; or (3)&nbsp;the first day on which a majority of the members of the Company&#146;s Board of Directors are not Continuing Directors. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Notwithstanding the foregoing, a transaction will not be deemed to involve a Change of Control if (1)&nbsp;the Company becomes
a direct or indirect wholly-owned subsidiary of a holding company and (2)(A) the direct or indirect holders of the voting stock of such holding company immediately following that transaction are substantially the same as the holders of the
Company&#146;s voting stock immediately prior to that transaction or (B)&nbsp;immediately following that transaction no person (other than a holding company satisfying the requirements of this sentence) is the beneficial owner, directly or
indirectly, of more than 50% of the voting stock of such holding company. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">&#147;<B>Change of Control Triggering
Event</B>&#148; means the occurrence of both a Change of Control and a Below Investment Grade Rating Event. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">&#147;<B>Continuing Director</B>&#148; means, as of any date of
determination, any member of the Company&#146;s Board of Directors who (1)&nbsp;was a member of such Board of Directors on the date of the issuance of the Notes; or (2)&nbsp;was nominated for election or elected to such Board of Directors with the
approval of a majority of the Continuing Directors who were members of such Board of Directors at the time of such nomination or election (either by a specific vote or by approval of the Company&#146;s proxy statement in which such member was named
as a nominee for election as a director, without objection to such nomination). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">&#147;<B>Fitch</B>&#148; mean Fitch
Ratings Inc. and its successors. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">&#147;<B>Investment Grade Rating</B>&#148; means a rating equal to or higher than Baa3
(or the equivalent) by Moody&#146;s and <FONT STYLE="white-space:nowrap">BBB-</FONT> (or the equivalent) by S&amp;P. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">&#147;<B>Moody&#146;s</B>&#148; means Moody&#146;s Investors Service, Inc., or its successor. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">&#147;<B>Rating Agencies</B>&#148; means (1)&nbsp;each of Moody&#146;s, S&amp;P and Fitch; and (2)&nbsp;if any of
Moody&#146;s, S&amp;P or Fitch ceases to rate the Notes or fails to make a rating of the Notes publicly available for reasons outside of the Company&#146;s control, a &#147;nationally recognized statistical rating organization&#148; within the
meaning of Rule 3(a)(62) under the Exchange Act selected by the Company (as certified by a resolution of the Company&#146;s Board of Directors) as a replacement agency for Moody&#146;s, S&amp;P or Fitch or all of them, as the case may be. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">&#147;<B>S&amp;P</B>&#148; means S&amp;P Global Ratings, a division of S&amp;P Global Inc., or its successor. </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(g)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">Denominations; Transfer; Exchange </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The Notes are in registered form without coupons in denominations of $2,000 and integral multiples of $1,000 in excess
thereof. Holders of Notes may transfer or exchange Notes in accordance with the Indenture. The Registrar may require a Holder of Notes, among other things, to furnish appropriate endorsements or transfer documents and to pay any taxes and fees
required by law or permitted by the Indenture. The Registrar need not register the transfer of or exchange any Notes selected for redemption (except, in the case of a Note to be redeemed in part, the portion of the Note not to be redeemed) or any
Notes for a period of 15&nbsp;days before a selection of Notes to be redeemed or 15&nbsp;days before an interest payment date. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(h)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">Persons Deemed Owners </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The registered Holder of this Note may be treated as the sole owner of such Note for all purposes. </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(i)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">Unclaimed Money </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Subject to applicable abandoned property law, if money for the payment of principal or interest remains unclaimed for two
years, the Trustee or Paying Agent shall pay the money back to the Company at its request unless an abandoned property law designates another Person. After any such payment, Holders entitled to the money must look only to the Company and not to the
Trustee or Paying Agent for payment. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(j)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">Discharge and Defeasance </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Subject to certain conditions, the Company at any time may terminate some or all of its obligations under the Notes and the
Indenture if the Company deposits with the Trustee money or U.S. Government Obligations for the payment of principal and interest on the Notes to redemption or maturity, as the case may be. </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(k)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">Amendment; Waiver </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Subject to certain exceptions set forth in the Indenture, (i)&nbsp;the Indenture or the Notes may be amended with the written
consent of the Holders of at least a majority in principal amount outstanding of the Notes; and (ii)&nbsp;any default or compliance with any provision may be waived with the written consent of the Holders of a majority in principal amount of the
Notes then outstanding. Subject to certain exceptions set forth in the Indenture, without the consent of any Holder of a Note, the Company and the Trustee may amend the Indenture or the Notes to cure any ambiguity, omission, defect or inconsistency
that does not materially and adversely affect the rights of any Holder of a Note, or to comply with Article&nbsp;5 of the Indenture or to comply with requirements of the SEC in connection with the qualification of the Indenture under the TIA. </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(l)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">Defaults and Remedies </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">If an Event of Default occurs and is continuing, the Trustee or the Holders of at least 25% in aggregate principal amount of
the Notes may declare all the Notes to be due and payable immediately. Certain events of bankruptcy or insolvency are Events of Default which will result in the Notes being due and payable immediately upon the occurrence of such Events of Default.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Holders of Notes may not enforce the Indenture or the Notes except as provided in the Indenture. The Trustee may refuse
to enforce the Indenture or the Notes unless it receives indemnity or security satisfactory to it. Subject to certain limitations, Holders of a majority in principal amount of the Notes may direct the Trustee in its exercise of any trust or power.
The Trustee may withhold from Holders of Notes notice of any continuing Default (except a Default in payment of principal or interest) if it determines that withholding such notice is in the interest of the Holders of Notes. </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(m)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">Trustee Dealings with the Company </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Subject to certain limitations imposed by the TIA, the Trustee under the Indenture, in its individual or any other capacity,
may become the owner or pledgee of Notes and may otherwise deal with and collect obligations owed to it by the Company or its Affiliates and may otherwise deal with the Company or its Affiliates with the same rights it would have if it were not
Trustee. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(n)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">No Recourse Against Others </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">A director, officer, employee or stockholder, as such, of the Company or the Trustee shall not have any liability for any
obligations of the Company under the Notes or the Indenture or for any claim based on, in respect of or by reason of such obligations. By accepting a Note, each Holder of a Note waives and releases all such liability. The waiver and release are part
of the consideration for the issue of the Notes. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(o)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">Authentication </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">This Note shall not be valid until an authorized signatory of the Trustee (or an authenticating agent) manually signs the
certificate of authentication on the face of this Note. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(p)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">Abbreviations </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Customary abbreviations may be used in the name of a Holder of a Note or an assignee, such as TEN COM (=tenants in common),
TEN ENT (=tenants by the entireties), JT TEN (=joint tenants with rights of survivorship and not as tenants in common), CUST (=custodian), and U/G/M/A (=Uniform Gift to Minors Act). </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(q)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">Governing Law </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">This Note shall be governed by, and construed in accordance with, the laws of the State of New York. </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(r)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">CUSIP Numbers </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Pursuant to the recommendation promulgated by the Committee on Uniform Security Identification Procedures, the Company has
caused CUSIP numbers to be printed on the Notes and has directed the Trustee to use such CUSIP numbers in notices of redemption as a convenience to Holders of Notes. No representation is made as to the accuracy of such numbers either as printed on
the Notes or as contained in any notice of redemption and reliance may be placed only on the other identification numbers placed thereon. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">------------------------------------------- </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The Company will furnish to any Holder of a Note upon written request and
without charge to such Holder of a Note a copy of the Indenture. Requests may be made to: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">CVS Health Corporation </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">One CVS Drive &#151; MC 1008 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Woonsocket, Rhode Island 02895 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Attention: Tom Cowhey </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">ASSIGNMENT FORM </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">To assign this Note, complete the form below: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">I or we assign and transfer this Note to: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[Print or type assignee&#146;s name, address and zip code] </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[Insert assignee&#146;s soc. sec. or tax I.D. No.] </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:30%; text-indent:4%; font-size:10pt; font-family:Times New Roman">and irrevocably appoint ___________ as agent to </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:30%; text-indent:4%; font-size:10pt; font-family:Times New Roman">transfer this Note on the books of CVS Health Corporation. </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:30%; text-indent:4%; font-size:10pt; font-family:Times New Roman">The agent may substitute another to act for him. </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</DIV> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="4%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="37%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="4%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="12%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="34%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="4%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Date:</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">&#8195;&#8195;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Your&nbsp;Signature:</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">&#8195;&#8195;</TD></TR>
</TABLE> <P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</DIV>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Sign exactly as your name appears on the face of this Note. </P>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-5.1
<SEQUENCE>7
<FILENAME>d32562dex51.htm
<DESCRIPTION>EX-5.1
<TEXT>
<HTML><HEAD>
<TITLE>EX-5.1</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE" STYLE="line-height:Normal">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 5.1 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[Letterhead of Wachtell, Lipton, Rosen&nbsp;&amp; Katz] </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">August&nbsp;15, 2025 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">CVS Health Corporation </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">One CVS Drive </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Woonsocket, RI 02895 </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Re: CVS Health Corporation Current Report on Form <FONT STYLE="white-space:nowrap">8-K</FONT> filed on August&nbsp;15, 2025 </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Ladies and Gentlemen: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">We have acted as special
outside counsel to CVS Health Corporation, a Delaware corporation (the &#147;Company&#148;), in connection with the sale by the Company to the Underwriters (as defined below) pursuant to the Underwriting Agreement, dated August&nbsp;11, 2025 (the
&#147;Underwriting Agreement&#148;), among the Company and the representatives of the several underwriters listed in Schedule I of the Underwriting Agreement (the &#147;Underwriters&#148;) of $750,000,000 in aggregate principal amount of its 5.000%
Senior Notes due 2032 (the &#147;2032 Notes&#148;), $1,500,000,000 in aggregate principal amount of its Company&#146;s 5.450% Senior Notes due 2035 (the &#147;2035 Notes&#148;), $1,250,000,000 in aggregate principal amount of its 6.200% Senior Notes
due 2055 (the &#147;2055 Notes&#148;) and $500,000,000 in aggregate principal amount of its 6.250% Senior Notes due 2065 (the &#147;2065 Notes,&#148; and together with the 2032 Notes, the 2035 Notes and the 2055 Notes, the &#147;Notes&#148;). The
Notes are to be issued under the senior indenture dated as of August&nbsp;15, 2006, between the Company and The Bank of New York Mellon Trust Company, N.A., as trustee (the &#147;Trustee&#148; and such indenture, the &#147;Base Indenture&#148;).
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">We have examined and relied on originals or copies certified or otherwise identified to our satisfaction of such documents, corporate
records, certificates of the Company and public officials and other instruments as we have deemed necessary or appropriate for the purposes of this letter, including (a)&nbsp;the Company&#146;s Registration Statement on Form <FONT
STYLE="white-space:nowrap">S-3ASR</FONT> (File <FONT STYLE="white-space:nowrap">No.&nbsp;333-272200)</FONT> as filed with the Securities and Exchange Commission (the &#147;Commission&#148;) on May&nbsp;25, 2023 (the &#147;Registration
Statement&#148;); (b) the base prospectus, dated May&nbsp;25, 2023, included in the Registration Statement, but excluding the documents incorporated by reference therein; (c)&nbsp;the preliminary prospectus supplement, dated August&nbsp;11, 2025, as
filed with the Commission pursuant to Rule 424(b)(3) under the Securities Act of 1933, as amended (the &#147;Act&#148;), but excluding the documents incorporated by reference therein; (d)&nbsp;the final term sheet, dated August&nbsp;11, 2025, as
filed with the Commission pursuant to Rule 433 under the Act; (e)&nbsp;the final prospectus supplement (the &#147;Prospectus Supplement&#148;), dated August&nbsp;11, 2025, as filed with the Commission pursuant to Rule 424(b)(2) under the Act, but
excluding the documents incorporated by reference therein; (f)&nbsp;a copy of the certificate of incorporation of the Company and a copy of the bylaws of the Company, each as set forth in the certificate of the Secretary of the Company, dated as of
August&nbsp;15, 2025; (g) the Base Indenture; (h) the Executive Officers&#146; Certificate of the Company, dated as of August&nbsp;15, 2025, establishing the terms of the Notes (the &#147;Executive Officers&#146; Certificate&#148;; and the Base
Indenture as supplemented by the Executive Officers&#146; Certificate, the &#147;Indenture&#148;); (i) a copy of the global notes for each series of the Notes, each dated August&nbsp;15, 2025; (j) an executed copy of the Underwriting Agreement;
(k)&nbsp;resolutions of the Board of Directors of the Company relating to the issuance of the Notes and (l)&nbsp;such other corporate records, certificates and other documents and such matters of law, in each case, as we have deemed necessary or
appropriate. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">In such examination, we have assumed (a)&nbsp;the authenticity of original documents and the genuineness of all signatures;
(b)&nbsp;the conformity to the originals of all documents submitted to us as copies; (c)&nbsp;the truth, accuracy and completeness of the information, representations and warranties contained in the agreements, records, documents, instruments and
certificates we have reviewed; (d)&nbsp;all Notes will be issued and sold in compliance with applicable foreign, U.S. federal and state securities laws and in the manner stated in the Registration Statement and the Prospectus Supplement; and
(e)&nbsp;the Underwriting Agreement has been duly authorized and validly executed and delivered by the Underwriters. We also have assumed that the terms of the Notes have been established so as not to, and that the execution and delivery by the
parties thereto and the performance of such parties&#146; obligations under the Notes will not, breach, contravene, violate, conflict with or constitute a default under (i)&nbsp;any law, rule or regulation to which any party thereto is subject
(excepting the laws of the State of New York and the federal securities laws of the United States of America as such laws apply to the Company), (ii) any judicial or regulatory order or decree of any governmental authority, or (iii)&nbsp;any
consent, approval, license, authorization or validation of, or filing, recording or registration with, any governmental authority. We also have assumed that the Indenture and the Notes are the valid and legally binding obligation of the Trustee. As
to any facts material to the opinion expressed herein that we did not independently establish or verify, we have relied upon statements and representations of officers and other representatives of the Company and others. We have further assumed the
legal capacity of all natural persons, the genuineness of all signatures, the authenticity of all documents submitted to us as originals, the conformity to original documents of all documents submitted to us as certified, facsimile, conformed,
electronic or photostatic copies, and the authenticity of the originals of such copies. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">We are members of the Bar of the State of New
York, and we have not considered, and we express no opinion as to, the laws of any jurisdiction other than the laws of the State of New York and the federal securities laws of the United States of America, in each case as in effect on the date
hereof. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Based upon the foregoing, and subject to the qualifications set forth in this letter, we advise you that, in our opinion, the
Notes, when duly executed, authenticated, issued, delivered and paid for in accordance with the terms of the Indenture and the Underwriting Agreement, will be valid and binding obligations of the Company, enforceable against the Company in
accordance with their terms. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">The opinion set forth above is subject to the effects of (a)&nbsp;bankruptcy, insolvency,
fraudulent conveyance, fraudulent transfer, reorganization, moratorium and other similar laws relating to or affecting the enforcement of creditors&#146; rights generally; (b)&nbsp;general equitable principles (whether considered in a proceeding in
equity or at law); (c) an implied covenant of good faith and fair dealing; (d)&nbsp;provisions of law that require that a judgment for money damages rendered by a court in the United States be expressed only in United States dollars;
(e)&nbsp;limitations by any governmental authority that limit, delay or prohibit the making of payments outside the United States; and (f)&nbsp;generally applicable laws that (i)&nbsp;provide for the enforcement of oral waivers or modifications
where a material change of position in reliance thereon has occurred or provide that a course of performance may operate as a waiver, (ii)&nbsp;limit the availability of a remedy under certain circumstances where another remedy has been elected,
(iii)&nbsp;limit the enforceability of provisions releasing, exculpating or exempting a party from, or requiring indemnification of a party for, liability for its own action or inaction, to the extent the action or inaction involves negligence,
gross negligence, recklessness, willful misconduct or unlawful conduct, (iv)&nbsp;may, where less than all of a contract may be unenforceable, limit the enforceability of the balance of the contract to circumstances in which the unenforceable
portion is not an essential part of the agreed-upon exchange, (v)&nbsp;may limit the enforceability of provisions providing for compounded interest, imposing increased interest rates or late payment charges upon delinquency in payment or default or
providing for liquidated damages or for premiums upon acceleration, or (vi)&nbsp;limit the waiver of rights under usury laws. Furthermore, the manner in which any particular issue relating to the opinion would be treated in any actual court case
would depend in part on facts and circumstances particular to the case and would also depend on how the court involved chose to exercise the wide discretionary authority generally available to it. We express no opinion as to the effect of
Section&nbsp;210(p) of the Dodd-Frank Wall Street Reform and Consumer Protection Act of 2010, as amended. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">We express no opinion as to
whether, or the extent to which, the laws of any particular jurisdiction apply to the subject matter hereof, including, without limitation, the enforceability of the governing law provision contained in the Notes and the Indenture. We express no
opinion as to the ability of another court, federal or state, to accept jurisdiction and/or venue in the event the chosen court is unavailable for any reason, including, without limitation, natural disaster, act of God, human health or safety
reasons (including a pandemic) or otherwise. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">This letter speaks only as of its date and is delivered in accordance with the requirements
of Item 601(b)(5) of Regulation <FONT STYLE="white-space:nowrap">S-K</FONT> under the Act. We hereby consent to the filing of a copy of this letter as an exhibit to the Company&#146;s Current Report on Form
<FONT STYLE="white-space:nowrap">8-K,</FONT> filed on August&nbsp;15, 2025, and to the use of our name in the Prospectus Supplement forming a part of the Registration Statement under the caption &#147;Legal Matters.&#148; In giving this consent, we
do not thereby admit that we are within the category of persons whose consent is required under Section&nbsp;7 of the Act. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Very truly yours, </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">/s/ Wachtell, Lipton, Rosen&nbsp;&amp; Katz </P>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>8
<FILENAME>cvs-20250811.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!-- DFIN - https://www.dfinsolutions.com/ -->
<!-- CTU Version: Release 2512 Build:20250722.1 -->
<!-- Creation date: 8/15/2025 12:04:44 PM Eastern Time -->
<!-- Copyright (c) 2025 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<xsd:schema
  xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric"
  xmlns:num="http://www.xbrl.org/dtr/type/numeric"
  xmlns:us-types="http://fasb.org/us-types/2025"
  xmlns:cvs="http://www.cvshealth.com/20250811"
  xmlns:dei="http://xbrl.sec.gov/dei/2025"
  xmlns:xbrli="http://www.xbrl.org/2003/instance"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xbrldt="http://xbrl.org/2005/xbrldt"
  attributeFormDefault="unqualified"
  elementFormDefault="qualified"
  targetNamespace="http://www.cvshealth.com/20250811"
  xmlns:xsd="http://www.w3.org/2001/XMLSchema">
    <xsd:import schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" namespace="http://www.xbrl.org/2003/instance" />
    <xsd:import schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" namespace="http://www.xbrl.org/2003/linkbase" />
    <xsd:import schemaLocation="https://xbrl.sec.gov/dei/2025/dei-2025.xsd" namespace="http://xbrl.sec.gov/dei/2025" />
    <xsd:import schemaLocation="http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd" namespace="http://www.xbrl.org/dtr/type/numeric" />
    <xsd:import schemaLocation="http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd" namespace="http://www.xbrl.org/dtr/type/non-numeric" />
    <xsd:import schemaLocation="https://xbrl.sec.gov/naics/2025/naics-2025.xsd" namespace="http://xbrl.sec.gov/naics/2025" />
    <xsd:import schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd" namespace="http://xbrl.org/2005/xbrldt" />
  <xsd:annotation>
    <xsd:appinfo>
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="cvs-20250811_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:title="Label Links, all" xlink:type="simple" />
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="cvs-20250811_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:title="Presentation Links, all" xlink:type="simple" />
      <link:roleType roleURI="http://www.cvshealth.com//20250811/taxonomy/role/DocumentDocumentAndEntityInformation" id="Role_DocumentDocumentAndEntityInformation">
        <link:definition>100000 - Document - Document and Entity Information</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xsd:appinfo>
  </xsd:annotation>
</xsd:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>9
<FILENAME>cvs-20250811_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii" standalone="yes"?>
<!-- DFIN - https://www.dfinsolutions.com/ -->
<!-- CTU Version: Release 2512 Build:20250722.1 -->
<!-- Creation date: 8/15/2025 12:04:44 PM Eastern Time -->
<!-- Copyright (c) 2025 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<link:linkbase
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
  xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CoverAbstract" xlink:type="locator" xlink:label="dei_CoverAbstract" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_CoverAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Cover [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_CoverAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Cover [Abstract]</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityRegistrantName" xlink:type="locator" xlink:label="dei_EntityRegistrantName" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityRegistrantName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Registrant Name</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityRegistrantName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Registrant Name</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AmendmentFlag" xlink:type="locator" xlink:label="dei_AmendmentFlag" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_AmendmentFlag_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Amendment Flag</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_AmendmentFlag_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Amendment Flag</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCentralIndexKey" xlink:type="locator" xlink:label="dei_EntityCentralIndexKey" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityCentralIndexKey_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Central Index Key</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityCentralIndexKey_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Central Index Key</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentType" xlink:type="locator" xlink:label="dei_DocumentType" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_DocumentType_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Document Type</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_DocumentType_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Type</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentPeriodEndDate" xlink:type="locator" xlink:label="dei_DocumentPeriodEndDate" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_DocumentPeriodEndDate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Document Period End Date</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_DocumentPeriodEndDate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Period End Date</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityIncorporationStateCountryCode" xlink:type="locator" xlink:label="dei_EntityIncorporationStateCountryCode" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Incorporation State Country Code</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Incorporation State Country Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityFileNumber" xlink:type="locator" xlink:label="dei_EntityFileNumber" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityFileNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity File Number</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityFileNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity File Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityTaxIdentificationNumber" xlink:type="locator" xlink:label="dei_EntityTaxIdentificationNumber" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Tax Identification Number</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Tax Identification Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine1" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine1" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Address Line One</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, Address Line One</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressCityOrTown" xlink:type="locator" xlink:label="dei_EntityAddressCityOrTown" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressCityOrTown_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, City or Town</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressCityOrTown_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, City or Town</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressStateOrProvince" xlink:type="locator" xlink:label="dei_EntityAddressStateOrProvince" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressStateOrProvince_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, State or Province</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressStateOrProvince_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, State or Province</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressPostalZipCode" xlink:type="locator" xlink:label="dei_EntityAddressPostalZipCode" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressPostalZipCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Postal Zip Code</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressPostalZipCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CityAreaCode" xlink:type="locator" xlink:label="dei_CityAreaCode" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_CityAreaCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">City Area Code</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_CityAreaCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">City Area Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_LocalPhoneNumber" xlink:type="locator" xlink:label="dei_LocalPhoneNumber" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_LocalPhoneNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Local Phone Number</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_LocalPhoneNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Local Phone Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_WrittenCommunications" xlink:type="locator" xlink:label="dei_WrittenCommunications" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_WrittenCommunications_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Written Communications</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_WrittenCommunications_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Written Communications</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SolicitingMaterial" xlink:type="locator" xlink:label="dei_SolicitingMaterial" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_SolicitingMaterial_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Soliciting Material</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_SolicitingMaterial_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Soliciting Material</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementTenderOffer" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Pre Commencement Tender Offer</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Pre Commencement Tender Offer</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementIssuerTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementIssuerTenderOffer" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Pre Commencement Issuer Tender Offer</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Pre Commencement Issuer Tender Offer</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Security12bTitle" xlink:type="locator" xlink:label="dei_Security12bTitle" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_Security12bTitle_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Security 12b Title</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_Security12bTitle_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Security 12b Title</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_TradingSymbol" xlink:type="locator" xlink:label="dei_TradingSymbol" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_TradingSymbol_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Trading Symbol</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_TradingSymbol_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Trading Symbol</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SecurityExchangeName" xlink:type="locator" xlink:label="dei_SecurityExchangeName" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_SecurityExchangeName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Security Exchange Name</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_SecurityExchangeName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Security Exchange Name</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityEmergingGrowthCompany" xlink:type="locator" xlink:label="dei_EntityEmergingGrowthCompany" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Emerging Growth Company</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Emerging Growth Company</link:label>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>10
<FILENAME>cvs-20250811_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii" standalone="yes"?>
<!-- DFIN - https://www.dfinsolutions.com/ -->
<!-- CTU Version: Release 2512 Build:20250722.1 -->
<!-- Creation date: 8/15/2025 12:04:44 PM Eastern Time -->
<!-- Copyright (c) 2025 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<link:linkbase
    xmlns:link="http://www.xbrl.org/2003/linkbase"
    xmlns:xlink="http://www.w3.org/1999/xlink"
    xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
    xmlns:xbrldt="http://xbrl.org/2005/xbrldt"
    xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.cvshealth.com//20250811/taxonomy/role/DocumentDocumentAndEntityInformation" xlink:href="cvs-20250811.xsd#Role_DocumentDocumentAndEntityInformation" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.cvshealth.com//20250811/taxonomy/role/DocumentDocumentAndEntityInformation">
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CoverAbstract" xlink:type="locator" xlink:label="dei_CoverAbstract" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityRegistrantName" xlink:type="locator" xlink:label="dei_EntityRegistrantName" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityRegistrantName" order="22.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AmendmentFlag" xlink:type="locator" xlink:label="dei_AmendmentFlag" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_AmendmentFlag" order="23.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCentralIndexKey" xlink:type="locator" xlink:label="dei_EntityCentralIndexKey" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityCentralIndexKey" order="24.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentType" xlink:type="locator" xlink:label="dei_DocumentType" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentType" order="26.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentPeriodEndDate" xlink:type="locator" xlink:label="dei_DocumentPeriodEndDate" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentPeriodEndDate" order="27.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityIncorporationStateCountryCode" xlink:type="locator" xlink:label="dei_EntityIncorporationStateCountryCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityIncorporationStateCountryCode" order="28.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityFileNumber" xlink:type="locator" xlink:label="dei_EntityFileNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityFileNumber" order="29.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityTaxIdentificationNumber" xlink:type="locator" xlink:label="dei_EntityTaxIdentificationNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityTaxIdentificationNumber" order="30.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine1" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine1" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressAddressLine1" order="31.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressCityOrTown" xlink:type="locator" xlink:label="dei_EntityAddressCityOrTown" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressCityOrTown" order="32.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressStateOrProvince" xlink:type="locator" xlink:label="dei_EntityAddressStateOrProvince" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressStateOrProvince" order="33.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressPostalZipCode" xlink:type="locator" xlink:label="dei_EntityAddressPostalZipCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressPostalZipCode" order="34.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CityAreaCode" xlink:type="locator" xlink:label="dei_CityAreaCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_CityAreaCode" order="35.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_LocalPhoneNumber" xlink:type="locator" xlink:label="dei_LocalPhoneNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_LocalPhoneNumber" order="36.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_WrittenCommunications" xlink:type="locator" xlink:label="dei_WrittenCommunications" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_WrittenCommunications" order="37.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SolicitingMaterial" xlink:type="locator" xlink:label="dei_SolicitingMaterial" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_SolicitingMaterial" order="38.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementTenderOffer" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_PreCommencementTenderOffer" order="39.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementIssuerTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementIssuerTenderOffer" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_PreCommencementIssuerTenderOffer" order="40.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Security12bTitle" xlink:type="locator" xlink:label="dei_Security12bTitle" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_Security12bTitle" order="41.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_TradingSymbol" xlink:type="locator" xlink:label="dei_TradingSymbol" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_TradingSymbol" order="42.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SecurityExchangeName" xlink:type="locator" xlink:label="dei_SecurityExchangeName" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_SecurityExchangeName" order="43.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityEmergingGrowthCompany" xlink:type="locator" xlink:label="dei_EntityEmergingGrowthCompany" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityEmergingGrowthCompany" order="44.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>11
<FILENAME>g32562g0814233928094.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g32562g0814233928094.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1"  3 &@# 2(  A$! Q$!_\0
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+ "BBB@ HHHH _]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Document and Entity Information<br></strong></div></th>
<th class="th"><div>Aug. 11, 2025</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">CVS HEALTH Corp<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0000064803<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Aug. 11,  2025<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation State Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-01011<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">05-0494040<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">One CVS Drive<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Woonsocket<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">RI<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">02895<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">(401)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">765-1500<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre Commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre Commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Security 12b Title</a></td>
<td class="text">Common Stock, par value $0.01 per share<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">CVS<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14a<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>15
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
.report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

.report table.authRefData a {
	display: block;
	font-weight: bold;
}

.report table.authRefData p {
	margin-top: 0px;
}

.report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

.report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

.report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

.report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
.pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
.report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

.report hr {
	border: 1px solid #acf;
}

/* Top labels */
.report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

.report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

.report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

.report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

.report td.pl div.a {
	width: 200px;
}

.report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
.report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
.report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
.report .re, .report .reu {
	background-color: #def;
}

.report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
.report .ro, .report .rou {
	background-color: white;
}

.report .rou td {
	border-bottom: 1px solid black;
}

.report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
.report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
.report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

.report .nump {
	padding-left: 2em;
}

.report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
.report .text {
	text-align: left;
	white-space: normal;
}

.report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

.report .text .more {
	display: none;
}

.report .text .note {
	font-style: italic;
	font-weight: bold;
}

.report .text .small {
	width: 10em;
}

.report sup {
	font-style: italic;
}

.report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>17
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.25.2</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>22</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="d32562d8k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>100000 - Document - Document and Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com//20250811/taxonomy/role/DocumentDocumentAndEntityInformation</Role>
      <ShortName>Document and Entity Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File>cvs-20250811.xsd</File>
    <File>cvs-20250811_lab.xml</File>
    <File>cvs-20250811_pre.xml</File>
    <File doctype="8-K" isOnlyDei="true" original="d32562d8k.htm">d32562d8k.htm</File>
  </InputFiles>
  <SupplementalFiles>
    <File>g32562g0814233928094.jpg</File>
  </SupplementalFiles>
  <BaseTaxonomies>
    <BaseTaxonomy items="22">http://xbrl.sec.gov/dei/2025</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>20
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "d32562d8k.htm": {
   "nsprefix": "cvs",
   "nsuri": "http://www.cvshealth.com/20250811",
   "dts": {
    "schema": {
     "local": [
      "cvs-20250811.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd",
      "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd",
      "https://www.xbrl.org/dtr/type/2024-01-31/types.xsd",
      "https://xbrl.sec.gov/dei/2025/dei-2025.xsd",
      "https://xbrl.sec.gov/naics/2025/naics-2025.xsd"
     ]
    },
    "labelLink": {
     "local": [
      "cvs-20250811_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "cvs-20250811_pre.xml"
     ]
    },
    "inline": {
     "local": [
      "d32562d8k.htm"
     ]
    }
   },
   "keyStandard": 22,
   "keyCustom": 0,
   "axisStandard": 0,
   "axisCustom": 0,
   "memberStandard": 0,
   "memberCustom": 0,
   "hidden": {
    "total": 3,
    "http://xbrl.sec.gov/dei/2025": 3
   },
   "contextCount": 1,
   "entityCount": 1,
   "segmentCount": 0,
   "elementCount": 23,
   "unitCount": 0,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2025": 22
   },
   "report": {
    "R1": {
     "role": "http://www.cvshealth.com//20250811/taxonomy/role/DocumentDocumentAndEntityInformation",
     "longName": "100000 - Document - Document and Entity Information",
     "shortName": "Document and Entity Information",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "duration_2025-08-11_to_2025-08-11",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "p",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d32562d8k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "duration_2025-08-11_to_2025-08-11",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "p",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d32562d8k.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://www.cvshealth.com//20250811/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "CityAreaCode",
     "presentation": [
      "http://www.cvshealth.com//20250811/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "City Area Code",
        "terseLabel": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Cover [Abstract]",
        "terseLabel": "Cover [Abstract]",
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://www.cvshealth.com//20250811/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentType",
     "presentation": [
      "http://www.cvshealth.com//20250811/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Type",
        "terseLabel": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://www.cvshealth.com//20250811/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line One",
        "terseLabel": "Entity Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://www.cvshealth.com//20250811/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, City or Town",
        "terseLabel": "Entity Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://www.cvshealth.com//20250811/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://www.cvshealth.com//20250811/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, State or Province",
        "terseLabel": "Entity Address, State or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://www.cvshealth.com//20250811/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://www.cvshealth.com//20250811/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://www.cvshealth.com//20250811/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity File Number",
        "terseLabel": "Entity File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://www.cvshealth.com//20250811/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Incorporation State Country Code",
        "terseLabel": "Entity Incorporation State Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://www.cvshealth.com//20250811/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityTaxIdentificationNumber": {
     "xbrltype": "employerIdItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityTaxIdentificationNumber",
     "presentation": [
      "http://www.cvshealth.com//20250811/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number",
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://www.cvshealth.com//20250811/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "PreCommencementIssuerTenderOffer",
     "presentation": [
      "http://www.cvshealth.com//20250811/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre Commencement Issuer Tender Offer",
        "terseLabel": "Pre Commencement Issuer Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "dei_PreCommencementTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "PreCommencementTenderOffer",
     "presentation": [
      "http://www.cvshealth.com//20250811/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre Commencement Tender Offer",
        "terseLabel": "Pre Commencement Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "Security12bTitle",
     "presentation": [
      "http://www.cvshealth.com//20250811/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security 12b Title",
        "terseLabel": "Security 12b Title",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://www.cvshealth.com//20250811/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_SolicitingMaterial": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "SolicitingMaterial",
     "presentation": [
      "http://www.cvshealth.com//20250811/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Soliciting Material",
        "terseLabel": "Soliciting Material",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "TradingSymbol",
     "presentation": [
      "http://www.cvshealth.com//20250811/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "dei_WrittenCommunications": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "WrittenCommunications",
     "presentation": [
      "http://www.cvshealth.com//20250811/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Written Communications",
        "terseLabel": "Written Communications",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r1": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r2": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14a",
   "Subsection": "12"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "425"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>21
<FILENAME>0001193125-25-181862-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001193125-25-181862-xbrl.zip
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M?#,P@3 <C0]>CU^_ANN/<.:KF$D!$[Y@Q5Q<;B2?S6/X(?@1DJQ3%()%$=O
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M8CU[82PO!&DER$H1O<;7H@W+BWQUO11/7.HC\W<GLE,\_>L+^LQ_4$L#!!0
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M,_H-(\:VQ2KTT0-RV!I*ND33NOD!=I>Q6D*0S//F&MM<"9:&:WH<E+/4J^T
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M* DKSEPTD@IX4YH;#*&5(N5%TM/.2(<%(\;<I Z CG'8]]3]AGB<QG$^@2*
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MU:HM3@R6=EB?.MTHF4!&=<,*Z#(.<2M/=@>XZ7L<%F8M[-_]3 ''^1#CW&Y
M$8.%VP<=5][%N&4W*\X<'F@2Q6GD<R[4]&Q70NZSH3%'2<>Y6G"[ Z9/[/.[
M7_2FC=*U/WBPNWV#TF.%@2.+DA;.8:N]X+VHZH=;*F&\D42I9S\"04O[Z_VD
M<BPZ?-IYT@VG+?9.(I'?*QC3M<U4-2=RY#VWH0XT@A9+KQ)X%:NO8G56/4DN
MKS3R2B.+U>O32W/_:9N,W',FY(^MREVB6M]F73++[FG*>W7Y,L=TWJ.\S*G?
M3Y8_K5S]?U!+ P04    " !7@0];9C6I*\5M   &K0( #P   &0S,C4V,F1E
M>#$Q+FAT;>U]:7/;2);@=T;P/V2XIR:D'4BETW<[ECILJUNVM*+<-34;^P$D
M01%M$&#CD,S^]?N./'&0E$Q=59SH*4L4F,A\^>[S_>?++Z<?WG\^[AQ]:+?>
M7YY<GAY_./[OC>W-[?>_\F_P\:_R[^+]P=G1[^+@T^'9Z=G%7U_\]OGD\OB%
MZ%[^?GK\UQ=1& <;HR"\&N5OOR;IV(]>?!#M%GS_,(CS(/WP_NCD'^KAFW"0
MC]Z^WMP/XQ?"C\*K&!8(AOD+>LVY>FSLIU=AO)$GD[=;D_R=D+_WDCQ/QOS1
M,(GSC2S\=_!VV_P^],=A-'U[&8Z#3'P-;L1%,O;A39W3DT]?__HBQ4V^^/#^
MX,/QCU'8"W,!!Q;O?SWX\/[7<SQQW0:V=Y:X@SZ!A+9P^(^N  "?7GX6AV<7
MYV<7G<N3LZ_S=O/R?C;S'Z_VM[RM+?I_L;\)__U%=(,X3%+Q-<GAVX,B$#M;
MNSOS]K?,Z[+WM^WM;]D[W-MOV.'^X^UPQX+AR\V=!ACN/]H.;0C"_AH@^'+N
M_NX)!]]_^_ M'@3I31KF87PE.E=I$(SA[["?;Q\>DDHEG^@45T66_V?<RR;O
MMK<]@,T.PN;\0SVG6LH6/ASX:3_RIYDX]"=A[D?B).YOBGO&E@]_VSS?%%^2
M],J/ 2?Z!5X!/'%Z>CCCP$MY\V]!%&7B(ZR26&_V]*MO>]]Y\"/?" &/XOSM
MWB^WW$PG$Q?!) TR^+:?A]?PUV0H\E$@LN Z2.$V-(8&:7:76_FI[<7^.!B(
M,!9 *MW^*!@442!.D#K$*$B#/+EW[.S_F@B%H>U6!47O$4]>[>T#?EP#W$:B
M _\ K[KG-^*/OR?I=T^HG\3VUM;V&]2,[A_*CT>1NZ]WQ1=_$&9);$/Z/ME/
M+:BW7[UY$'R^(P=:RL'W][=$-RD IR_3*<"[FX/,RSVQ#Y]\C!(0S?=\V8<C
M/XW@RP& _E#LO 89=R>V>ZN7G@)VP2=^/!"?@* CE/)O9YRT2>'X*69*^G?@
M1P#IPR2=)"DP_"3VA-]N'061?^.G@>B;/X@U% /_^9?7.SM;[U!]3\83/YZB
M6D(?;K];]\0D329)!N\!5AQF&5 .GC$#!!..ANU?@6YSY><!?".,^^$$F*@_
M3@K0=4#>A'DV6P<O;65GBY2C@P^[._('_H*[MY(*7;.%=JN\AQE:=N,>]F?O
M8>=68)BI1C=M8;]Y"W0?MB(,9UYD$\VZ<M,F7C9N@O:0)U<!?#,5-R$@(*Y!
M-TO/>NKW??DR^L)(GMH\@HOK=>GMU?,"(MKJ2V&I+^T6ZQ/)#'VB=#I;^W%O
M=@B0N1F%_9&H56"]6?(,CS>+"2,E^GVR"?Q,I"4%K;3%DOYF[W)37(Z"=HMA
M>A,"4:[YZZS>C_SK -A).F9@ QU?AQE0?28/A5O(BC'P(. NI(+A6X_"K!\E
M60%_//?[W_VK #<H-<;.9!*%?;\'($7>HR_Q/$VR2=#/"T BP+J!]17\G2 /
MOZ\%/KX7'@J&8<SO!, @*Y(6"6Q>/LQHO=:3A^D%S'S@'$6:%3Y@,ERE'[=;
M)\0K<;_VJQT[9Q_MG*V79;#J;SK8U0ORFR!@8$B&*-8 %<9!&DW%]SBYB?$=
M<AGDN!:K=6@2;@8P)_Z.^]$ZP!= "L#.RQ2VI]8'.;79V:Q[2^T2]%W05.TO
M [K"XSG^)0C*![WDC\MX$P)B:'L4OA)FUG>TI>H )R0QT$_B89B."41F!?BT
M'Z0QHC3^ >ZI/_*S0"$"H^@P3<8.:'M3^M6FPIFFX4)&TIO;"LYM>.>)0V=
M)Y[XS4]30#4EV#5,-'9KB7GR@2A1'TM3-'_SAA="Z'GT 8$M(T[I"2(+"P+M
M5C[R\[MH#_(C=#^2]O!30$%B[,0*)_P"W@* Z8ML%$1#..%5F.52D<@ 9 09
M)0_67"J_0"Z\M[7/S)I 9S',3A_E4KNU_69WE_ 8>#@\-RCCL?L5&S'7D>-_
M!/(1[S^>?;W4KMD1@',CF_C]X"V05.I/7GSH;NR^_Q4?^H ;@TM"QN4BZ=K'
M$+8[=Z6OR28SF-W=W8V=5[#)K76U]%H(C Q.TD-6 J@P 6X[4,BND"0$]H6T
M!/L.\ZD1FVGPKR),74PK@4MQWA0 RR@&]U%$C+@5^:$?NC /.71=?0D^??P#
M*#B^H@V/@?W6JXSR+_9Z;$[B?X]._O'A_:_2:]YN"?K?^PD@S#0*7,(.QA64
MQH\F(((V>FG@?]_H!0"JX*T?W8 L?H&*P@1?\OE"=$_^!RYI]X5:E[SZ;__R
MAO[OA?CMY.CR\U]?@*G[BW:('1Y_O3R^>!"_?IDJ;T6%R Q (A+A>(!7H1;O
M$KN&@*P#@SS673426YSDP'32**0_^[&1U,AXB,N/@#^)*3R4H0X)FI#4N@Y!
M.4 6?X1/DX@.]9:*";P4M4O8$CZC]D2R2FX*Z%LQ$C\"4=<+^K[4)."UP7"(
M^@ H+DU[WX0#3D)V8F4%\,UZ/L1,%FB,6 E]DBO]+_C1CXH!;C#@D D)M5F+
M]0H 2JR^!?L6@Z1?,'W"YU+^,X&GP1#> Z*0R)M8^\2H1T#NN4]<D;83QL@F
MX+ATDX,@@J/7, H)^Y(>R%IWG(B$M&ZU)0:[8FQS3@87BR^@1_0"S4>2FR;6
MQN!$BK3Q,$'I!;(N Y:&7T<ENH0.%HIN(M-&58%-3&)#@ 9:T++9,$Q 9[HA
MQ8+46=9LT02 (X;#$%XS#GS4/+*WLW2'NTC-6].KI4*YVK)M+N%V,['W=GM?
M3#;'H/IIY>X0)4$.CY-(TW19@<R[)W30 U3SC U0/2@>HX</693 Z )X!*)1
MR]\+&TN["DL]99R@I"2R8@LFS D1QPFHTFF 81=B*("+2H& 51"_; 9F&20>
M? NE(2)68N3_NR4K7K>&['MC_[*];8RR=DM:914@>\UV&E.1!2:X+& UXS#V
MTZEU<5[)A"?F=8)F5RH^HCSX38:QSLO7". MLBK?8O"SV&XT($,$$E-QV6RW
M[7:OW6(^1P++%VGB#T 536ZTS(*/YVR6A0HKH[N[&NGJU*.G1%_'6BJBU*V2
M%X*:T)HQ0)KW\.%\TE(" /AOOJ&E+WK-RF*SEE2D^/9PF1 U_@"]+_"$%&K]
M!/\X7ZHC@?M]D#H#'\6,EA2U5P,JAY;%MC= WNO6P<R+77]*-_L12# 2ER#5
M1'<4!'D]ZT2IAU97D!M3PCZXXT/90[.M(BX0"NU65O1 ] .UD>IE,U4_SWTD
MNTHDSJ'!1^>,EO-F)J5;<&RW&)#$S.3WA_@M%9,W,FF>\3H3K1PK#\@!J*P7
MC'RPE%U?@>:5\"\I5BE33,4V1%TQYILU!)$ *:6X:]M@]2SE%#\DK&JW#%II
M;9@YZ!PNN2!#?D+(8(DS$) S%!%B=9;LL_216OY6AFQ)T]%P;5@S*T#>!38;
M50L:A^L,OIS-L.W*C*_=VMO96^NMST12XP@>,-+56!6DL0."UGGFGA+KG*=O
M#HFU+N."]6KMULR[;7K#K>Y1/,@UX@)/YRKK2:!&P^V#(<B:1#1EI?;:!]V^
M8"-"J[]^+[D.-K35.G",7Y""QJY0 0EE+Q@5VM6Y")ID)..+;*1!ZJ_7IFNB
M(Q[Y#A;U.A!S6=#7( WSGW>=WSZ_*';VD5C.P<6L#ON>*8+5"RQ%DI96. [X
M'V1-Z[1;B[-6IL<[T9XV)EG&5V)<&C4X@#C+MT%Z^^*7V_1J,(S*:Z]OBLJ]
MS,#4)"V'\69<!-EL#.G;G\""^*W=]=IX:+?*WG WW*A<@XN>EF-G\%$?N?_8
M1R=" P"-740,P8B ^X=ON\586VM#:5<]QU+$]IO=O5FA%/MY-^KM#W.Y_-)@
MZ:DS-3I*Y[R#?.!S7O).*V,S+DW+REK&4+T4^Q[\."Y HP M/S%6M>7I('S>
MWMKX^X+2WHU\[Y+9EHKM_;6!XD#MEG.MYF9*PDDY0&9"N/G<,L\1HQJ3AJA&
M16@(6TJ\GN0@SND<]YO:5<ZPWE$[7X6:[B4 #++PTD5@]+=B]$@F8[ ]B_P(
ME$],9"73%#DC4&JLM.IV2WN XB#+YGND9BU&2BVLT,QN6;#.,7(KC$M'4T"Q
M[@<!O6YHAT>D)!<LU.O)^'5'DVY91%WY89SE94\ F0Q&B=?FO8[NX9?"O,C)
M8>#I*!RO@%Q[^]6[C!)&@.=<D:L7$#@/8L<;J\,MBU[G( 2=36[,%D)S>4R[
M-5_CJY4:%>#?#P@JT;%;G:Y)G;6]#M73-8(=_I_]+ Y6,&XGO7]*YX\\<&%R
M:<AE-Y.*9AH"#Y,]TE]W,F+4=?)58QPTC M.*R4-02DG-T$4;7 "5!;X64).
M.*+EV[CGVJV*?PX_4("OVPA^KC:CLU[@)<".0PQ8W'X3%1\A!;+(YB3%!:0V
MVG<Y@0Z0*;A&GC++1[Z 2U F \XJ7GB8^Q_P_3=P>9GWPC[&&IU&W@T^([G#
M7$T.>*Y>7D8775U6FFBDYLFUZ4;P$L;P0!J2?D=4FVE&<XMLG-I;9^I?@"NJ
MX]:8E5Z],X&A8D=K2E:)<CK:1Y;6$CH@!@K2QH"R\SL>##C&A"RIU?<C;0SR
M&<P:%FEN9U%D(DO<U[MH<S.:E7K3#+E9@'.-N#H>@(8/7+>.HGJSH:MU&B>_
M([-23II-%< "-MP%AIY)]/0*^-!2X*RG)<H>J">.P"8+QP#A$  031M#\&+-
M"NKF(WR1V>: P]Y:/6JWRDY.9UGDH[@U3C=9?WP.&,SD@(.$A8Y7GRWMJ5PA
M)O$BSM,BL#-W0$TPZ#7T&662<<@Y/SF3]K3TB$0[CCC)Y70N$BX X@7N#RD(
MGAC[WV6BC7IMII]%<0FW'P4^:FOO,']6N:0],4IN,#O?P\18-D_CQ,ERY\P
MF18[1>-U[ \H@$U6-]*8Y.DF8XHWF*C$(I5)W !>2NZ,0HHG4V(:^R!$.>$2
M?>(Y:9GZI<@,XC ;&;U<)V*-TJ2X&M4ZW&O"?O@5R_&N\I4X\PV-"_(O$ $I
ML*Y1]!Y]F68[ !V3Z53)F=_1&?/*GM A"(#[ BD ]!R 16K9[%GIVHAV3#H0
MD%4^)3#^GP*,5#P'NT07SKV]W-A6SCRY)9F:;OOV.#7>I/4;C]:;QR?I(9-T
M397$(!R4J;F2AF-1M"@3-'EQ'Y.B=995A*7BZ@S], 5VC%D#L(J\)DXP@;\"
M"<%7B72]VS.$=NLN'$',90@UE_-$F$&[=2=N(.[ #!Z?5*[6N3:I1F-M=J,[
M"JM%3HZV*I4-5U6=15L/*BRM ./CT=:=A.U\TK*S1&I("L76\Q"P=R>I1_6I
MC-9_SEY:Q RMFDM*M+%3I=Y:FA_[,R0]SW;Z$Y'R\XV][*YB+_=*ZF&]^U0,
MBJA$Y[)V!@SHX ?H]R@2[2)_S)>_2I(!(CU'48R',?)OC-LFE_%>U2K 8^K4
M;Q(3$#0IR_ ";/642A42@:Y:E,_8*2!(=?484/&@0+<E_$E[#LAKFO73L&?2
M-!;@257OUSO]F>9]&</F7VR<$*VW6X/$>;F/4B& 2RZ!2+@0DMX;]DW\LTC#
M;!#VV=A!3B:K#S(\>I!FHW""+ 1(FOTD$A!3Q4H5)*0>H_<CF5+&[IE_V4:5
M!W?9#X#6;Y#KL-/?#R/4:24'2ZR#4I*].@4Q+3[&35)$TBH!/ Q!7RA(,I)@
MI$5UIP"/G4(6:_4'H%3 @3AVIY0N3(2+^_AW/%7(>U4G\BP<P.**K(A81N&'
MRE@$#!K"6=**\"(\1L=;T<O"0>BGB$DYL.*8;^YFE( EM>9;:0Q?Y&;;K8[<
M+;N1W5+GQ]:$_[DNCM'IKP\V+1]=1? U\$MJ43-H0"9;L*DFR%G5LX#UA%]
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M@_6J@8W:\_:EK7T;Z2F.N'3F\9C&R;_6L: "SSDG%H8IB@LW\)A+L_*Z *O
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MT2<UE\.IJ>C_F;=0J'MDUBX)9*W7I%(/[CW)0_1Z' S%21X)_8L-.T-9YBV
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M<* 4#532-B:FKRM[]">S8FHNS^ECHKU(/W)VPZJF[^YF/?MHS1L7]?MF!+#
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MU\@?M<>O9[]==!RD%2Z:BEJJ*:D4FUOX9$FK&(39)/*G;REE;@.[5Y4V-><
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M*>-.7@>\RB''N%]$UBC(D6'"9V->GKM(6JN0#HW'%X:F?X?3(<\%DI(*A]D
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MGIU].3B^^(1OZGSE<QY_Z9R<BN[OW<OC+YOV))J5R7%7-Z"9+W7\WY]/#DX
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M;@^. U;RJ=NY_/CA^AS@V>Q=X'*;/0*L ^K.ITN8@H=O+-CO&;P&&VE?XBN
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MA),[%@$]C(2/2*>2E >0GA?/[?MR&LUAGH1@(@>!(M#19E7L1T,Q K!5+1_
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ML)R8W"V1?3R1@>9=@9*)&DBP)V4<HU)+9O\#IRKN7 9)A(>=QKZ7<FA-#OP
M:W8*9$?.AY 2!$BTQ,#98]"LZ<S@$ZZ:2J$098Q!CU@)7^$*4ADRV=*7N"Y
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MQRXG674##,8;.UNF/#<9#!4FG+%NRODGE*!#+^'*D =&@BV9Y>/7#0RJE1F
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M9>.O=;=<,P=&"$"$<F045=M7@ WX:J7\18 -O<<Y]E3T$IDJ%QL1'$O/CYT
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MS6&>A/9$#@)%6T>+5;$?#<4(MJT*?-@^?(K^-M#"DA"VG9^/PVVSY"L-VBG
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MMFH=AEUN!KX\;,XDSAQGK?;'LSZL^$U^Q<[WV=0O-Q:._AUMA..[@R56@0%
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M)\60JU?QH%CRL\QZC,P:K*?,NE"@+0T14TV8>LV%USWL?%-]]8!=@VHWDO,
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MB9$:TIFC'H0KEE\MV V17U>C.#I')[5#E[B-%$-_1+P4%%"LN&H(K'_"Q;Y
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M@!Q&WIR_)5<?7TI)E2CRJTZ8&"E%UQ-E^>>!O*4<%K2)4H>1+UP(Z-!#G:O
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ML%.CV;.]NSIO-7GG>/3K7DO ?UOP.&[ZGXWSZ^S73VWX]>2SAHF6T>KVX#@
MDD_=SN7'#]?GL)^-W@6"V^C1QCI;W?ET"5/P\+4EZSV#UV A[4M\!3 &GVY?
MU@7213E=_E"RP/.[AA,X9P+Y>-XY:9R+RPX3B,%$PJI/9YUSVCOX^ZK192QN
M5"NY=RZ!1CZT+]MT1LY6P;,7M<4Y+AJ?\0]QTK)GB$_#O*VK/NYX0T\+IX3X
MAL<$+URT+UL6!P$*1);BU_"H_K5QJ1&][#W[S&=&2O,0S03?G,(NP>^:\AM=
MPA98M3,8O5?V*)\R\GM@U, )-=L&ADS_>S\327H7J/SIJ^G"X>-7,SE6NX-8
MR2^[ S6*8G4H@UMYEX!(>/]BAI.< 54#I?RQ]6K+C$MBY?"7=_1O2WQJ-_MG
M?VSM[^W]:A'B%!E@=V,%BT< ;1V?_MD#TFF<]\^ K+I7'<TWB]+%F0*IJ #4
M DQ;QTRO1(PHKALG@&NGK?/SWE7CM'WY\8^MO2WZ?-5H-LWGW#:>=+K-5I>^
MUS#P-[NP]^>-JU[KT/RQ<L'%W5G8 #P> K%[K/]H&D .]G\%T?NBW\Q^^5._
MS4O-0#8/Y@=X_=9\#_^OZTQEEN0@GQ\F_A"0[R;RA^)A2SHN  ?'LG5\&=7Y
M#/Z.DO/=T3]<^ K+T*=ESFSQ.1RQH)+\+3>N7A_\!T_ZH0SX(0A\?'K=:U\)
MN[S]EV_>'.R)UL7;%:S_*2CGN-UK7P)_BNH@_'A6F/3=BEE?OOX.!/NF_O)@
M[U?14Z$?Q; -J1+#N1(O]]X<+%#M#Q=^Y=RD)J1HJD#>RE@)+XIG42Q3/PK%
M=C+W)NXW\&0X%'Z:"/C%4TD2Q0E])9,$&&0BY@!H+-*)$FT">1ZK:F6B8N6'
M<@3[(V(U4G&LAB*-:F( 7X\%_RP\&03X/;S+2B4HU:?1=";#.]2GM7Y9@P7'
MXD8&L*>Q\I1_ ^_,XFCJ)[#T- )Y<8?_*=5)(IQ_["< B+(PUVC*6>R'GC^3
M :QL*J*1L/0C8"-Z:I:JZ4#%&J</:G2@==$>"=JCJ82E^NF=&$HX<#\1890*
M6:V<S!,P9I)$-.4=310B@%/8&9PCF_36#P+8#AAGJ'!"!"F$D^=]5D/<)W<L
MVO0P$CXBG4I2'D!Z7CRW[\MI-(=Y$MH3.0@4;1TM5L5^-!0CV+8R\&'[\"GZ
MVT +2T+8ZC\?A]MFR5<:M"; F1R*"QE[$W,^M#_VU,3^P08 WE5 24,#;DO"
MOKLPYT'67]:$/YW"\<,[P1W@"V \X8+"MTMW8@,6VA@.?>06@-= F3=^ G\G
MB._I!-"(6")RFD2EB)'IQ"!LK&Y4G, //A*!\_BWK>DQ7/SO[]MP7E/I$S]#
M4@5-@*@MY)7!:: R* :!#+^\?]$^_L>SSOM4"'6,1E>[?XEVVB=M91*":'$@
M)C(!<3%/2%P8E *N-4!9"R>COBIOGJKA(MX\0D^F?<KK6 ]6G5]_3\UYE:K\
M^R,UY7<O?YJF#*(;M_82<1T=;>4Z#+O<#'QYV)Q)G#G.6NV/9WU8\9O\BIWO
MLZE?;BT=_3O:""=WARNL @. 1JC=DTZ_W[F -7X%F1\ !+_LT;\,B9<8#GDL
M7&N8'[L/]YM&R]9V?"FGZO"?"^2^GP;+87Y&YF=D_B<"N8C,F0^"%:7OZ(DH
MT^EZH-*@K:- 9QZ3SD"Z SH-P-Y[N__N  V^$9OK^%/RK-L]SBN#-LGP4#3F
M8S /7//YY;?Y0QXT.06K6BVTY-\<Y<-@G0\49,$HS&GF4_V.&X$QE)/&Y;_C
MS)>M3]7*YT[WW\4%*(HP=RZJ5A.7]4:]]BVA$OT5GNO#U6[0JOLQG))2->&I
M&(PY'WTJ$YFRF@W_BT)MF2G15(,4[%4/'0?XG./9676PR_;R49#[8=[GM!!F
M^I'^\9^FY+]YK)+_ZN>YPYVS$OG3$?>BRWY]CUBK:W/NFB\?A$<G=V3I/:LI
MCY+YFW&6C7DZB6)X>"A8ZD=Q=KH_+A[RK(5L@!;R3Q6DZ5N75B9P)3NV9(;3
MB8I1ZL)OA"!&*FL764T,54)81H$."MDL+CJQJZY6MI=$:?#M7$Q&XZ.-R'P?
M6?NT,65'&A>%=E&HNUAMN"WAO_A#+..W6P5!^OK7,AYIHM9 +65Q6Z:";;GC
MON/^]C@F^P"4/!(KHBYY%FH8Z$\FF,PU7 P%V@"9CC%D(3<='LN')5(.1%#D
M"^A AN%\*I))=!L*.8AN-B&ZXJZ6HGYERV3J3M34W\4U4+P"?EH1([/?PH90
M=.E.R1CL@&@Z5;!CX;A:R;U-)MR;>A:$RLWLAB,IS(@_32-X#$-8L.TFT'@[
M\6$N"SYZ]@>*HJ2@Q@";H@#2$#@1""D,X-:$/\H%/N]Y@R8O,SX=R$WP%=8Z
MP["!6<I )LB!1]6*%.\_="[[5HA-_%3M)C/IJ<,PNHTET..K-WN[0PD:!CYX
M3+M'N'6K@ANUQNOT-H,X!728)'4SE'O@R426G#@@9HR<W$%N!Y$'40Q"9'"7
M'0_%K7$X.X@)\SXH?.T7-_ G1:_+5_&@*/:SS'J,S!ILILRZ4* M#1%338!\
MPX77/>Q\6WWU@%V#:C>2\P 9E7ENQV#[E8H3#+;?3B**L3OI+F=1,(1?\;%8
MH4J95BOXBA=$">F8 T.A>M)[DQ/$]NU$X7#(=HECY*A\9TGN HY=3K+J!AB,
M/W*63!E),O04I@:Q;LJ9 I1*02\A9,@#8\&6S/+QZV8/JI4I;#\P#]!Q*<#/
MDZ&RBZB"0#;&^!9\XT5!H+S4X:UZ2."BI6=G'ZSAFJ?^?$HRBY1RRIXRH/DA
M2,10W1G5_3KT\4Q[J4R-VTVS\120B),0+!L+U!A 21E\Y(QN6M%\$/@>30;
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M]^:@5R1+ &#TE]J[=<,YRF,VF"5'=FAT4FL, 1LRHGF.,F<F#D06%IM7Q0W
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MAUD*E%:MT"D"EQ[Z3""6+I:O%<5#V6 %W%RZ""-B2L=P;*FU?2>,R*RKK84
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MYDU&8+<N-YQ+15(%K+A2(V"FSR_7P%B'BO/9'TCV</Z_WMQ_>7T5*,#Z:W"
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M+3(P,C4P.#$Q+GAS9%!+ 0(4 Q0    ( %>!#UM'',:<808  +U#   4
M          "  6P#  !C=G,M,C R-3 X,3%?;&%B+GAM;%!+ 0(4 Q0    (
M %>!#UOG!;(*MP0  'PJ   4              "  ?\)  !C=G,M,C R-3 X
M,3%?<')E+GAM;%!+ 0(4 Q0    ( %>!#UN,3[__6A(  +I\   -
M      "  >@.  !D,S(U-C)D.&LN:'1M4$L! A0#%     @ 5X$/6V8UJ2O%
M;0  !JT"  \              ( !;2$  &0S,C4V,F1E>#$Q+FAT;5!+ 0(4
M Q0    ( %>!#UO'<_H]P"D  #K>   /              "  5^/  !D,S(U
M-C)D97@T,2YH=&U02P$"% ,4    " !7@0];&[NIXMHI  !<X   #P
M        @ %,N0  9#,R-38R9&5X-#(N:'1M4$L! A0#%     @ 5X$/6_-F
ME5*Z*0  B]T   \              ( !4^,  &0S,C4V,F1E>#0S+FAT;5!+
M 0(4 Q0    ( %>!#UO/-UHKN"D   3>   /              "  3H- 0!D
M,S(U-C)D97@T-"YH=&U02P$"% ,4    " !7@0];O7A0N5D0   ),@  #P
M            @ $?-P$ 9#,R-38R9&5X-3$N:'1M4$L! A0#%     @ 5X$/
M6_C3"V!I!0  !08  !@              ( !I4<! &<S,C4V,F<P.#$T,C,S
@.3(X,#DT+FIP9U!+!08     "P + +$"  !$30$    !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>22
<FILENAME>d32562d8k_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2025"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="cvs-20250811.xsd" xlink:type="simple"/>
    <context id="duration_2025-08-11_to_2025-08-11">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
        </entity>
        <period>
            <startDate>2025-08-11</startDate>
            <endDate>2025-08-11</endDate>
        </period>
    </context>
    <dei:EntityRegistrantName
      contextRef="duration_2025-08-11_to_2025-08-11"
      id="Hidden_dei_EntityRegistrantName">CVS HEALTH Corp</dei:EntityRegistrantName>
    <dei:AmendmentFlag contextRef="duration_2025-08-11_to_2025-08-11" id="ixv-347">false</dei:AmendmentFlag>
    <dei:EntityCentralIndexKey
      contextRef="duration_2025-08-11_to_2025-08-11"
      id="Hidden_dei_EntityCentralIndexKey">0000064803</dei:EntityCentralIndexKey>
    <dei:DocumentType contextRef="duration_2025-08-11_to_2025-08-11" id="ixv-358">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="duration_2025-08-11_to_2025-08-11" id="ixv-359">2025-08-11</dei:DocumentPeriodEndDate>
    <dei:EntityIncorporationStateCountryCode contextRef="duration_2025-08-11_to_2025-08-11" id="ixv-360">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="duration_2025-08-11_to_2025-08-11" id="ixv-361">001-01011</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="duration_2025-08-11_to_2025-08-11" id="ixv-362">05-0494040</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="duration_2025-08-11_to_2025-08-11" id="ixv-363">One CVS Drive</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown contextRef="duration_2025-08-11_to_2025-08-11" id="ixv-364">Woonsocket</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="duration_2025-08-11_to_2025-08-11" id="ixv-365">RI</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="duration_2025-08-11_to_2025-08-11" id="ixv-366">02895</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="duration_2025-08-11_to_2025-08-11" id="ixv-367">(401)</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="duration_2025-08-11_to_2025-08-11" id="ixv-368">765-1500</dei:LocalPhoneNumber>
    <dei:WrittenCommunications contextRef="duration_2025-08-11_to_2025-08-11" id="ixv-369">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="duration_2025-08-11_to_2025-08-11" id="ixv-370">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="duration_2025-08-11_to_2025-08-11" id="ixv-371">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="duration_2025-08-11_to_2025-08-11" id="ixv-372">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle contextRef="duration_2025-08-11_to_2025-08-11" id="ixv-373">Common Stock, par value $0.01 per share</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="duration_2025-08-11_to_2025-08-11" id="ixv-374">CVS</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="duration_2025-08-11_to_2025-08-11" id="ixv-375">NYSE</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany contextRef="duration_2025-08-11_to_2025-08-11" id="ixv-376">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
